<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">54572</article-id><article-id pub-id-type="doi">10.7554/eLife.54572</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Building the vertebrate codex using the gene breaking protein trap library</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-172360"><name><surname>Ichino</surname><given-names>Noriko</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7009-8299</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172361"><name><surname>Serres</surname><given-names>MaKayla R</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172362"><name><surname>Urban</surname><given-names>Rhianna M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6399-5015</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172363"><name><surname>Urban</surname><given-names>Mark D</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9992-7820</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172364"><name><surname>Treichel</surname><given-names>Anthony J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4393-7034</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172673"><name><surname>Schaefbauer</surname><given-names>Kyle J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172365"><name><surname>Greif</surname><given-names>Lauren E</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-144197"><name><surname>Varshney</surname><given-names>Gaurav K</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0429-1904</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172674"><name><surname>Skuster</surname><given-names>Kimberly J</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-83049"><name><surname>McNulty</surname><given-names>Melissa S</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172675"><name><surname>Daby</surname><given-names>Camden L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172676"><name><surname>Wang</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172677"><name><surname>Liao</surname><given-names>Hsin-kai</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172678"><name><surname>El-Rass</surname><given-names>Suzan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2075-4275</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172679"><name><surname>Ding</surname><given-names>Yonghe</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172680"><name><surname>Liu</surname><given-names>Weibin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172681"><name><surname>Anderson</surname><given-names>Jennifer L</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172682"><name><surname>Wishman</surname><given-names>Mark D</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con18"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198729"><name><surname>Sabharwal</surname><given-names>Ankit</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4355-0355</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con19"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172683"><name><surname>Schimmenti</surname><given-names>Lisa A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="con20"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172684"><name><surname>Sivasubbu</surname><given-names>Sridhar</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="fund9"/><xref ref-type="fn" rid="con21"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-69607"><name><surname>Balciunas</surname><given-names>Darius</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1938-3243</contrib-id><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="con22"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-49135"><name><surname>Hammerschmidt</surname><given-names>Matthias</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-3709-8166</contrib-id><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="con23"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-147864"><name><surname>Farber</surname><given-names>Steven Arthur</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8037-7312</contrib-id><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con24"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-172686"><name><surname>Wen</surname><given-names>Xiao-Yan</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con25"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-55117"><name><surname>Xu</surname><given-names>Xiaolei</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4928-3422</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con26"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-167583"><name><surname>McGrail</surname><given-names>Maura</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9308-6189</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con27"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-166221"><name><surname>Essner</surname><given-names>Jeffrey J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-8816-3848</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="fund8"/><xref ref-type="fn" rid="con28"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94424"><name><surname>Burgess</surname><given-names>Shawn M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1147-0596</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund7"/><xref ref-type="fn" rid="con29"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-154464"><name><surname>Clark</surname><given-names>Karl J</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-9637-0967</contrib-id><email>Clark.Karl@mayo.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con30"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-110185"><name><surname>Ekker</surname><given-names>Stephen C</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0726-4212</contrib-id><email>ekker.stephen@mayo.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con31"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Biochemistry and Molecular Biology, Mayo Clinic</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Translational and Functional Genomics Branch, National Human Genome Research Institute, National Institutes of Health</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution>Functional &amp; Chemical Genomics Program, Oklahoma Medical Research Foundation</institution><addr-line><named-content content-type="city">Oklahoma City</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution>Department of Genetics, Development and Cell Biology, Iowa State University</institution><addr-line><named-content content-type="city">Ames</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution>Zebrafish Centre for Advanced Drug Discovery &amp; Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto &amp; University of Toronto</institution><addr-line><named-content content-type="city">Toronto</named-content></addr-line><country>Canada</country></aff><aff id="aff6"><label>6</label><institution>Department of Cardiovascular Medicine, Mayo Clinic</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff7"><label>7</label><institution>Department of Embryology, Carnegie Institution for Science</institution><addr-line><named-content content-type="city">Baltimore</named-content></addr-line><country>United States</country></aff><aff id="aff8"><label>8</label><institution>Department of Clinical Genomics, Mayo Clinic</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff9"><label>9</label><institution>Department of Otorhinolaryngology, Mayo Clinic</institution><addr-line><named-content content-type="city">Rochester</named-content></addr-line><country>United States</country></aff><aff id="aff10"><label>10</label><institution>Genomics and Molecular Medicine Unit, CSIR–Institute of Genomics and Integrative Biology</institution><addr-line><named-content content-type="city">Delhi</named-content></addr-line><country>India</country></aff><aff id="aff11"><label>11</label><institution>Department of Biology, Temple University</institution><addr-line><named-content content-type="city">Philadelphia</named-content></addr-line><country>United States</country></aff><aff id="aff12"><label>12</label><institution>Institute of Zoology, Developmental Biology Unit, University of Cologne</institution><addr-line><named-content content-type="city">Cologne</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Chen</surname><given-names>Wenbiao</given-names></name><role>Reviewing Editor</role><aff><institution>Vanderbilt University</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Stainier</surname><given-names>Didier YR</given-names></name><role>Senior Editor</role><aff><institution>Max Planck Institute for Heart and Lung Research</institution><country>Germany</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>11</day><month>08</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e54572</elocation-id><history><date date-type="received" iso-8601-date="2019-12-19"><day>19</day><month>12</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-08-07"><day>07</day><month>08</month><year>2020</year></date></history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-54572-v2.pdf"/><abstract><p>One key bottleneck in understanding the human genome is the relative under-characterization of 90% of protein coding regions. We report a collection of 1200 transgenic zebrafish strains made with the gene-break transposon (GBT) protein trap to simultaneously report and reversibly knockdown the tagged genes. Protein trap-associated mRFP expression shows previously undocumented expression of 35% and 90% of cloned genes at 2 and 4 days post-fertilization, respectively. Further, investigated alleles regularly show 99% gene-specific mRNA knockdown. Homozygous GBT animals in <italic>ryr1b</italic>, <italic>fras1</italic>, <italic>tnnt2a</italic>, <italic>edar</italic> and <italic>hmcn1</italic> phenocopied established mutants. 204 cloned lines trapped diverse proteins, including 64 orthologs of human disease-associated genes with 40 as potential new disease models. Severely reduced skeletal muscle Ca<sup>2+</sup> transients in GBT <italic>ryr1b</italic> homozygous animals validated the ability to explore molecular mechanisms of genetic diseases. This GBT system facilitates novel functional genome annotation towards understanding cellular and molecular underpinnings of vertebrate biology and human disease.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>The human genome counts over 20,000 genes, which can be turned on and off to create the proteins required for most of life processes. Once produced, proteins need move to specific locations in the cell, where they are able to perform their jobs. Despite striking scientific advances, 90% of human genes are still under-studied; where the proteins they code for go, and what they do remains unknown.</p><p>Zebrafish share many genes with humans, but they are much easier to manipulate genetically. Here, Ichino et al. used various methods in zebrafish to create a detailed ‘catalogue’ of previously poorly understood genes, focusing on where the proteins they coded for ended up and the biological processes they were involved with.</p><p>First, a genetic tool called gene-breaking transposons (GBTs) was used to create over 1,200 strains of genetically altered fish in which a specific protein was both tagged with a luminescent marker and unable to perform its role. Further analysis of 204 of these strains revealed new insight into the role of each protein, with many having unexpected roles and localisations. For example, in one zebrafish strain, the affected gene was similar to a human gene which, when inactivated, causes severe muscle weakness. These fish swam abnormally slowly and also had muscle problems, suggesting that the GBT fish strains could ‘model’ the human disease.</p><p>This work sheds new light on the role of many previously poorly understood genes. In the future, similar collections of GBT fish strains could help researchers to study both normal human biology and disease. They could especially be useful in cases where the genes responsible for certain conditions are still difficult to identify.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>protein trap</kwd><kwd>gene-break transposon</kwd><kwd>disease model</kwd><kwd>human genetic disorders</kwd><kwd>light sheet microscopy</kwd><kwd>gene reversion</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Zebrafish</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM63904</award-id><principal-award-recipient><name><surname>Ekker</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DA14546</award-id><principal-award-recipient><name><surname>Ekker</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK093399</award-id><principal-award-recipient><name><surname>Ekker</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>HG006431</award-id><principal-award-recipient><name><surname>Ekker</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution>The Mayo Foundation</institution></institution-wrap></funding-source><award-id>Internal</award-id><principal-award-recipient><name><surname>Ekker</surname><given-names>Stephen C</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000038</institution-id><institution>Natural Sciences and Engineering Research Council of Canada</institution></institution-wrap></funding-source><award-id>RGPIN 05389-14</award-id><principal-award-recipient><name><surname>Wen</surname><given-names>Xiao-Yan</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution>The intramural Reserch Program of the National Human Genome Research Institute, National Institutes of Health</institution></institution-wrap></funding-source><award-id>1ZIAHG000183</award-id><principal-award-recipient><name><surname>Burgess</surname><given-names>Shawn M</given-names></name></principal-award-recipient></award-group><award-group id="fund8"><funding-source><institution-wrap><institution>The Roy J. Carver Charitable Trust</institution></institution-wrap></funding-source><award-id>07-2991</award-id><principal-award-recipient><name><surname>McGrail</surname><given-names>Maura</given-names></name><name><surname>Essner</surname><given-names>Jeffrey J</given-names></name></principal-award-recipient></award-group><award-group id="fund9"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001412</institution-id><institution>Council of Scientific and Industrial Research</institution></institution-wrap></funding-source><award-id>MLP1801</award-id><principal-award-recipient><name><surname>Sivasubbu</surname><given-names>Sridhar</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The analysis of the first 1000 revertible protein trap alleles in zebrafish resulted in new functional genomic annotations and produced a panel of potential new models of human disease.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Analyses of genomic sequences from over 100 vertebrate species (<xref ref-type="bibr" rid="bib40">Meadows and Lindblad-Toh, 2017</xref>) have revealed that we need more than nucleic acid sequence alone to comprehend the vertebrate genome. A more complete understanding of any genetic locus requires knowledge of its expression pattern and its function(s) in subcellular, cellular, and organismal contexts—the compendium of information that can be described as a gene ‘codex’. Despite their importance, the expression patterns and functions of most protein coding genes remain surprisingly uncharacterized. The number of these genes linked to human disease without functional insights into their gene-disease relationships highlights the significance of this knowledge gap (<xref ref-type="bibr" rid="bib30">Kettleborough et al., 2013</xref>). In recent estimates, 80% of rare, undiagnosed diseases are thought to have genetic underpinnings (<xref ref-type="bibr" rid="bib48">Robe, 2005</xref>; <xref ref-type="bibr" rid="bib61">Varga et al., 2018</xref>; <xref ref-type="bibr" rid="bib64">Wangler et al., 2017</xref>). Tools are therefore needed to identify and annotate the expression and function(s) of these poorly characterized gene products in both biological and pathological processes.</p><p>Zebrafish (<italic>Danio rerio</italic>) has emerged as an outstanding model to bridge the gap between sequence and function in the vertebrate genome. Investigations of gene function in zebrafish, from organismal to subcellular, are amenable to both forward and reverse genetic approaches (<xref ref-type="bibr" rid="bib54">Stoeger et al., 2018</xref>). Additionally, the natural transparency of developing zebrafish enables live, non-invasive collection of gene expression data at a subcellular resolution on an organismal scale. Therefore, the zebrafish facilitates parallel discovery of gene expression and function towards a comprehensive codex of the vertebrate genome. To begin constructing this vertebrate codex, we previously developed a unique, revertible mutagenesis tool called the gene-break transposon (GBT) with elements that cooperate to report gene sequence, expression pattern, and function (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>). Specifically, when integrated in the sense orientation of a transcriptional unit, the GBT protein trap overrides endogenous splicing and creates a fusion between upstream exons and its start-codon deficient monomeric RFP (mRFP) reporter. Then, the strong internal polyadenylation site and putative border element following the mRFP truncate the gene product. Finally, the GBT construct is flanked by loxP sites on either side to enable excision and subsequent rescue with Cre-recombinase (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>).</p><p>Visualization of the start-codon deficient mRFP reporter requires an in-frame integration. In the original GBT protein trap construct, RP2.1 (<xref ref-type="fig" rid="fig1">Figure 1A</xref>), this in-frame requirement restricts mRFP expression to a single reading frame and leaves the potential to truncate genes without reporting their expression with mRFP (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>). We therefore developed a new series of GBT protein trap constructs, including versions to trap expression in each of the three potential reading frames (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Alongside the original, we employed these new vectors in zebrafish to generate and catalog over 800 additional GBT protein trap lines with visible mRFP expression at 2 days post-fertilization (dpf) (end of embryogenesis) or four dpf (larval stage). 147 of these additional GBT lines were cloned, and candidate genes were identified for another 144 GBT lines. mRFP expression in cloned GBT lines showcased novel expression patterns for a population of genes encoding diverse proteins in function and localization, including 64 implicated in human disease. Further, animals homozygous for the GBT allele in <italic>ryr1b</italic> displayed severely dampened skeletal muscle Ca<sup>2+</sup> transients, demonstrating the ability to elucidate molecular mechanisms of genetic disorders. Since detailed investigations of mutant phenotypes are vital to functional annotation of the vertebrate genome, the mutagenic reporters in our GBT system provide the basis for this functional annotation to better understand normal biology and human disease.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Schematic of the RP2 and RP8 gene-break transposon (GBT) system with all three reading frames of AUG-less mRFP reporter.</title><p>(<bold>A–C</bold>) Schematic of the GBT system, RP2 and RP8 incorporate a protein-trap cassette fused with three reading frames of AUG-less mRFP reporter and a 3’ exon trap cassette with GFP or tagBFP reporters, respectively. (<bold>A</bold>) RP2 series (RP2.1, RP2.2 and RP2.3). Underline: Previously published vector construct (<bold>B–C</bold>) RP8 series (RP8.1, RP8.2 and RP8.3) with a schematic RP8 insertion event showing expected transcription off of a locus below (<bold>C</bold>). ITR: inverted terminal repeat, SA: splice acceptor, lox: Cre recombinase recognition sequence, *mRFP: AUG-less mRFP sequence, poly (A)+: polyadenylation signal, red octagon: extra transcriptional terminator and putative border element, <italic>β-act</italic>: carp beta-actin enhancer, <italic>γ-cry</italic>: gamma crystalline promoter, SD: splice donor, E: enhancer, P: promoter, and WT: wild-type.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54572-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Representative expression patterns of mRFP fusion protein integrated all reading frames of RP2 and RP8.</title><p>Lateral and dorsal views of representative bright field images at four dpf and lateral or dorsal views of RFP expression patterns at four dpf in GBT1577 integrated RP2.2, GBT1625 and GBT1629 integrated RP2.3, GBT0409 (<italic>npr2</italic>) and GBT0726 (<italic>radx</italic>) integrated RP8.1, GBT1599 integrated RP8.2 and GBT1631 integrated RP8.3. Scale bars = 200 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54572-fig1-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>GBT vector series RP2 and RP8 illuminate all three vertebrate proteomic reading frames</title><p>We previously reported the intron-based gene-break transposon (GBT) as an effective and revertible loss-of-function tool for zebrafish (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>). The original GBT construct called RP2/RP2.1 contains the following key features (<xref ref-type="fig" rid="fig1">Figure 1A</xref>): 1) flanking miniTol2 sequences for transposase-mediated random integration (<xref ref-type="bibr" rid="bib5">Balciunas et al., 2006</xref>; <xref ref-type="bibr" rid="bib29">Kawakami et al., 2004</xref>; <xref ref-type="bibr" rid="bib60">Urasaki et al., 2006</xref>), 2) a 5’ protein trap containing a strong splice-acceptor (SA) and a start codon-free mRFP reporter to detect 5’ sequence and visualize in vivo expression of the trapped locus with the endogenous promoter (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; <xref ref-type="bibr" rid="bib14">Ding et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Ding et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Liao et al., 2012</xref>; <xref ref-type="bibr" rid="bib45">Petzold et al., 2009</xref>; <xref ref-type="bibr" rid="bib65">Westcot et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Xu et al., 2012</xref>), 3) a mutagenic transcriptional terminator containing both a polyadenylation signal (pA) and a putative border element to truncate the trapped locus in conjunction with the protein trap (<xref ref-type="bibr" rid="bib51">Sivasubbu et al., 2006</xref>), 4) a 3’ exon trap with a β-actin promoter driving expression of GFP to report 3’ sequence and detect lines with weak (or absent) mRFP expression or with the integration in other frames of the mRFP reporter. (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; <xref ref-type="bibr" rid="bib45">Petzold et al., 2009</xref>; <xref ref-type="bibr" rid="bib51">Sivasubbu et al., 2006</xref>), 5) a second mini-intron within the GFP expression cassette that can further contribute to loss of wild-type transcripts, and 6) flanking loxP sites for Cre-mediated excision and restoration of trapped locus function using both germline (<xref ref-type="bibr" rid="bib45">Petzold et al., 2009</xref>) and somatic approaches (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; <xref ref-type="bibr" rid="bib14">Ding et al., 2013</xref>; <xref ref-type="bibr" rid="bib65">Westcot et al., 2015</xref>).</p><p>Initial experiments with the RP2.1 construct, however, revealed some limitations. First, effective transcript trapping does not always generate mRFP reporter expression because the RP2.1 plasmid is designed for a single reading frame. Molecular cloning of GFP<sup>+</sup>/mRFP<sup>-</sup> lines demonstrated the requirement to capture an appropriate reading frame to visualize the mRFP reporter. Even though RP2.1 is designed to use one main reading frame, some lines with mRFP expression used an alternate ‘CAG’ five nucleotides downstream of the main splice acceptor which offered a second chance at creating a functional mRFP reporter (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>). Therefore, to maximize genome coverage of our mutagenesis vectors in this study, we created a series of RP2 constructs to encode functional mRFP in each of the three reading frames (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Second, the 3’ exon trap in the RP2 series uses the nearly ubiquitous β-actin promoter to drive expression of GFP (detectable around the seven- to eight-somite-stage similar to ubiquitous GFP expression driven under the <italic>EF1α</italic> enhancer/promoter [<xref ref-type="bibr" rid="bib13">Davidson et al., 2003</xref>]) which could interfere with another GFP-based reporter system in future studies (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>). To overcome this limitation, we engineered a novel, next-generation GBT series called RP8. RP8 constructs possess a new 3’ exon trap cassette that uses the γ-crystalline promoter to drive expression of lens-specific tagBFP instead of the ubiquitous expression GFP with RP2 series vectors. (<xref ref-type="fig" rid="fig1">Figure 1B–C</xref>). Additionally, all RP8 series for three reading frames reporting mRFP constructs are built on a smaller vector backbone and include new restriction enzyme sites that render these vectors modular for subsequent genetic engineering. Using all five of these new GBT constructs in zebrafish, we conducted an initial screen for expression of protein trap mRFP and observed that all RP2 and RP8 series constructs readily produced mRFP fusion proteins expressed from their endogenous promoters (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p></sec><sec id="s2-2"><title>Creation of a GBT-line collection enables illumination of the vertebrate genome</title><p>We then deployed all of these GBT vectors to generate over 800 additional zebrafish GBT lines. A key feature of the protein trap in these lines is the ability to non-invasively image the spatial and temporal expression patterns of the trapped loci. Our initial mRFP<sup>+</sup> lines demonstrated that, using standard methods, this imaging was going to be a major bottleneck (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Consequently, we utilized both SCORE imaging—a capillary tube placed in a refractive index-matched medium for efficient sample rotation—on an ApoTome (<xref ref-type="bibr" rid="bib46">Petzold et al., 2010</xref>, and see Materials and methods) or a Zeiss Lightsheet Z.1 SPIM microscope (see Materials and methods) to enable high throughput fluorescence imaging. To date, we have now cataloged over 1,200 GBT lines with robust mRFP expression in heterozygous F2 animals at two dpf and/or four dpf according to our screening pipeline and made all imaging data freely accessible on zfishbook (<ext-link ext-link-type="uri" xlink:href="http://www.zfishbook.org">www.zfishbook.org</ext-link>) (<xref ref-type="bibr" rid="bib12">Clark et al., 2012</xref>; <xref ref-type="fig" rid="fig2">Figure 2A</xref>). We have cryopreserved these 1,200 GBT lines and have retained them at the Mayo Clinic Zebrafish Facility (MCZF) with a copy also sent to the Zebrafish International Resource Center (ZIRC) (<xref ref-type="fig" rid="fig2">Figure 2A</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>GBT screening pipeline.</title><p>(<bold>A</bold>) Overview of GBT screening pipeline. Wild-type embryos at 1 cell were co-injected with RP plasmid and Tol2 transposase mRNA to create F0 founders. These F0 larvae were screened for non-mosaic RP expression, raised, and outcrossed for two generations. Then, mRFP<sup>+</sup> F2 heterozygous larvae were 3-dimensionally imaged at 2 and 4 dpf and this imaging data were uploaded to zfishbook (<ext-link ext-link-type="uri" xlink:href="http://www.zfishbook.org/">http://www.zfishbook.org/</ext-link>). Sperm from four F2 males in over 1200 robust mRFP expressing lines were cryopreserved using the Zebrafish International Resource Center (ZIRC) standard protocol and stored at both ZIRC and Mayo Clinic Zebrafish Core Facility (MCZF). DNA and RNA isolated from these four F2 males with cryopreserved sperm was utilized to perform next-generation sequencing and to confirm RFP linkage of candidate lines by manual PCRs (iPCR, TAIL-PCR, 5’ RACE and 3’ RACE). Venn diagram illustrates current library of over 1,200 GBT lines with 204 GBT-confirmed lines out of 348 molecularly analyzed GBT-candidate lines. (<bold>B</bold>) Next generation sequencing based validation for GBT integration loci. Fin biopsies from four F2 males were utilized as DNA source for the validation process to identify GBT integration loci. Extracted genomic DNA was fragmented, pooled in 96-wells plate, and ligated with barcode linker to identify each single male with cryopreserved sperm. Linker-mediated (LM) PCR with the primers, R-ITR P1 and LP1 and nested PCR with the primers, R-ITR P2 and LP2 were conducted to perform Illumina sequencing the final PCR products. The integration events of individual sperm-cryopreserved male were mapped on zebrafish reference genome sequence with bioinformatics analysis. This figure was created with <ext-link ext-link-type="uri" xlink:href="http://BioRender.com">BioRender.com</ext-link>. The area proportional Venn diagram was produced using BioVenn (<ext-link ext-link-type="uri" xlink:href="http://www.biovenn.nl/">http://www.biovenn.nl/</ext-link>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54572-fig2-v2.tif"/></fig></sec><sec id="s2-3"><title>Molecular cloning of a subset of GBT lines highlights the genetic diversity of this protein trap collection</title><p>Traditional molecular methods, such as inverse PCR (iPCR) and thermal asymmetric interlaced (TAIL) PCR and 5’ and 3’ rapid amplification of cDNA ends (RACE), are labor-intensive and represent a functional bottleneck in identifying randomly integrated loci in GBT lines. To overcome this, we employed a rapid cloning process based on methods used to isolate retroviral integrations that leverage the massive parallel sequencing technology of the Illumina MiSeq and a custom bioinformatics pipeline that involves both mapping and annotation (<xref ref-type="fig" rid="fig2">Figure 2B</xref>; <xref ref-type="bibr" rid="bib62">Varshney et al., 2013a</xref>; <xref ref-type="bibr" rid="bib63">Varshney et al., 2013b</xref>). First, fin-clips from four male animals per GBT line were obtained during sperm cryopreservation and used as a source of DNA for cloning the integrated locus. Next, high-throughput sequencing amplified reads with barcodes linked to the source of DNA from the sperm-cryopreserved males. Mapping reads to the genome indicated potential GBT integration loci in each individual. A shared integration locus in multiple individuals from a single GBT line was considered a candidate integrated locus, and we termed a GBT line with at least one candidate integrated locus a ‘GBT-candidate line’. After a candidate was determined using the sequencing pipeline or other manual molecular approaches, such as 5’ RACE, 3’ RACE, iPCR, or TAIL PCR, we used standard PCR to test if the candidate integration locus segregates with mRFP expression.</p><p>At the end of this pipeline, 204 GBT-candidate lines met the highest stringency of confirmed expression linkage and were classified as ‘GBT-confirmed lines’ (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). While 57 of these GBT-confirmed lines have been previously published (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; <xref ref-type="bibr" rid="bib14">Ding et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Ding et al., 2017</xref>; <xref ref-type="bibr" rid="bib19">El-Rass et al., 2017</xref>; <xref ref-type="bibr" rid="bib38">Ma et al., 2020</xref>; <xref ref-type="bibr" rid="bib65">Westcot et al., 2015</xref>), 147 of these GBT-confirmed lines are newly characterized in this manuscript and were selected for confirmation based upon their expression pattern and/or homozygous phenotype (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). A small subset of these GBT-confirmed lines mapped to areas in the genome without annotated transcripts. Publicly available RNA-sequencing data (<xref ref-type="bibr" rid="bib66">White et al., 2017</xref>) revealed reads flanking a majority of these mapped integrations. Some of these reads contained evidence of splicing in the sense orientation of the mRFP reporter (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Finally, another 144 GBT-candidate lines from this pipeline have yet to be confirmed (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Integration locus annotation of both GBT-candidate and GBT-confirmed lines is available on zfishbook (<ext-link ext-link-type="uri" xlink:href="http://www.zfishbook.org">www.zfishbook.org</ext-link>) (<xref ref-type="bibr" rid="bib12">Clark et al., 2012</xref>).</p></sec><sec id="s2-4"><title>RP2.1 induces high knockdown efficiency of endogenous transcripts in GBT-confirmed lines</title><p>We wanted to determine the knockdown efficacy of the GBT system as a quantitative assessment of mutagenicity. We therefore compiled qRT-PCR data to compare wild-type and truncated, mRFP-fused transcript levels for all 26 RP2.1-derived GBT-confirmed lines that we and others have tested (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; <xref ref-type="bibr" rid="bib14">Ding et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Ding et al., 2017</xref>, GBT0235—this manuscript). This compilation determined at minimum 97% knockdown in animals homozygous for the RP2.1 alleles. We next directly compared the transcriptional effects of RP2.1 with those of other published transposon-based protein trap systems (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The FlipTrap system produced a range of 70–96% knockdown in six tested fish alleles (<xref ref-type="bibr" rid="bib56">Trinh et al., 2011</xref>), similar to our initial R-series protein trap vectors (R14-R15) that contained a single splice acceptor and a simple transcriptional terminator (<xref ref-type="bibr" rid="bib35">Liao et al., 2012</xref>; <xref ref-type="bibr" rid="bib45">Petzold et al., 2009</xref>). The pFT1, which contains a single splice acceptor, but a tandem array of five simple polyadenylation sites, appears to be an improvement over these systems with 89–94% knockdown from four tested fish alleles (<xref ref-type="bibr" rid="bib42">Ni et al., 2012</xref>). The 97% minimum knockdown observed with RP2.1 is quantitatively higher than these other systems and could be deployed with other insertional genome engineering approaches. We expect the RP8 series vectors to have similar transcriptional knockdown to RP2.1, but to date we have not quantified the effect to measure their mutagenicity.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Knockdown efficiency of RP2.1 compared with previous gene-trap systems.</title><p>Violin plots comparing percent knockdown efficiency in the analyzed individual lines generated by four protein trap systems. All plots show median. The data of previous protein trap systems were converted from the data in the original articles, R14-R15, our initial R-series protein trap vectors (n = 6), (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; FlipTrap, FlipTrap vectors (n = 6), <xref ref-type="bibr" rid="bib56">Trinh et al., 2011</xref>; FT1, FT1 vector (n = 4), <xref ref-type="bibr" rid="bib42">Ni et al., 2012</xref>; RP2.1, RP2.1 vector (n = 26), <xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; <xref ref-type="bibr" rid="bib14">Ding et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Ding et al., 2017</xref>; <xref ref-type="bibr" rid="bib19">El-Rass et al., 2017</xref>; <xref ref-type="bibr" rid="bib65">Westcot et al., 2015</xref> and unpublished data) (<xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). The graph was made in JMP14 (SAS, Cary, NC).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numeric data analyzing knockdown efficiency in <italic>lrpprc<sup>mn0235Gt</sup></italic><sup>/<italic>mn0235Gt</italic></sup>.</title><p>Source data analyzing relative expression of <italic>lrpprc</italic> mRNA in six dpf-larvae with RFP expression and dark liver phenotype crossed with heterozyous <italic>lrpprc</italic><sup>+/<italic>mn0235Gt</italic></sup> adults. no RT: no reverse transcriptase, RT: with reverse transcriptase, DL: dark liver phenotype, Cq: quantification cycle, d: delta, KD: knockdown, N/A: not applicable.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54572-fig3-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54572-fig3-v2.tif"/></fig></sec><sec id="s2-5"><title>Phenotype appearance rate in GBT lines is comparable to other mutagenic technologies for forward genetic screening</title><p>In parallel to knockdown efficacy, we wanted to know the GBT construct effectiveness at mutagenizing its integrated locus. To assess this mutagenic efficiency, we conducted an initial phenotypic screen on F2 embryos and early larvae. In 179 mRFP<sup>+</sup> GBT lines, we identified 12 recessive phenotypes visible during the first five days of development that, among others, included lethal, cardiac, muscular, and integumentary defects as reported in previous studies (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>).</p><p>Molecular analyses revealed that a subset of these phenotypes stem from GBT integrations in genes with established loss of function mutant phenotypes including <italic>ryr1b, tnnt2a, fras1, hmcn1,</italic> and <italic>edar</italic> (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; <xref ref-type="bibr" rid="bib65">Westcot et al., 2015</xref>; Hatzold J et al., unpublished). In accord with their mRNA knockdown potency, these five GBT-confirmed lines (<italic>ryr1b, tnnt2a, fras1, hmcn1,</italic> and <italic>edar</italic>) phenocopied their respective homozygous mutants generated with other strategies and thereby validated the mutagenicity of the GBT constructs. To date, 17 of our GBT-confirmed lines have been published with homozygous phenotypes ranging from embryonic lethal, to reduced adult viability, to differences in pharmacological susceptibility (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). Additional GBT-confirmed lines with homozygous phenotypes will continue to be identified and characterized in future studies.</p></sec><sec id="s2-6"><title><italic>ryr1b</italic> confirmed line is a pioneer model of human disease that validates GBT ability to functionally annotate a genetic locus</title><p>We next sought to validate the ability of GBT constructs to functionally annotate genes. During the initial GBT library creation, we identified a GBT line with skeletal muscle-specific mRFP expression and a slow swimming phenotype (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>). We confirmed that this line possesses an RP2.1 integration between exon 81 and exon 82 of <italic>ryr1b</italic> and designated it <italic>ryr1b<sup>mn0348Gt</sup></italic>. Animals homozygous for this <italic>ryr1b<sup>mn0348Gt</sup></italic> allele show 97% knockdown of wild-type <italic>ryr1b</italic> mRNA levels (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>). Due to the well-characterized nature of <italic>ryr1b</italic> from the <italic>relatively relaxed</italic> mutant (<xref ref-type="bibr" rid="bib22">Hirata et al., 2007</xref>), this line was ideal for a proof of concept experiment in this study to validate functional genome annotation with GBT constructs. <italic>ryr1b</italic> orthologs are known across species to encode calcium-activated calcium channels that release sarcoplasmic reticulum Ca<sup>2+</sup> stores to facilitate excitation-contraction coupling in skeletal muscles (<xref ref-type="bibr" rid="bib21">Hernández-Ochoa et al., 2015</xref>; <xref ref-type="bibr" rid="bib22">Hirata et al., 2007</xref>). Therefore, we set out to test whether loss of ryr1b in <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals dampens skeletal muscle Ca<sup>2+</sup> transients and may explain their previously reported slow swimming phenotype (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>).</p><p>To address this, we injected the skeletal muscle-targeted construct <italic>p-mylpfa:GCaMP3</italic> (<xref ref-type="bibr" rid="bib8">Baxendale et al., 2012</xref>) into both <italic>ryr1b<sup>+/+</sup></italic> and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals, treated these animals at 2 dpf with 20 mM pentylenetetrazole (PTZ) to maximize the probability of recording muscle activity, and assayed individual skeletal muscle Ca<sup>2+</sup> transients associated with PTZ-induced convulsions (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). <italic>p-mylpfa:GCaMP3</italic> injection at the single-cell stage resulted in mosaic-labeled, GCaMP3<sup>+</sup> myocytes in both <italic>ryr1b<sup>+/+</sup></italic> and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals (<xref ref-type="fig" rid="fig4">Figure 4B,F</xref>). Likewise, PTZ-treated <italic>ryr1b<sup>+/+</sup></italic> and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals showed spontaneous, convulsion-associated Ca<sup>2+</sup> transients in their myocytes at two dpf (<xref ref-type="fig" rid="fig4">Figures 4C–E,G–I</xref>). However, PTZ-induced Ca<sup>2+</sup> transients in myocytes of <italic>ryr1b<sup>+/+</sup></italic> animals had higher peak amplitude when averaged within fish (<xref ref-type="fig" rid="fig4">Figure 4J–K</xref>) or within myocytes (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>) and shorter rise time (<xref ref-type="fig" rid="fig4">Figure 4J,M</xref>) than those in <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals. PTZ-induced Ca<sup>2+</sup> transient peak-width (<xref ref-type="fig" rid="fig4">Figure 4J,L</xref>) and decay time (<xref ref-type="fig" rid="fig4">Figure 4J,N</xref>) were not significantly different between <italic>ryr1b<sup>+/+</sup></italic> and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals. In contrast, myocytes in <italic>ryr1b<sup>+/+</sup></italic> animals had more Ca<sup>2+</sup> transients during the imaging period than myocytes in <italic>ryr1b<sup>RP2.1/RP2.1</sup></italic> animals (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). We were thus able to use a GBT-confirmed line to demonstrate that a smaller peak amplitude (consistent with <italic>relatively relaxed</italic> [<xref ref-type="bibr" rid="bib22">Hirata et al., 2007</xref>]), slower upstroke, and lower frequency of Ca<sup>2+</sup> transients in skeletal muscle likely provide the basis for the slow swimming phenotype in <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals. The consistency of our findings in <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> with those in <italic>relatively relaxed</italic> mutants (<xref ref-type="bibr" rid="bib22">Hirata et al., 2007</xref>) validates the functional genome annotation available with the GBT mutagenic system.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>GBT demonstrates that neural disinhibition mediated Ca<sup>2+</sup> transients in <italic>mylpfa<sup>+</sup></italic> myocytes require the ryanodine receptor <italic>ryr1b</italic> in vivo.</title><p>(<bold>A</bold>) Cartoon showing approach to assay Ca<sup>2+</sup> transients in zebrafish myocytes through (1) injection of <italic>p-mylpfa:GCaMP3</italic> (<xref ref-type="bibr" rid="bib8">Baxendale et al., 2012</xref>) at the single cell stage, (2) embedding in 1% low melt agar/20 mM pentylenetetrazole (PTZ)/5 µM (<bold>S</bold>)-(-)-blebbistatin, (3) imaging for 3 min to record transient-associated changes in myocyte GCaMP3 fluorescence at 2 days post-fertilization, and (4) Ca<sup>2+</sup> transient analysis. (B–I) Static images of GCaMP3 expressing myocytes (<bold>B, F</bold>) and representative GCaMP3 time-series images showing baseline (<bold>C, G</bold>), transient peak (<bold>D, H</bold>), and recovery (<bold>E, I</bold>) in <italic>ryr1b<sup>+/+</sup></italic> (C–E) and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> (G–I) animals, respectively. Scale bar = 20 µm. (<bold>J</bold>) Representative ∆F/F<sub>0</sub> traces of Ca<sup>2+</sup> transients from <italic>ryr1b</italic><sup>+/+</sup> (black) and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> (gray) myocytes. (K–N) Violin plots comparing transient peak ∆F/F<sub>0</sub> (averaged within fish) (<bold>K</bold>), Ca<sup>2+</sup> transient peak-width (<bold>L</bold>), Ca<sup>2+</sup> transient rise (<bold>M</bold>) and decay (<bold>N</bold>) time between <italic>ryr1b</italic><sup>+/+</sup> and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals. All plots show median with interquartile range. For (<bold>K</bold>) n<italic><sub>ryr1b+/+</sub></italic> = 19 animals, n<italic><sub>ryr1bmn0348Gt</sub></italic><sub>/<italic>mn0348Gt</italic></sub> = 16 animals. For (<bold>L–M</bold>) n<italic><sub>ryr1b+/+</sub></italic> = 32 cells, n<italic><sub>ryr1bmn0348Gt</sub></italic><sub>/<italic>mn0348Gt</italic></sub> = 16 cells. For (<bold>N</bold>) n<italic><sub>ryr1b+/+</sub></italic> = 32 cells, n<italic><sub>ryr1bmn0348Gt</sub></italic><sub>/<italic>mn0348Gt</italic></sub> = 15 cells. Data are compiled from four independent experiments containing at least two animals in each group. p-values determined using the Mann-Whitney U test. Effect size (Cohen’s d)=1.829 (<bold>K</bold>) and 0.866 (<bold>M</bold>). Source data can be found in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref> (<bold>K, L, M, N</bold>) and <xref ref-type="supplementary-material" rid="fig4sdata2">Figure 4—source data 2</xref> (<bold>J</bold>).</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Summary data analyzing the parameters of Ca<sup>2+</sup> transients in individual tested animals.</title><p>wt = <italic>ryr1b<sup>+/+</sup></italic>, gbt348hom = <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup>, peak = peak ∆F/F<sub>0</sub>, num = number of transients/responses, totcell = number of cells, width = peak width at half max, rise = 10–90% rise time, and decay = 90–50% decay time.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54572-fig4-data1-v2.xlsx"/></supplementary-material></p><p><supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Individual ∆F/F<sub>0</sub> traces of GCaMP3-fluorescence in both <italic>ryr1b<sup>+/+</sup></italic> and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> myocytes.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54572-fig4-data2-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54572-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Ca<sup>2+</sup> transients in <italic>ryr1b<sup>+/+</sup></italic> myocytes have higher peak amplitude and are more frequent than in <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> myocytes.</title><p>(<bold>A</bold>) Dot plot comparing peak ∆F/F<sub>0</sub> responses (averaged within cell) between <italic>ryr1b<sup>+/+</sup></italic> and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals. (<bold>B</bold>) Dot plot representing the number of responses per cell (≥0.05 ∆F/F<sub>0</sub>) recorded during the 3 min imaging window in <italic>ryr1b<sup>+/+</sup></italic> and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals. Plots show median with interquartile range. n<italic><sub>ryr1b+/+</sub></italic> = 64 cells, n<italic><sub>ryr1bmn0348Gt</sub></italic><sub>/<italic>mn0348Gt</italic></sub> = 48 cells. Data were compiled from four independent experiments containing at least two animals in each group. p-values determined using the Mann-Whitney U test. Effect size (Cohen’s d)=1.445 (<bold>A</bold>) and 0.931 (<bold>B</bold>). Source data can be found in <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Summary data analyzing the parameters of Ca<sup>2+</sup> transients in individual tested cells.</title><p>wt = <italic>ryr1b<sup>+/+</sup></italic>, gbt348hom = <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup>, peak = peak ∆F/F<sub>0</sub>, and peaknum = number of transients/responses ≥ 0.05 ∆F/F<sub>0</sub>.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54572-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54572-fig4-figsupp1-v2.tif"/></fig></fig-group></sec><sec id="s2-7"><title>GBT protein trapping generates a variety of potential models of human disease</title><p>This functional genome annotation available with the GBT system in zebrafish is powerful for understanding the genetic causes of human disease. For instance, mutations in <italic>RYR1</italic>, the human ortholog of <italic>ryr1b,</italic> are well-associated with a rare genetic neuromuscular disorder called central core disease. Central core disease commonly presents with mild to severe muscle weakness (<xref ref-type="bibr" rid="bib28">Jungbluth et al., 2018</xref>) which is analogous to the slow swimming phenotype we saw in our <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>) and likely arises from similar disruptions to skeletal muscle Ca<sup>2+</sup> transients (<xref ref-type="fig" rid="fig4">Figure 4</xref>). A subset of this GBT collection consequently represents a potential library of human disease models. Intriguingly, 82% of OMIM listed human disease-associated genes (2601 genes) can be related to at least one zebrafish ortholog (<xref ref-type="bibr" rid="bib25">Howe et al., 2013</xref>).</p><p>We therefore took a new angle and investigated whether any GBT-confirmed lines represent potential human disease models. Within the set of GBT-confirmed lines that match a human ortholog (n = 177), 64 (36%) are integrated in genes associated with human diseases, including those of the nervous, circulatory, endocrine, metabolic, digestive, musculoskeletal, immune, and integumentary systems (select genes listed in <xref ref-type="fig" rid="fig5">Figure 5A</xref>, all 64 genes with disease-associated human orthologs listed in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). 40 of these human disease-associated GBT-confirmed lines represent potential novel genetic disease models as we failed to find a description for any established disease models in mice or zebrafish for orthologs of these genes (<xref ref-type="fig" rid="fig5">Figure 5B</xref> and <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Disease-associated human orthologs of the GBT trapped genes are implicated in human genetic disorders of multiple organ systems.</title><p>(<bold>A</bold>) Representative human orthologs of the GBT-tagged genes are associated with genetic disorders in multi-organ systems. Image provided by Mayo Clinic Media Services. Underline: Disease causative genes with documentations of established disease model in mouse or zebrafish (<bold>B</bold>) Area proportional Venn diagram of 64 human orthologs tagged that are associated with human genetic disorders. 40 human orthologs of GBT-tagged genes are associated with human genetic disorders without an established disease model in zebrafish or mouse. Area proportional Venn diagram was produced using BioVenn (<ext-link ext-link-type="uri" xlink:href="http://www.biovenn.nl/">http://www.biovenn.nl/</ext-link>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54572-fig5-v2.tif"/></fig></sec><sec id="s2-8"><title>GBT protein trapping creates loss of function products for a diverse population of proteins</title><p>Functional genome annotation with GBT constructs is equally powerful in detecting roles for genes in basic cellular processes. We and others have previously used imaging to investigate effective protein trapping in GBT-confirmed lines. This imaging has revealed diverse cellular and subcellular protein expression patterns (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; <xref ref-type="bibr" rid="bib14">Ding et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Ding et al., 2017</xref>; <xref ref-type="bibr" rid="bib19">El-Rass et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Liao et al., 2012</xref>; <xref ref-type="bibr" rid="bib45">Petzold et al., 2009</xref>; <xref ref-type="bibr" rid="bib65">Westcot et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Xu et al., 2012</xref>). In this study, we imaged GBT lines using a Lightsheet microscope for the first time. Multi-area tiling with a 20 × objective enabled rapid acquisition of 3-dimensional mRFP fusion protein localization across the entire organism (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). Confocal imaging in areas of interest revealed even more detail with subcellular resolution (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). Further confocal imaging demonstrated diverse subcellular localizations in GBT-confirmed lines, (<xref ref-type="fig" rid="fig6">Figure 6B–C</xref>) GBT-candidate lines, and GBT lines (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). This subcellular protein localization data from GBT lines can provide crucial information in piecing together gene function.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>GBT-confirmed lines illuminate and disrupt genes encoding proteins with diverse functions and subcellular localizations.</title><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>PANTHER protein classes of human orthologs tagged in GBT-confirmed lines.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54572-fig6-data1-v2.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54572-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>GBT protein traps illuminate diverse subcellular protein localizations.</title><p>(<bold>A–B</bold>) Confocal images demonstrating patterns of subcellular localization seen in muscle with strong banding in GBT0374 (candidate gene = unannotated transcript) (<bold>A</bold>) and large, diffuse puncta in GBT0708 (candidate gene = <italic>adam15</italic>) (<bold>B</bold>). Scale bars = 10 µm. (<bold>C</bold>) Confocal image of GBT0908 with ubiquitous, cytoplasmic expression. Note apical enrichment in enterocytes. (<bold>D</bold>) Confocal image of GBT0743 (candidate gene = <italic>pole4</italic>) with variegated expression in the liver. (<bold>E–F</bold>) Confocal images of gut expression with cytoplasmic, pan-enterocyte labeling in GBT0361 (<bold>E</bold>) in contrast with endomembrane puncta and enrichment of mRFP signal in a subset of enterocytes in GBT0775 (candidate gene = <italic>cd83</italic>) (<bold>F</bold>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54572-fig6-figsupp1-v2.tif"/></fig></fig-group><p>We therefore wanted to assess the subcellular diversity of all gene products trapped in our current collection of GBT-confirmed lines. As an approach to complement our imaging assessments, we focused on computational approaches to explore subcellular protein diversity in current GBT-confirmed lines. 177 of the GBT-trapped genes were annotated to their human orthologs in at least one public database (ZFIN, Ensembl, Homologene, and InParanoid version 8) (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Several of these genes were provisionally annotated using BLASTP or a synteny analysis tool, SynFind in Comparative Genomics (CoGe) database (<ext-link ext-link-type="uri" xlink:href="https://genomevolution.org/CoGe/SynFind.pl">https://genomevolution.org/CoGe/SynFind.pl</ext-link>) (<xref ref-type="bibr" rid="bib37">Lyons and Freeling, 2008</xref>). We assessed the functional diversityhuman orthologs of human orthologs of these 177 GBT-confirmed loci with data from the PANTHER version 14.1 database on protein class ontology (<ext-link ext-link-type="uri" xlink:href="http://www.pantherdb.org/">http://www.pantherdb.org/</ext-link>) (<xref ref-type="bibr" rid="bib41">Mi et al., 2019</xref>), the Human Protein Atlas on genome-wide experimental proteomics (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org">www.proteinatlas.org</ext-link>. August 27, 2019) (<xref ref-type="bibr" rid="bib58">Uhlén et al., 2015</xref>), and the UniProtKB on knowledge-based proteomics (UniProtKB, <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/">https://www.uniprot.org/</ext-link>, <xref ref-type="bibr" rid="bib59">UniProt Consortium, 2018</xref>). PANTHER protein classification revealed that 105 human orthologs (60%, n = 176: see Materials and methods) are classified to at least one of 21 protein classes, and 19 human orthologs (11%) belong to transcription factors (<xref ref-type="fig" rid="fig6">Figure 6D</xref> and <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). Human Protein Atlas and UniProtKB subcellular localization data likewise showed diverse classifications of expression with a large group of nuclear localized human orthologs of these 177 GBT-confirmed loci (<xref ref-type="fig" rid="fig6">Figure 6E</xref> and <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p><p>We then asked whether this if our computational analysis corresponded to the patterns seen in our imaging data. We found that <italic>LRPPRC</italic> (human ortholog of <italic>lrpprc</italic> (GBT0235)—<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>) was not annotated to a protein class in PANTHER but mapped to mitochondria in Human Protein Atlas, consistent with its puncta expression pattern (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). <italic>RYR1</italic> (human ortholog of <italic>ryr1b</italic> (GBT0348)—<xref ref-type="fig" rid="fig6">Figure 6C</xref>) was annotated as a transporter in PANTHER and was mapped to the cytosol, Golgi apparatus, and vesicles in Human Protein Atlas, consistent with its more uniform expression pattern (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). Overall, protein class ontology and known subcellular localizations of cloned GBT genes suggest that the GBT system traps and enables functional annotation for a rich diversity of proteins. Additionally, the GBT-confirmed lines in orthologs of human genes without a known subcellular localization potentiate the discovery of their subcellular expression pattern in the context of a living animal.</p></sec><sec id="s2-9"><title>mRFP expression profiling in GBT-confirmed lines reveals substantial new expression data at both 2 dpf and 4 dpf</title><p>We next asked if the mRFP expression patterns in our GBT-confirmed lines unveiled novel cellular expression data. To address this, we focused on the GBT-confirmed lines that were non-redundant and mapped to a known protein coding gene. Importantly, these GBT-confirmed lines exhibited expression patterns that are tissue specific and include assorted brain regions, heart, skin, muscle, vasculature, and blood (<xref ref-type="fig" rid="fig7">Figure 7A–R</xref>). We analyzed publicly available expression data of these 193 tagged genes in wild-type fish (downloaded from ZFIN on August 28<sup>th</sup>, 2019). Our GBT-confirmed lines revealed expression patterns (available on <ext-link ext-link-type="uri" xlink:href="http://www.zfishbook.org">www.zfishbook.org</ext-link>) for 67 genes at 2 dpf and 174 genes at four dpf without publicly available expression data in ZFIN (<xref ref-type="fig" rid="fig7">Figure 7S–T</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>GBT protein trap elucidates novel gene expression patterns in embryonic and larval zebrafish.</title><p>(<bold>A–C</bold>) Dorsal views of 2 days post-fertilization (dpf) embryos with GBT protein trap mRFP expression patterns ranging from <italic>bcl11ba</italic> in the forebrain and hindbrain (<bold>A</bold>), to <italic>col7a1</italic> in the skin (<bold>B</bold>), and <italic>plpp2a</italic> in the otoliths (<bold>C</bold>). (<sc><bold>D-F</bold></sc>) Lateral views of 2 dpf embryos with GBT protein trap mRFP expression patterns ranging from <italic>cyth3a</italic> in blood cells (<bold>D</bold>), to <italic>dph1</italic> in somites (<bold>E</bold>), and <italic>ino80c</italic> around the yolk (<bold>F</bold>). (<bold>G–L</bold>) Dorsal views of GBT protein trap mRFP expression patterns in 4 dpf larvae including <italic>nusap1</italic> in the forebrain and midbrain (<bold>G</bold>), <italic>gpm6ba</italic> in the brain, spinal cord, and pineal gland (<bold>H</bold>), <italic>unkl</italic> in the olfactory pits (<bold>I</bold>), <italic>foxl2a</italic> in the forebrain and midbrain (<bold>J</bold>), <italic>zgc:194659</italic> in the brain and spinal cord (<bold>K</bold>), and <italic>marcksl1a</italic> in the lens, skin, and notochord (<bold>L</bold>). (<bold>M–R</bold>) Lateral views of GBT protein trap mRFP expression patterns in 4 dpf larvae including <italic>nfatc3a</italic> in heart and muscle (<bold>M</bold>), <italic>dele1</italic> in muscle (<bold>N</bold>), <italic>pard3bb</italic> in the gut and pronephros (<bold>O</bold>), <italic>LOC100537272</italic> in vessels (<bold>P</bold>), <italic>mgat5</italic> in neuromasts (<bold>Q</bold>), and <italic>ahnak</italic> in skin (<bold>R</bold>). Scale bars = 200 µm. (<bold>S–T</bold>) Area proportional Venn diagrams of 193 genes trapped in GBT-confirmed lines comparing the ZFIN-assembled database with mRFP expression in GBT lines available through zfishbook at two dpf (<bold>S</bold>) and four dpf (<bold>T</bold>). 67 (35%) and 174 (90%) of 193 genes trapped in GBT-confirmed lines have no description about wild-type expression at 2 dpf and 4 dpf, respectively.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-54572-fig7-v2.tif"/></fig></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><sec id="s3-1"><title>Gene-break transposon system as a next generation mutagenesis system</title><p>GBT technology represents the first method for revertible allele generation in vertebrates outside of the mouse model (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>). In this manuscript we broadened GBT genomic coverage through the development of an RP2 construct series to encode functional mRFP in each of the potential reading frames (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). While each individual construct still only integrates in-frame in a subset of introns, the RP2 series potentiates in-frame mRFP for any intron with Tol2-mediated integration. We also desired to increase GBT utility for subsequent genomic engineering applications. As RP2 series constructs were not modularly designed, we iteratively developed a next generation RP8 GBT series. All RP8 constructs include new restriction enzyme sites that render them modular for custom engineering. Additionally, RP8 series constructs use a smaller backbone designed to enhance transgenic efficiency. RP8 vectors most notably possess a new 3’ exon trap cassette that uses the γ-crystalline promoter to drive expression of lens-specific tagBFP instead of the ubiquitous expression of GFP delivered from RP2 vectors (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). We found this lens-specific tagBFP to be equally useful in screening founders with GBT integrations. While we did not explicitly validate that the RP8 series provides transcriptional effects equivalent to the RP2 series, the major functional change in RP8 lies in its 3’ exon trap. We therefore expect the knockdown to be similar between RP8 and RP2.</p><p>Two additional zebrafish transposon-based protein trap vectors have been established. Dr. Fraser’s group developed the FlipTrap system (<xref ref-type="bibr" rid="bib56">Trinh et al., 2011</xref>) that is mutagenic in the presence of Cre-recombinase. However, this FlipTrap system is primarily focused on imaging fusion proteins in vivo and addressing cellular dynamics. The Chen lab developed a complementary flipping system called the FT1 system that uses either Cre or Flp recombinase to regulate its alleles depending on the original insertion orientation (<xref ref-type="bibr" rid="bib42">Ni et al., 2012</xref>). Our GBT system is highly complementary and non-redundant with these alternative transposon-based protein trap methods. The 5’ protein trap in the GBT system is terminated through an enhanced polyadenylation signal in conjunction with a putative border element and a second splice acceptor in the 3’ exon trap helps eliminate any pass-through. Together these elements achieve higher gene-specific mRNA knockdown than the single splice acceptor and the basic polyadenylation signal in FlipTrap and FT1 (<xref ref-type="fig" rid="fig3">Figure 3</xref>). In addition to a 5’ protein trap, our GBT system also possesses a 3’ exon trap that serves as a means for screening integrations, reports 3’ sequence, and possesses the ability to trap (without mRFP expression) non-coding RNAs that undergo splicing (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Consistent with its mRNA knockdown abilities, the mutagenic efficacy of the GBT system is functionally similar to other genome-wide forward genetic approaches at identifying critical early developmental loci. The GBT system achieved 7% recovery of visible early (through five dpf) developmental phenotypes during an initial forward genetic screen. This recovery is comparable to the 5% recovered visible phenotypes from the Sanger TILLING consortium analysis of truncated zebrafish genes (<xref ref-type="bibr" rid="bib30">Kettleborough et al., 2013</xref>). Our 7% phenotype recovery is also comparable to prior retroviral (<xref ref-type="bibr" rid="bib3">Amsterdam and Hopkins, 2004</xref>) and ENU (<xref ref-type="bibr" rid="bib20">Haffter et al., 1996</xref>) zebrafish mutagenesis works that estimated between 1400 and 2400 genes (~5–9% of the genome) would result in a visible embryonic phenotype when mutated.</p></sec><sec id="s3-2"><title>Gene-break transposon system enables functional genome annotation and generates novel potential human disease models</title><p>The connections between gene, expression pattern, function, and phenotype (or human disease) can be elucidated using our GBT system. During the initial GBT library creation, we identified a GBT-confirmed line with an RP2 integration between exon 81 and exon 82 of <italic>ryr1b</italic> (ENSDART00000036015.9, Ensembl Release 100 on April 2020), a zebrafish ortholog of human <italic>RYR1</italic>. Mutations in <italic>RYR1</italic> are well-linked to a rare genetic neuromuscular disorder known as central core disease that presents with mild to severe muscle weakness (<xref ref-type="bibr" rid="bib28">Jungbluth et al., 2018</xref>). Indeed, homozygous animals in this <italic>ryr1b</italic> GBT-confirmed line possess skeletal muscle-specific mRFP expression and a slow swimming phenotype (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>). Previously, a spontaneous mutant called <italic>relatively relaxed</italic> (<italic>ryr1b<sup>mi340/mi340</sup></italic>) was shown to have a slow swimming phenotype, truncated ryr1b protein with a pre-mature stop involved in an insertional mutagen, and defective skeletal muscle Ca<sup>2+</sup> transients (<xref ref-type="bibr" rid="bib22">Hirata et al., 2007</xref>). Our <italic>ryr1b</italic> GBT-confirmed line was therefore ideal to validate the functional genome annotation abilities of GBT constructs.</p><p>Similar to the <italic>relatively relaxed</italic> mutants which carry an insertion that introduces a premature stop codon between exons 48 and 49 of <italic>ryr1b</italic> (<xref ref-type="bibr" rid="bib22">Hirata et al., 2007</xref>), we noted severely dampened skeletal muscle Ca<sup>2+</sup> transients in animals homozygous for the <italic>ryr1b</italic> GBT allele (<xref ref-type="fig" rid="fig4">Figure 4</xref>). In addition to previously reported decreases in peak amplitude (<xref ref-type="bibr" rid="bib22">Hirata et al., 2007</xref>) we found that <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals also displayed a slower upstroke and lower frequency of skeletal muscle Ca<sup>2+</sup> transients than wildtypes, functionally annotating these roles for the C-terminal region of <italic>ryr1b</italic> gene in vivo. Including this <italic>ryr1b</italic> line, we generated GBT-confirmed lines with integrations in 64 zebrafish orthologs of human disease-associated genes (<xref ref-type="fig" rid="fig5">Figure 5</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>) in this study. GBT-confirmed lines with integrations in 40 zebrafish orthologs of human disease-associated genes may represent novel potential disease models, as we failed to find any description of existing zebrafish or mouse models for these genes or diseases. Our GBT system importantly possesses a built-in cure due to its revertible nature. Therefore, these GBT potential disease models will allow direct comparison of tissue-specific gene restoration with any therapeutic approach.</p></sec><sec id="s3-3"><title>GBT protein trapping provides the basis for annotation of functionally diverse proteins and novel transcripts mapped on poorly assembled genomic regions</title><p>To achieve genomic representation, unbiased protein trapping is an important consideration. Tol2 transposase-mediated systems are known to facilitate near-random integration, but we wanted to explore this in the context of the GBT protein trapping constructs. We utilized PANTHER, Human Protein Atlas, and UniProtKB to explore the protein class and subcellular localization of the human orthologs of the genes trapped in GBT-confirmed lines (<xref ref-type="fig" rid="fig6">Figure 6</xref>). While nuclear localized proteins, such as transcription factors, represented the largest class of GBT-trapped genes, we identified a diverse set of proteins in our GBT-confirmed lines that localize all the way from the nucleoli to the extracellular space. The reason for the enrichment of nuclear genes is unknown. The rich diversity of proteins observed in our GBT-confirmed lines still supports that the entire collection has high diversity and is consistent with the random nature of Tol2-mediated genome integration events (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>). Completion of the zebrafish reference genomes also has enabled many new discoveries to be made with regards to the position of hundreds of genes that affect embryogenesis, behavior, and physiology. However, poorly assembled regions remain in both the zebrafish and the human genome (<xref ref-type="bibr" rid="bib25">Howe et al., 2013</xref>). We indeed found that 10 GBT integrations in the confirmed lines (with mRFP expression) failed to map to any predicted genes. However, RNA sequencing reads in public datasets identified potential unannotated coding sequences aligned with these GBT integration loci (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). While 5’ and 3’ RACE are necessary to confirm the mRNA fusion products, these unannotated coding sequences represent the possibility to annotate novel, protein-coding transcripts in these GBT lines. Therefore, GBT protein trapping can find, illuminate expression, and elucidate in vivo functions of novel genes and/or gene variants in poorly annotated regions of reference genomes.</p></sec><sec id="s3-4"><title>GBT protein trapping annotates novel endogenous gene expression</title><p>GBT-based mRFP fusion proteins represent a notable advance over traditional techniques for probing endogenous gene expression (e.g., immunohistochemistry, in situ hybridization) that have yielded very little gene expression data at later developmental stages. The truncated mRFP fusion proteins in both RP2 and RP8 series constructs exhibited distinct cellular localizations in our GBT lines throughout development, including two dpf and beyond. Approximately 90% of GBT-confirmed lines showcased novel expression patterns of their annotated genes at four dpf (<xref ref-type="fig" rid="fig7">Figure 7</xref>).</p><p>These GBT-based mRFP fusion proteins allow investigation of subcellular localization of these tagged-gene products (<xref ref-type="fig" rid="fig6">Figure 6</xref>, <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>), with the exception of cases where the protein localization signal is contained in the C-terminal domain (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; <xref ref-type="bibr" rid="bib57">Trinh and Fraser, 2013</xref>). We indeed observed mRFP accumulation in the kidney tubules, white blood cells or developing bones in some GBT lines, likely based upon the remaining signal sequences at the N-terminus of the endogenous protein. Still, visualizing protein expression dynamics of GBT-trapped proteins in most lines should facilitate important initial annotations regarding subcellular localization of uncharacterized proteins to investigate molecular functions in vivo. With ever-improving fluorescence-based imaging tools (<xref ref-type="bibr" rid="bib36">Liu et al., 2018</xref>), our GBT lines have the potential to annotate both cellular and subcellular gene expression at diverse stages on an organismal scale.</p></sec><sec id="s3-5"><title>Gene-break protein trap library is a rich resource for the community</title><p>Taken together, GBT-based mRFP-reporters demonstrate how much we still have left to understand about the expression patterns of the overall proteome and, ultimately, the complex codex that is our genome. Even at the relatively well-studied 2-dpf stage, nearly 40% of GBT-confirmed lines elucidated novel gene expression data (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Cataloging these expression patterns enables investigators to make collections of lines with expression in their cell/tissue of interest and/or a phenotype. The remaining 144 GBT-candidate lines and over 800 GBT lines represent a rich resource for genomic discoveries. For any GBT-candidate or GBT lines of interest, a similar cloning pipeline (<xref ref-type="fig" rid="fig2">Figure 2</xref>) can be employed to identify the GBT integration locus. In addition, the refinement of the zebrafish genome will enhance our ability to complete the annotation from GBT-line to GBT-confirmed line for any given line with a desired expression profile and/or phenotype. Together, this 1,200+ GBT-line collection is a new contribution for using zebrafish to annotate the vertebrate genome.</p></sec><sec id="s3-6"><title>Future genomic insights using the GBT system</title><p>Although our GBT lines were made with random integration, new targeted integration tools, such as GeneWeld (<xref ref-type="bibr" rid="bib67">Wierson et al., 2020</xref>), that employ gene editing techniques will empower labs to build custom GBT lines for their gene of interest (<xref ref-type="bibr" rid="bib17">El Khoury et al., 2018</xref>). The three reading frames and modularity of the RP8 series are especially well suited to targeted integration approaches. Further, a combination of targeted and random integration may best facilitate discovery. For instance, a targeted approach could integrate a GBT cassette into a well-characterized, process-associated gene. Then, random integration could be used to probe for genes that potentiate or abrogate the disruption in the original process-associated gene. With this approach, GBTs are a powerful tool to investigate multigenic processes, including human disease.</p></sec><sec id="s3-7"><title>GBT system offers advantages over frame-shift mutations</title><p>Finally, targeted mutagenic technology, such as CRISPR and TALEN systems, has become the gold standard reverse genetic approach. However, engineered mutant animals using approaches generate targeted indel mutation frequently fail to display overt phenotypes, often explained by genetic compensation (<xref ref-type="bibr" rid="bib6">Balciunas, 2018</xref>; <xref ref-type="bibr" rid="bib18">El-Brolosy and Stainier, 2017</xref>). One mechanism includes cellular increases in transcripts of genes in the same family that can functionally substitute when activated in a mutant background (<xref ref-type="bibr" rid="bib6">Balciunas, 2018</xref>). Recently, a number of studies using reverse genetics tools have revealed phenotype differences between knockouts (indel mutants), and knockdowns (antisense-treated animals) in multiple model systems including <italic>Arabidopsis</italic>, <italic>Drosophila</italic>, zebrafish, mouse, and human cell lines. This discrepancy is attributed to transcriptomic changes in mutant but not in knockdown animals (Reviewed from <xref ref-type="bibr" rid="bib18">El-Brolosy and Stainier, 2017</xref>). For example, knockdown of <italic>egfl7</italic>, an endothelial extracellular matrix (ECM) gene, induces severe vascular defects, whereas most <italic>egfl7</italic> mutants exhibit no obvious defect, resulting from upregulation of other ECM proteins, especially emilins in <italic>egfl7</italic> mutants, but not in <italic>egfl7</italic> morphants (<xref ref-type="bibr" rid="bib49">Ronzitti, 2019</xref>). As another mechanism of genetic compensation, mRNA processing—including nonsense-associated exon skipping and the use of alternative start or splice sites to escape nonsense-mediated decay—has been recently demonstrated to hinder loss-of-function approaches in zebrafish (<xref ref-type="bibr" rid="bib4">Anderson et al., 2017</xref>; <xref ref-type="bibr" rid="bib47">Prykhozhij et al., 2017</xref>), in human cell lines (<xref ref-type="bibr" rid="bib33">Lalonde et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Winter et al., 2019</xref>) and in the human population (<xref ref-type="bibr" rid="bib27">Jagannathan and Bradley, 2016</xref>). In contrast, the molecular mechanism of GBT mutagenesis can normally avoid this genetic compensation effect seen with small indel mutations because the strong poly (A)-trapping element in the 5’ exon trap domain of RP cassettes can reduce mRNA to below 1% of the complete wild-type transcript level. This reduction eliminates many sources of transcriptional adaptations triggered by a loss of function mutation, such as alternative transcriptional start sites, splicing, or alternative translation initiation. The GBT can therefore act as a useful validation tool when targeted mutations with other technologies fail to display any phenotype.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type <break/>(species) or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Recombinant DNA reagent</td><td>pGBT-RP2.1</td><td><xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_31828">Addgene_31828</ext-link>, Genbank: HQ335170</td><td><xref ref-type="fig" rid="fig1">Figure 1A</xref></td></tr><tr><td>Recombinant DNA reagent</td><td>pGBT-RP2.2</td><td>This paper</td><td>Genbank: MT815588</td><td><xref ref-type="fig" rid="fig1">Figure 1A</xref></td></tr><tr><td>Recombinant DNA reagent</td><td>pGBT-RP2.3</td><td>This paper</td><td>Genbank: MT815589</td><td><xref ref-type="fig" rid="fig1">Figure 1A</xref></td></tr><tr><td>Recombinant DNA reagent</td><td>pGBT-RP8.1</td><td>This paper</td><td>Genbank: MT815590</td><td><xref ref-type="fig" rid="fig1">Figure 1B</xref></td></tr><tr><td>Recombinant DNA reagent</td><td>pGBT-RP8.2</td><td>This paper</td><td>Genbank: MT815591</td><td><xref ref-type="fig" rid="fig1">Figure 1B</xref></td></tr><tr><td>Recombinant DNA reagent</td><td>pGBT-RP8.3</td><td>This paper</td><td>Genbank: MT815592</td><td><xref ref-type="fig" rid="fig1">Figure 1B</xref></td></tr><tr><td>Recombinant DNA reagent</td><td>pGBT-RP7.1</td><td>This paper</td><td/><td>An intermediate construct to create pGBT-RP8.1</td></tr><tr><td>Recombinant DNA reagent</td><td>pGBT-RP6.1</td><td>This paper</td><td/><td>An intermediate construct to create pGBT-RP8.1</td></tr><tr><td>Recombinant DNA reagent</td><td>pGBT-RP5.1</td><td>This paper</td><td/><td>An intermediate construct of pGBT-RP8.1</td></tr><tr><td>Recombinant DNA reagent</td><td>pre(−1)GBT-RP5.1</td><td>This paper</td><td/><td>An intermediate construct of pGBT-RP5.1</td></tr><tr><td>Recombinant DNA reagent</td><td>pre(−2)GBT-RP5.1</td><td>This paper</td><td/><td>An intermediate construct of pGBT-RP5.1</td></tr><tr><td>Recombinant DNA reagent</td><td>pre(−3)GBT-RP5.1</td><td>This paper</td><td/><td>An intermediate construct of pGBT-RP5.1</td></tr><tr><td>Recombinant DNA reagent</td><td>pKTol2-SE</td><td><xref ref-type="bibr" rid="bib11">Clark et al., 2011b</xref></td><td/><td/></tr><tr><td>Recombinant DNA reagent</td><td>pUC57-I-SceI_LoxP_Splice</td><td>This paper</td><td/><td>DNA source to create pre(−3)GBT-RP5.1</td></tr><tr><td>Recombinant DNA reagent</td><td>pUC57</td><td>Genscript</td><td>SD1176</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pKTol2gC-nlsTagBFP</td><td>This paper</td><td/><td>DNA source to create pre(−2)GBT-RP5.1</td></tr><tr><td>Recombinant DNA reagent</td><td>pGBT-R15</td><td><xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_31826">Addgene_31826</ext-link>, Genbank ID: HQ335168</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pGBT-PX</td><td><xref ref-type="bibr" rid="bib51">Sivasubbu et al., 2006</xref></td><td>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/Addgene_31824">Addgene_31824</ext-link>, Genbank ID: HQ335166</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pCR4-bactmIntron</td><td>This paper</td><td/><td>DNA source to create pGBT-RP8.1</td></tr><tr><td>Recombinant DNA reagent</td><td>pCR4-bact_I1</td><td>This paper</td><td/><td>DNA source of the carp beta-actin intron amplified from pGBT-RP2.1</td></tr><tr><td>Recombinant DNA reagent</td><td>pCR4-TOPO</td><td>Invitrogen</td><td>450030</td><td/></tr><tr><td>Recombinant DNA reagent</td><td>pEXPR-mylpfa:GCaMP3</td><td><xref ref-type="bibr" rid="bib8">Baxendale et al., 2012</xref></td><td/><td/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">phenylthiocarbamide</td><td valign="top">Sigma-Aldrich</td><td valign="top">P7629</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">tricaine</td><td valign="top">Sigma-Aldrich</td><td valign="top">A5040</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">low melt agarose</td><td valign="top">Fisher Scientific</td><td valign="top">BP1360</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">pentylenetetrazole</td><td valign="top">Sigma-Aldrich</td><td valign="top">P6500</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">(<italic>S</italic>)-(-)-blebbistatin</td><td valign="top">Tocris</td><td valign="top">1852</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">β-mercaptoethanol</td><td valign="top">Sigma-Aldrich</td><td valign="top">M6250</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">proteinase K</td><td valign="top">Roche</td><td valign="top">3115879001</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">T4 DNA ligase</td><td valign="top">New England Biolabs</td><td valign="top">M0202S</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">RNeasy Micro Kit</td><td valign="top">QIAGEN</td><td valign="top">74004</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Stainless steel beads</td><td valign="top">Next Advance</td><td valign="top">SSB05</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">MaXtract High Density tubes</td><td valign="top">QIAGEN</td><td valign="top">129056</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">SuperScript II Reverse Transcriptase</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">18064014</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">SensiFAST SYBR Lo-ROX kit</td><td valign="top">Bioline</td><td valign="top">BIO-94005</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">QIAquick Gel Extraction Kit</td><td valign="top">QIAGEN</td><td valign="top">28704</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">GraphPad Prism 8</td><td valign="top">GrapgPad</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">R</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">www.R-project.org</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001905">SCR_001905</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">R-Studio</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://www.rstudio.com/">www.rstudio.com/</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">pwr package</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=pwr">https://CRAN.R-project.org/package=pwr</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">wilcox.test function</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://www.r-project.org/">www.R-project.org</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">coin package</td><td valign="top"><xref ref-type="bibr" rid="bib23">Hothorn et al., 2006</xref>, <xref ref-type="bibr" rid="bib24">Hothorn et al., 2008</xref></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">outliers package</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=outliers">https://CRAN.R-project.org/package=outliers</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">effsize package</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=effsize">https://CRAN.R-project.org/package=effsize</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">JMP version 14</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://www.jmp.com/en_us/software/jmp.html">http://www.jmp.com/en_us/software/jmp.html</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_014242">SCR_014242</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">SynFind</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://genomevolution.org/CoGe/SynFind.pl">https://genomevolution.org/CoGe/SynFind.pl</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">BLASTP</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&amp;PAGE_TYPE=BlastSearch&amp;LINK_LOC=blasthome">http://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&amp;PAGE_TYPE=BlastSearch&amp;LINK_LOC=blasthome</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001010">SCR_001010</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">BioMart, Ensembl tool</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://useast.ensembl.org/biomart/martview/">http://useast.ensembl.org/biomart/martview/</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002344">SCR_002344</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">PANTHER version 14.1</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://www.pantherdb.org/">http://www.pantherdb.org/</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004869">SCR_004869</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">FIJI</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://fiji.sc/">https://fiji.sc/</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002285">SCR_002285</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">MetaMorph Microscopy Automation and Image Analysis Software</td><td valign="top">Molecular Devices</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002368">SCR_002368</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Digidata 1440A</td><td valign="top">Molecular Devices</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Clampex 10.3</td><td valign="top">Molecular Devices</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Integrative Genomics Viewer (version 2.4.19)</td><td valign="top"><xref ref-type="bibr" rid="bib55">Thorvaldsdóttir et al., 2013</xref></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_011793">SCR_011793</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Galaxy</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://usegalaxy.org/">https://usegalaxy.org/</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006281">SCR_006281</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">BAMtools</td><td valign="top"><xref ref-type="bibr" rid="bib7">Barnett et al., 2011</xref></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_015987">SCR_015987</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">TopHat</td><td valign="top"><xref ref-type="bibr" rid="bib31">Kim et al., 2013</xref></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_013035">SCR_013035</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Zebrafish Information Network (ZFIN)</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://zfin.org/">https://zfin.org/</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002560">SCR_002560</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Ensembl</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://useast.ensembl.org/index.html">https://useast.ensembl.org/index.html</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002344">SCR_002344</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">InParanoid version 8</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://inparanoid.sbc.su.se/cgi-bin/index.cgi">http://inparanoid.sbc.su.se/cgi-bin/index.cgi</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006801">SCR_006801</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">The Human Protein Atlas</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org/">www.proteinatlas.org</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006710">SCR_006710</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">UniProtKB</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/">https://www.uniprot.org/</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_004426">SCR_004426</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Online Mendelian Inheritance in Man (OMIM)</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://omim.org/">https://omim.org/</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006437">SCR_006437</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Mouse Genome Informatics (MGI)</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org">http://www.informatics.jax.org</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006460">SCR_006460</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">zfishbook</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="https://zfishbook.org/">https://zfishbook.org/</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006896">SCR_006896</ext-link></td><td valign="top"/></tr><tr><td valign="top">Other</td><td valign="top">RNA-seq dataset</td><td valign="top"><xref ref-type="bibr" rid="bib66">White et al., 2017</xref></td><td valign="top">GRCz10.WTSI.36hpf.1.bam</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="ftp://ftp.ensembl.org/pub/data_files/danio_rerio/GRCz10/rnaseq/">ftp://ftp.ensembl.org/pub/data_files/danio_rerio/GRCz10/rnaseq/</ext-link></td></tr><tr><td valign="top">Other</td><td valign="top">RNA-seq dataset</td><td valign="top"><xref ref-type="bibr" rid="bib66">White et al., 2017</xref></td><td valign="top">GRCz10.WTSI.48hpf.1.bam</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="ftp://ftp.ensembl.org/pub/data_files/danio_rerio/GRCz10/rnaseq/">ftp://ftp.ensembl.org/pub/data_files/danio_rerio/GRCz10/rnaseq/</ext-link></td></tr><tr><td valign="top">Other</td><td valign="top">RNA-seq dataset</td><td valign="top"><xref ref-type="bibr" rid="bib66">White et al., 2017</xref></td><td valign="top">GRCz10.WTSI.4dpf.1.bam</td><td valign="top"><ext-link ext-link-type="uri" xlink:href="ftp://ftp.ensembl.org/pub/data_files/danio_rerio/GRCz10/rnaseq/">ftp://ftp.ensembl.org/pub/data_files/danio_rerio/GRCz10/rnaseq/</ext-link></td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Zebrafish husbandry</title><p>All zebrafish (<italic>Danio rerio</italic>) were maintained according to the procedures described previously (<xref ref-type="bibr" rid="bib34">Leveque et al., 2016</xref>).</p></sec><sec id="s4-2"><title>Generating GBT constructs, RP2 and RP8 series</title><p>pGBT-RP8.2 and -RP8.3 were made by combining three restriction endonuclease fragments of pGBT-RP8.1, a 2.2 kb AflII to AgeI, a 0.7 kb EcoRI to SpeI, and a 3.0 kb SpeI to AflII, with a short adapter to close the space between AgeI and EcoRI that effectively removed one or two thymine nucleotides just following the splice acceptor prior to the AUG-less mRFP cassette. For pGBT-RP8.2, Adapter-GBT(+2) was made by annealing oligos adapter-GBT(+2)-a [<named-content content-type="sequence">CCGGTTTTCTCATTCATTTACAGTCAGCCGG</named-content>] and adapter-GBT (+2)-b [<named-content content-type="sequence">AATTCCGGCTGACTGTAAATGAATGAGAAAA</named-content>]. For pGBT-RP8.3, Adapter-GBT(+3) was made by annealing oligos adapter-GBT (+3)-a [<named-content content-type="sequence">CCGGTTTTCTCATTCATTTACAGCAGCCGG</named-content>] and adapter-GBT(+3)-b [<named-content content-type="sequence">AATTCCGGCTGCTGTAAATGAATGAGAAAA</named-content>].</p><p>pGBT-RP2.2 and -RP2.3 were made by combining three restriction endonuclease fragments of pGBT-RP2.1 (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>), a 3.6 kb BlpI to AgeI, a 1.9 kb EcoRI to AvrII, and a 3.55 kb AvrII to BlpI, with a short adapter to close the space between AgeI and EcoRI that effectively removed one or two thymine nucleotides just following the splice acceptor prior to the AUG-less mRFP cassette. For pGBT-RP2.2, Adapter-GBT(+2) was made by annealing oligos adapter-GBT(+2)-a and adapter-GBT(+2)-b. For pGBT-RP2.3, Adapter-GBT(+3) was made by annealing oligos adapter-GBT(+3)-a and adapter-GBT(+3)-b. pGBT-RP8.1 was made by cloning a mini-intron derived from carp beta actin intron one into pGBT-RP7.1. The 234 bp SalI to XhoI mini-intron fragment was isolated from pCR4-bactmIntron following digestion. The pGBT-RP7.1 plasmid was digested with XhoI so that the SalI to XhoI fragment was cloned between the gamma-crystallin promoter and nls tagBFP.</p><p>pCR4-bactmIntron was made by removing a 1.1 kb internal portion of the carp beta actin intron one by digestion of pCR4-bact_I1 with BstBI and BssHII, followed by filling in 5’ overhangs and ligating remaining vector fragment.</p><p>pCR4-bact_I1 was cloning a PCR product containing the carp beta-actin intron into pCR4-TOPO (450030, Invitrogen, Thermo Fisher Scientific, Waltham, MA). The intron was amplified from pGBT-RP2.1 (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>) using MISC-bact_exon-F1 [<named-content content-type="sequence">CAGCTAGTGCGGAATATCATCTGCC</named-content>] and MISC-bact_intron-R1 [<named-content content-type="sequence">CTTCTCGAGGTGAATTCCGGCTGAACTGTA</named-content>] primers.</p><p>pGBT-RP7.1 was made by replacing a 501 bp PstI to PstI fragment of pGBT-RP6.1 with a 480 bp PstI to PstI fragment of pRP2.1. This changed the nucleotide sequence between the carp beta-actin splice acceptor to replicate the sequences in pGBT-RP2.1. pGBT-RP7.1 was never directly tested in zebrafish.</p><p>pGBT-RP6.1 was made by flipping the internal trap cassette relative the Tol2 inverted terminal repeats in pGBT-RP5.1. To do this, pGBT-RP5.1 was cut with EcoRV and SmaI. The 2.27 kb EcoRV to SmaI vector backbone fragment, which included the ITRs, was ligated to the 3.51 kb EcoRV to SmaI trap fragment. pGBT-RP6.1 was then selected based on the right ITR of Tol2 being in front of the RFP trap, which is the same orientation of pGBT-RP2.1.</p><p>pGBT-RP5.1 was made by cloning a PCR product with the AUG-less mRFP into pre(−1)GBT-RP5.1. The 698 bp mRFP* PCR product was obtained by amplification of pGBT-R15 (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>) with CDS-mRFP*-F1 [<named-content content-type="sequence">AAGAATTCGAAGGTGCCTCCTCCGAGGATGTCATCAAGG</named-content>] and CDS-mRFP-R1 [<named-content content-type="sequence">AAACTAGTCTTAGGCTCCGGTGGAGTGGCGG</named-content>]. Prior to cloning the PCR mRFP* product was digested with EcoRI and SpeI to prepare the ends for subcloning into pre(−1)GBT-RP5.1 that was opened between the carp beta actin splice acceptor and the ocean pout terminator.</p><p>pre(−1)GBT-RP5.1 was made by cloning 1.2 kb SpeI to AvrII fragment from pGBT-PX (<xref ref-type="bibr" rid="bib51">Sivasubbu et al., 2006</xref>) that contained the ocean pout terminator into the SpeI site of pre(−2)GBT-RP5.1. The resulting products were screened for the proper orientation of the ocean pout terminator relative to the carp beta actin splice acceptor.</p><p>pre(−2)GBT-RP5.1 was made by inserting an expression cassette to make a 3’ poly(A) trap that makes blue lenses. A 1.15 kb SpeI to BglII fragment from pKTol2gC-nlsTagBFP was cloned into pre(−3)GBT-RP5.1 that had been cut with AvrII and BglII. This moved the <italic>Xenopus</italic> gamma crystallin promoter driving a nuclear-localized TagBFP in front of the carp beta actin splice donor within pre(−3)GBT-RP5.1 to create a localized BFP poly(A) trap signal replacing the ubiquitous GFP signal that was in pGBT-RP2.1.</p><p>pre(−3)GBT-RP5.1 was made by cloning a 492 bp XmaI to NheI scaffold fragment from pUC57-I-SceI_loxP_splice into pKTol2-SE (<xref ref-type="bibr" rid="bib11">Clark et al., 2011b</xref>) opened with XmaI and NheI.</p><p>pUC57-I-SceI_LoxP_Splice contains a synthetic sequence (see below) cloned into pUC57 (SD1176, Genscript, Piscataway, NJ). The scaffold contains an I-SceI site; loxP site; carp beta actin splice acceptor; cloning sites for mRFP, ocean pout terminator, and BFP lens cassettes; carp beta actin splice donor; loxP site; and an I-SceI site.</p><p>The synthetic sequence described above is: <named-content content-type="sequence">cccgggatagggataacagggtaatataacttcgtatagcatacattatacgaagttat cgttaccacccactagcggtcagactgcagattgcagcacgaaacaggaagctgac tccacatggtcacatgctcactgaagtgttgacttccctgacagctgtgcactttctaaa ccggttttctcattcatttacagttcagcctgttacctgcactcaccgacaagctgttacc ctggaattcgtttaaacactagtcaccggcgttcctaggttataagatctacctaaggtg agttgatctttaagctttttacattttcagctcgcatatatcaattcgaacgtttaattagaat gtttaaataaagctagattaaatgattaggctcagttaccggtcttttttttctcatttacact gagctcaagacgtctgataacttcgtatagcatacattatacgaagttattaccctgttatccctatggctagc</named-content>.</p></sec><sec id="s4-3"><title>Generating GBT collection</title><p>Generation of the GBT collection was based on the prior described protocols (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>; <xref ref-type="bibr" rid="bib43">Ni et al., 2016</xref>). RP2 constructs were injected and sorted by low mosaicism of GFP expression. RP8 constructs were sorted on the basis of strong tagBFP expression in the eyes. Overall ~30% of injected fish met these criteria. ~ 25% of these F0 fish gave RFP offspring.</p></sec><sec id="s4-4"><title>Fluorescent microscopy of mRFP reporter protein expression</title><p>Larvae were treated with 0.2 mM phenylthiocarbamide (P7629, Sigma-Aldrich, St. Louis, MO) at one dpf to inhibit pigment formation. The anesthetized fish were mounted in 1.5% low-melt agarose (BP1360, Fisher Scientific, Hampton, NH) prepared with 0.017 mg/ml tricaine (Ethyl 3-aminobenzoate methanesulfonate salt, A5040, Sigma-Aldrich) solution in an agarose column in the imaging chamber. The protocol of ApoTome microscopy was described in previous publication. (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>) For Lightsheet microscopy, larval zebrafish were anesthetized with 0.017 g/ml tricaine in 1.5% low-melt agarose (BP1360, Fisher Scientific) and mounted in glass capillaries. To capture RFP expression patterns of 2 dpf and four dpf larval zebrafish, LP 560 nm filter as excitation and LP 585 nm as emission was used for Lightsheet microscopy. The sagittal-, dorsal-, and ventral- oriented z-stacks of the mRFP expression were captured at either 50x magnification using an ApoTome microscope (Zeiss, Oberkochen, Germany) with a 5x/0.25 NA dry objective (Zeiss) or 50x magnification using a Lightsheet Z.1 microscope (Zeiss) 5x/0.16 NA dry objective. Each set of images were obtained from the same larva and the images shown are composites of the maximum image projections of the z-stacks obtained from each direction.</p><p>For confocal microscopy, larval zebrafish were anesthetized with 0.017 g/ml tricaine (Ethyl 3-aminobenzoate methanesulfonate salt, A5040, Sigma-Aldrich) in 1.0% low-melt agarose (BP1360, Fisher Scientific) and mounted 35 mm glass-bottom dishes (P35G-1.5–14 C, MatTek Life Sciences, Ashland, MA). Imaging was performed on an LSM-780 (Zeiss, Oberkochen, Germany) using either a C-Apochromat 63x/1.2 NA or a C-Apochromat 40x/1.2 NA water immersion objective. RFP was excited at 561 nm and emissions 570–750 nm were collected.</p></sec><sec id="s4-5"><title>Sperm cryopreservation</title><p>Sperm collection and cryopreservation was initially based on the protocol described in <xref ref-type="bibr" rid="bib16">Draper and Moens, 2009</xref> and moved to the Zebrafish International Resource Center (ZIRC) protocol described in <xref ref-type="bibr" rid="bib39">Matthews et al., 2018</xref>.</p></sec><sec id="s4-6"><title>Genomic DNA isolation</title><p>Genomic DNA was isolated from F2 fish tail biopsies to conduct next generation sequencing and from both wild-type and heterozygous larva to manually perform PCR-based analysis for the identification of GBT-insertion site. 60 µl of lysis buffer containing with 10 mM Tris (pH 8.0), 100 mM NaCl, 10 mM EDTA, 0.4% SDS and 5 µg/ml proteinase K (03115879001, Roche) was loaded into each well of a 96-wells plate and clipped adult fins/larvae were individually placed into each well and incubated at 50°C for 3 hr. The solution with lysed tissue were suspended with a multichannel micropipette to dissolve the tissue, mixed with 60 µl of isopropanol and centrifuged at ~3,000 rpm/ 15,000 × g for 20 min at 4°C. After removing the supernatant, 100 µl of 70% ethanol were added, centrifuged for 20 min at 4°C. After discarding ethanol, the pellets were dried and re-suspended in 50 µl of water/TE. As the alternative protocol to quickly extract genomic DNA from zebrafish larvae, the specimens were individually placed to 0.2 ml PCR tubes and lysed with 30–50 µl of 50 mM NaOH and incubated at 95 C<sup>o</sup> for 20 min. The solutions with lysed specimens were vortexed and neutralized with 1 of 10 vol 1M Tris-HCl.</p></sec><sec id="s4-7"><title>Identification of GBT insertion loci</title><p>In addition to the broad next gen sequencing approach used to identify GBT integration sites, we used a combination of several a la carte methods including 5' and 3' rapid amplification of cDNA ends (RACE) (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>), inverse PCR (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>), and Thermal Asymmetric Interlaced PCR (TAIL-PCR). The protocol used for TAIL-PCR was designed to amplify and clone junction fragments from Tol2-based gene-break transposons was based on a protocol from <xref ref-type="bibr" rid="bib44">Parinov et al., 2004</xref> with some modifications. The following primer mixtures (containing 0.4 μM GBT specific primer and 2 µM degenerate primers (DP)) were prepared: for primary PCR: 5R-mRFP-P1/DP1, 5R-mRFP-P1/DP2, 5R-mRFP-P1/DP3, 5R-mRFP-P1/DP4, 3 R-GM2-P1/DP1, 3 R-GM2-P1/DP2, 3 R-GM2-P1/DP3, 3 R-GM2-P1/DP4, 3R-tagBFP-P1/DP1, 3R-tagBFP-P1/DP2, 3R-tagBFP-P1/DP3, 3R-tagBFP-P1/DP4; for secondary PCR: 5R-mRFP-P2/DP1, 5R-mRFP-P2/DP2, 5R-mRFP-P2/DP3, 5R-mRFP-P2/DP4, 3 R-GM2-P2/DP1, 3 R-GM2-P2/DP2, 3 R-GM2-P2/DP3, 3 R-GM2-P2/DP4, 3R-tagBFP-P2/DP1, 3R-tagBFP-P2/DP2, 3R-tagBFP-P2/DP3, 3R-tagBFP-P2/DP4; for tertiary PCR: TAIL-bA-SA/DP1, TAIL-bA-SA/DP2, TAIL-bA-SA/DP3, TAIL-bA-SA/DP4, Tol2-ITR(L)-O1/DP1, Tol2-ITR(L)-O1/DP2, Tol2-ITR(L)-O1/DP3, Tol2-ITR(L)-O1/DP4, Tol2-ITR(L)-O3/DP1, Tol2-ITR(L)-O3/DP2, Tol2-ITR(L)-O3/DP3, Tol2-ITR(L)-O3/DP4. A total of 1 μl of primer mixtures were added to PCR reaction (total volume 25 µl). Cycle settings were as follows. Primary: (1) 95°C, 3 min; (2) 95°C, 20 s; (3) 61°C, 30 s; (4) 70°C, 3 min; (5) go to ‘cycle 2’ five times; (6) 95°C, 20 s; (7) 25°C, 3 min; (8) ramping 0.3°/sec to 70°C; (9) 70°C, 3 min; (10) 95°C, 20 s; (11) 61°C, 30 s; (12) 70°C, 3 min; (13) 95°C, 20 s; (14) 61°C, 30 s; (15) 70°C, 3 min; (16) 95°C, 20 s; (17) 44°C, 1 min; (18) 70°C, 3 min; (19) go to ‘cycle 10’ 15 times; (20) 70°C, 5 min; Soak at 12°C. A total of 5 μl of the primary reaction was diluted with 95 µl of 10 mM Tris-Cl or TE buffers and 1 μl of the mixture was added to the secondary reaction. Secondary: (1) 95°C, 2 min (2) 95°C, 20 s; (3)61°C, 30 s; (4) 70°C, 3 min; (5) 95°C, 20 s; (6) 61°C, 30 s; (7) 70°C, 3 min; (8) 95°C, 20 s; (9) 44°C, 1 min; (10) ramping 1.5°/sec to 70°C; (11) 70°C, 3 min; (12) go to ‘cycle 2’ 15 times; (13) 70°C, 5 min; Soak at 12°C. A total of 5 μl of the primary reaction was diluted with 95 µl of 10 mM Tris-Cl or TE buffers and 1 μl of the mixture was added to the tertiary reaction. Tertiary: (1) 95°C, 2 min; (2) 95°C, 20 s; (3) 44°C, 1 min; (3) ramping 1.5°/sec to 70°C; (4) 70°C, 3 min; (5) go to ‘cycle 2’ 32 times; (6) 70°C, 5 min; Soak at 12°C. Products of the secondary and tertiary reactions were separated by using 1–1.5% agarose gel. The individual bands from the ‘band shift’ pairs were cut from the gel and purified by using QIAquick Gel Extraction Kit (28704, QIAGEN, Hilden, Germany), and sequenced by the sequencing service in the Medical Genome Facility at Mayo Clinic.</p><p>Alternatively, 5' RACE, 3' RACE, or inverse PCR were used to identify the interrupted gene as previously described (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>).</p></sec><sec id="s4-8"><title>Bioinformatic analysis of public RNA sequencing data at the integrated loci</title><p>Public datasets of zebrafish wildtype at 36 hpf, 48 hpf and four dpf were downloaded from Ensembl database (Downloaded datasets: GRCz10.WTSI.36hpf.1.bam, GRCz10.WTSI.48hpf.1.bam and GRCz10.WTSI.4dpf.1.bam, URL: <ext-link ext-link-type="uri" xlink:href="ftp://ftp.ensembl.org/pub/data_files/danio_rerio/GRCz10/rnaseq/">ftp://ftp.ensembl.org/pub/data_files/danio_rerio/GRCz10/rnaseq/</ext-link>) (<xref ref-type="bibr" rid="bib66">White et al., 2017</xref>) to browse mapping RNA sequence (RNA-seq) reads around the integration loci. With Galaxy (<ext-link ext-link-type="uri" xlink:href="https://usegalaxy.org/">https://usegalaxy.org/</ext-link>) as a web-based platform for next generation sequencing data analysis (<xref ref-type="bibr" rid="bib1">Afgan et al., 2018</xref>), these downloaded BAM files of these datasets were converted FASTQ file format using BAMtools (<xref ref-type="bibr" rid="bib7">Barnett et al., 2011</xref>). TopHat created a new BAM file and re-aligned RNA-seq reads in the FASTQ file to identify splice junctions between exons in each dataset (<xref ref-type="bibr" rid="bib31">Kim et al., 2013</xref>). These re-mapped BAM files were used to predict candidate transcripts integrated with RP2/RP8 constructs with Integrative Genomics Viewer (version 2.4.19) (<xref ref-type="bibr" rid="bib55">Thorvaldsdóttir et al., 2013</xref>).</p></sec><sec id="s4-9"><title>Calcium imaging</title><p>Our calcium imaging protocols were modified from <xref ref-type="bibr" rid="bib8">Baxendale et al., 2012</xref>. Calcium data are compiled from two similar methods with independent experimenters and equipment. L.E.G. performed two independent runs of ‘Method 1’, and A.J.T. performed two independent runs of ‘Method 2’. Zebrafish embryos at the single cell (single-cell to 4 cell in Method 1) stage were injected with 80–100 pg (Method 1) or 2 nL of <italic>pEXPR-mylpfa:GCaMP3</italic> plasmid (a gift from Dr. Cunliffe) diluted in water (Method 1) or to 50 ng/µL in 200 mM KCl/0.05% phenol red (Method 2). On day 2, GCaMP3<sup>+</sup> embryos were de-chorionated and allowed to rest for 30 min.</p><p>For Method 1, embryos were singly incubated in E2 medium containing 20 mM pentylenetetrazole (PTZ) (P6500, Sigma-Aldrich) for approximately 5 min and mounted with a 3% methylcellulose solution containing 20 mM PTZ in a PPT tube and viewed laterally (similar to SCORE imaging [<xref ref-type="bibr" rid="bib46">Petzold et al., 2010</xref>]). After mounting, Ca<sup>2+</sup> transients in muscles were assessed using an Axio Scope.A1 (Zeiss) equipped with a D3 DSLR camera (Nikon, Minato, Tokyo, Japan) and a HXP 120 fluorescent lamp (Zeiss) using a 10x, 0.45 NA objective. Images were acquired at a rate of 2 Hz over 30 s.</p><p>For Method 2, four embryos at a time were transferred into E2 medium containing 5 µM (<italic>S</italic>)-(-)-blebbistatin (1852, Tocris, Bristol, United Kingdom) and incubated for at least 30 min until paralyzed. Once paralyzed, we embedded pairs of embryos into glass bottom dishes (MatTeK Corporation, Ashland, MA) with 1% low melting agarose (BP1360, Fisher Scientific) in E2 embryo medium with 5 µM (<italic>S</italic>)-(-)-blebbistatin and 20 mM PTZ. After an incubation period of 10–20 min, Ca<sup>2+</sup> transients in muscles were assessed using an inverted IX70 microscope (Olympus, Shinjuku, Tokyo, Japan) equipped with an OrcaFlash4.0 V2 sCMOS camera (Hamamatsu, Hamamatsu City, Shizuoka, Japan) and a pE-300ultra LED light source (CoolLED, Andover, United Kingdom) using a 20x, 0.75 NA objective. Images were acquired for 3 min at 5 Hz as a stream using Metamorph software (Molecular Devices, San Jose, CA), while the camera and LED were triggered through TTL output through a Digidata 1440A (Molecular Devices) with Clampex 10.3 software (Molecular Devices).</p><p>During the acquisition process, experimenters were blind to the genotype and mRFP expression pattern of the GCaMP3<sup>+</sup> animals in both Method one and Method 2. After acquisition, images were de-identified using a random number generator to blind the analysis. For Method 1, images were stitched together as TIFF series in NIH ImageJ/FIJI (<ext-link ext-link-type="uri" xlink:href="https://fiji.sc/">https://fiji.sc/</ext-link>). Due to the lack of paralysis in Method 1, some contractions resulted in axial motion that temporarily removed the cells from the focal plane. These frames with cells outside of the focal plane were manually removed from the image series. For Method 2, image series were filtered to 2.5 Hz and exported from Metamorph in TIFF format. The Template Matching plugin (<ext-link ext-link-type="uri" xlink:href="https://sites.google.com/site/qingzongtseng/template-matching-ij-plugin#description">https://sites.google.com/site/qingzongtseng/template-matching-ij-plugin#description</ext-link>) for NIH ImageJ/FIJI was used to adjust for lateral motion during contractions and drift.</p><p>After alignment, regions of interest (ROIs) were drawn around each cell using the magic wand tool and the background (an area in each animal devoid of GCaMP3<sup>+</sup> cells) using the rectangle tool in NIH ImageJ/FIJI. The average gray values of these ROIs were measured over the time series using the multi measure tool in NIH ImageJ/FIJI. Raw data were exported to Excel (Microsoft, Redmond, WA) and fluorescence time series were converted using background subtraction to ΔF/F<sub>0</sub> (ΔF/F<sub>0</sub> = (F − F<sub>0</sub>)/F<sub>0</sub>), where F<sub>0</sub> was the baseline fluorescence for each trial. Kinetic measurements for individual peaks (rise time (10%–90%), decay time (90%–50%), and peak-width at half max) were made on the data acquired with Method two using Clampfit 10.7 (Molecular Devices).</p><p>Due to the mosaic nature of injections, each field contained 1–8 (median = 2, 25% quartile = 2, 75% quartile = 5) GCaMP3<sup>+</sup> myocytes. Further, individual cells exhibited 0–9 (median = 1, 25% quartile = 0, 75% quartile = 2.75) calcium transients within the imaging window. For ΔF/F<sub>0</sub> quantitation, a unique F<sub>0</sub> was determined for each Ca<sup>2+</sup> transient event. In the case where a cell exhibited multiple Ca<sup>2+</sup> transient events, these events were treated as technical replicates and were averaged to give a single peak ΔF/F<sub>0</sub> for each cell. In the case where a field contained multiple cells, the peak ΔF/F<sub>0</sub> values for each cell were treated as technical replicates and averaged to give an average response for that animal. Cells or animals were considered biological replicates for analyses of peak ΔF/F<sub>0</sub> and number of responses. For kinetic measurements, only the first peak in from each cell was analyzed and each peak was considered a biological replicate. For cells with only ‘-ΔF/F<sub>0</sub>’ (photo-bleaching) recorded over the course of the trial, ‘0’ was denoted as the peak ΔF/F<sub>0</sub>. Otherwise, the maximum numerical value of ΔF/F<sub>0</sub> for each transient was assigned as peak ΔF/F<sub>0</sub>. For analysis of transient numbers, any transient with ΔF/F<sub>0</sub> ≥0.05 was counted as a response.</p><p>PCR genotyping was used to determine <italic>ryr1b</italic> alleles and assign data to its respective group. Only <italic>ryr1b<sup>+/+</sup></italic> and <italic>ryr1b<sup>mn0348Gt</sup></italic><sup>/<italic>mn0348Gt</italic></sup> animals were included in analyses due to the variable mRNA expression seen in <italic>ryr1b<sup>+/mn0348Gt</sup></italic> animals (<xref ref-type="bibr" rid="bib10">Clark et al., 2011a</xref>).</p></sec><sec id="s4-10"><title>Forward genetic screening with next-generation sequencing</title><p>Isolated genomic DNA (300–500 ng) was digested with MseI, and BfaI in parallel for 3 hr at 37°C and heat inactivated for 10 min at 80°C. The digested samples from each enzyme were pooled with pre-aliquoted barcoded linker in individual wells. The T4 DNA ligase (M0202S, New England Biolabs, Inc, Ipswich, MA) was added, and the reaction mix was incubated for 2 hr at 16°C. The linker-mediated PCR was performed in two steps. In the first step, PCR was done with one primer specific to the 3’- ITR (R-ITR P1, 5’- <named-content content-type="sequence">AATTTTCCCTAAGTACTTGTACTTTCACTTGAGTAA</named-content>-3’) and the other primer specific to linker sequences (LP1, 5’- <named-content content-type="sequence">GTAATACGACTCACTATAGGGCACGCGTG</named-content>- 3’) using the following conditions: 2 min at 95°C, 25 cycles of 15 s at 95°C, 30 s at 55°C and 30 s at 72°C. The PCR products were diluted to 1:50 in dH2O, and a second round of PCR was performed using ITR (R-ITR P2, 5’-<named-content content-type="sequence">TCACTTGAGTAAAATTTTTGAGTACTTTTTACACCTC</named-content>-3’) and linker specific (LP2, 5’ - <named-content content-type="sequence">GCGTGGTCGACTGCGCAT</named-content>-3’) nested primers to increase sensitivity and avoid non- specific amplification using the following conditions: 2 min at 95°C, 20 cycles of 15 s at 95°C, 30 s at 58°C and 30 s at 72°C. The nested PCR products from each 96-well plate are pooled and processed for Illumina library preparation as per manufacturer’s instructions.</p></sec><sec id="s4-11"><title>Quantitative reverse transcription–PCR</title><p>To quantify knockdown efficiencies for a GBT-confirmed lines, GBT0235 carrying the RP2.1 insertion into the <italic>lrpprc</italic> gene locus, quantitative reverse transcription-PCR (qRT-PCR) was performed by using the following protocol. Embryo collections were obtained from in-crossed <italic>lrpprc</italic><sup>+/<italic>mn0235Gt</italic></sup> adults. The larvae (six dpf) were sorted by mRFP expression to separate them based upon GBT allele and visible dark liver phenotype which has been characterized as a specific abnormality in <italic>lrpprc <sup>mn0235Gt</sup></italic><sup>/<italic>mn0235Gt</italic></sup> previously. Larvae with both RFP expression and dark liver phenotype were used as the experimental group (<italic>lrpprc <sup>mn0235Gt</sup></italic><sup>/<italic>mn0235Gt</italic></sup>) against larvae without either the RFP expression or the liver phenotype as a control (<italic>lrpprc <sup>+</sup></italic><sup>/<italic>+</italic></sup>). After the initial sorting, individual zebrafish larvae were placed into a 1.7 ml tube with 350 µl RLT buffer within RNeasy Micro Kit (74004, QIAGEN) with β-mercaptoethanol (M6250, Sigma-Aldrich). Embryos were homogenized at max frequency (30 shakes/s) for 5 min using ~30 of 0.5 mm stainless steel beads, RNase free (SSB05, Next Advance, Troy, NY) and Tissue Lyser II (QIAGEN). Homogenized samples were replaced to MaXtract High Density tubes (129056, QIAGEN) to separate between the organic solvent (phenol/chloroform) and the nucleic acid-containing aqueous. Total RNA was purified from the nucleic acid-containing aqueous using the RNeasy Micro Kit (QIAGEN). 250 ng of total RNA from the individual larva was used for cDNA synthesis with the SuperScript II Reverse Transcriptase (18064014, Thermo Fisher Scientific) using random hexamer primers. The 16-folds diluted cDNA with deionized water were used as templates and no reverse transcriptase (RT) controls were run parallel to test for genomic DNA contamination. To analyze transcript levels, quantitative PCR was performed using SensiFAST SYBR Lo-ROX kit (BIO-94005, Bioline) and the CFX96 Touch Real-Time PCR Detection System (Bio-Rad, Hercules, CA). <italic>eef1a1l1</italic> levels were used as reference. Three technical replicates were run for each sample and three biological replicates for each group and two no RT controls were also run. Data were analyzed through calculation of Delta Ct values. Quantitative reverse transcription-PCR was repeated for four individual clutches from the pair of <italic>lrpprc</italic><sup>+/<italic>mn0235Gt</italic></sup> adults. Primer sequences are the following information; <italic>lrpprc</italic> FP: 5’-<named-content content-type="sequence">TGATAATGCTGAGGAAGCTCTCAAACTG</named-content>-3’, <italic>lrpprc</italic> RP: 5’-<named-content content-type="sequence">CCTTCATCTCCTTCAGTATGTCTAACGC</named-content>-3’, <italic>eef1a1l1</italic> FP: 5’-<named-content content-type="sequence">CCGTCTGCCAACTTCAGGATGTGT</named-content>-3’, <italic>eef1a1l1</italic> RP: 5’-<named-content content-type="sequence">TTGAGGACACCAGTCTCCAACACGA</named-content>-3’. Source data can be found in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p></sec><sec id="s4-12"><title>Annotating human orthologues of GBT-tagged genes and disease-causing genes</title><p>The human orthologues of 177 cloned zebrafish genes were mainly collected from Zebrafish Information Network (ZFIN, University of Oregon, Eugene, OR 97403–5274; URL: <ext-link ext-link-type="uri" xlink:href="http://zfin.org/">http://zfin.org/</ext-link>) In some cases, the candidates of human orthologues unlisted in ZFIN database were manually searched by using both Ensembl released 98 (<ext-link ext-link-type="uri" xlink:href="https://useast.ensembl.org/index.html">https://useast.ensembl.org/index.html</ext-link>, (<xref ref-type="bibr" rid="bib70">Zerbino et al., 2018</xref>) and InParanoid8 (<ext-link ext-link-type="uri" xlink:href="http://inparanoid.sbc.su.se/cgi-bin/index.cgi">http://inparanoid.sbc.su.se/cgi-bin/index.cgi</ext-link>, (<xref ref-type="bibr" rid="bib53">Sonnhammer and Östlund, 2015</xref>) databases. In parallel, the candidates were manually identified by the result of Protein BLAST (<ext-link ext-link-type="uri" xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins">https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins</ext-link>) assembled with human proteins and by the result of an online synteny analysis tool, SynFind in Comparative Genomics (CoGe) database (<ext-link ext-link-type="uri" xlink:href="https://genomevolution.org/CoGe/SynFind.pl">https://genomevolution.org/CoGe/SynFind.pl</ext-link>) (<xref ref-type="bibr" rid="bib37">Lyons and Freeling, 2008</xref>). If the candidate multiply hit in those manual assessments, it was annotated as a human orthologue. The human phenotype data caused by mutations of 64 human orthologues were collected by using another data mining tool, BioMart provided by Ensembl (<ext-link ext-link-type="uri" xlink:href="http://useast.ensembl.org/biomart/martview/">http://useast.ensembl.org/biomart/martview/</ext-link>) (<xref ref-type="bibr" rid="bib32">Kinsella et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Smedley et al., 2015</xref>).</p></sec><sec id="s4-13"><title>Protein classification of the trapped human orthologs</title><p>The 177 human orthologs of cloned GBT-tagged genes were analyzed using PANTHER14.1 (<ext-link ext-link-type="uri" xlink:href="http://www.pantherdb.org/">http://www.pantherdb.org/</ext-link>) (<xref ref-type="bibr" rid="bib41">Mi et al., 2019</xref>). With those gene symbols, 176 gene were identified in the PANTHER system (the exception was <italic>NRXN</italic> Entrez Gene ID: 9378), and 105 genes were classified at least one PANTHER protein class (details are listed in <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>). 8282/20996 human genes have been annotated with 214 protein classes in PANTHER14.1 (April, 2018, <ext-link ext-link-type="uri" xlink:href="http://www.pantherdb.org/panther/summaryStats.jsp">http://www.pantherdb.org/panther/summaryStats.jsp</ext-link>).</p></sec><sec id="s4-14"><title>Subcellular localization of the trapped human orthologs</title><p>Experimentally validated subcellular localization data of 177 human orthologous genes tagged by GBT were manually collected from the Human Protein Atlas Subcellular Localization data downloaded on August 27th, 2019 (Courtesy of Human Protein Atlas, <ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org">www.proteinatlas.org</ext-link>) (<xref ref-type="bibr" rid="bib58">Uhlén et al., 2015</xref>) and knowledge-based subcellular localization data for the 49 genes un-validated in the Human Protein Atlas was acquired from UniProtKB on Oct 2nd, 2019 (<ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/">https://www.uniprot.org/</ext-link>) (<xref ref-type="bibr" rid="bib59">UniProt Consortium, 2018</xref>). This data (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>) contains 271 entries because some human orthologous genes were annotated to multiple subcellular localizations.</p></sec><sec id="s4-15"><title>Finding disease models in vertebrates</title><p>Mouse models were found by using descriptions of animal models in both Online Mendelian Inheritance in Man (OMIM. Johns Hopkins University, Baltimore, MD: October 28th, 2019. URL: <ext-link ext-link-type="uri" xlink:href="https://omim.org/">https://omim.org/</ext-link>) (<xref ref-type="bibr" rid="bib2">Amberger et al., 2019</xref>) and in Mouse Genome Database (MGD) at the Mouse Genome Informatics (MGI) website, The Jackson Laboratory, Bar Harbor, Maine: October 28th, 2019 (URL: <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org">http://www.informatics.jax.org</ext-link>)(<xref ref-type="bibr" rid="bib9">Bult et al., 2019</xref>). MGI provided the details of mouse models of human disease, such as the number of models that have been established. Zebrafish model were also found by using OMIM and ZFIN; August 28, 2019. ZFIN provided all data of fish strains listed in this database (<xref ref-type="bibr" rid="bib50">Ruzicka et al., 2019</xref>). The area proportional Venn diagram were created using BioVenn (<xref ref-type="bibr" rid="bib26">Hulsen et al., 2008</xref>) to visualize the number of human orthologs of the cloned genes associated with human genetic disorders which have at least one established disease model in zebrafish or mouse (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p></sec><sec id="s4-16"><title>Gene expression profiling of the cloned zebrafish genes</title><p>The cloned genes with published expression data were isolated by using the wild-type expression data retrieved from ZFIN; August 28, 2019 (<xref ref-type="bibr" rid="bib50">Ruzicka et al., 2019</xref>). In parallel, some published expression data were also manually searched from ZFIN. The mRFP reporter expression patterns of the cloned genes 2 and 4 dpf were manually searched using zfishbook database (<xref ref-type="bibr" rid="bib12">Clark et al., 2012</xref>). The comparison with the number of genes with description about expression in both ZFIN and zfishbook (<ext-link ext-link-type="uri" xlink:href="https://zfishbook.org/">https://zfishbook.org/</ext-link>) was presented using BioVenn (<xref ref-type="bibr" rid="bib26">Hulsen et al., 2008</xref>) to create the area proportional Venn diagrams in <xref ref-type="fig" rid="fig7">Figure 7S</xref> and <xref ref-type="fig" rid="fig7">Figure 7T</xref>.</p></sec><sec id="s4-17"><title>Statistical analysis</title><p>Knockdown efficiency and calcium imaging graphs were made in JMP 14 (SAS, Cary, NC) and in GraphPad Prism 8 (GraphPad Software, San Diego, CA), respectively. All other statistical analyses were performed with R (<ext-link ext-link-type="uri" xlink:href="http://www.R-project.org">www.R-project.org</ext-link>) using R-Studio (<ext-link ext-link-type="uri" xlink:href="http://www.rstudio.com/">www.rstudio.com/</ext-link>). Code used for analysis in R can be found in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>. Sample sizes for calcium imaging studies were estimated using peak ΔF/F<sub>0</sub> data from Method one and the ‘pwr’ package (<ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=pwr">https://CRAN.R-project.org/package=pwr</ext-link>). Statistical analyses for calcium imaging data were performed using the ‘wilcox.test’ function or the ‘coin’ package (<xref ref-type="bibr" rid="bib23">Hothorn et al., 2006</xref>; <xref ref-type="bibr" rid="bib24">Hothorn et al., 2008</xref>) due to the non-normality visualized in the data. Outliers (determined by Grubb’s test for one outlier in the ‘outliers’ package (<ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=outliers">https://CRAN.R-project.org/package=outliers</ext-link>) were included in overall analysis, although each statistical analysis was also performed without them as a proxy for the sensitivity of our conclusions to the outliers. All statistical tests supported the same conclusion with and without the outliers. Therefore, plots and p-values in the figures include all data points. p-values calculated excluding outliers can be found in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>. Effect size was measured by Cohen’s d using the ‘effsize’ package (<ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=effsize">https://CRAN.R-project.org/package=effsize</ext-link>). For ease of reporting, all p-values less than 0.0001 were reported in figures as ‘p&lt;0.0001’, but exact p-values are reported in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>.</p></sec><sec id="s4-18"><title>Availability of the materials and resources</title><p>All reagents are available upon request and all protein trap vectors in each reading frame will be deposited to Addgene (<ext-link ext-link-type="uri" xlink:href="http://www.addgene.org">http://www.addgene.org</ext-link>). Zebrafish lines are available either from Zebrafish International Resource Center (ZIRC, <ext-link ext-link-type="uri" xlink:href="http://zebrafish.org/">http://zebrafish.org/</ext-link>) or the Mayo Clinic Zebrafish Facility, respectively.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Zoltan Varga for sharing of the ZIRC sperm cryopreservation protocol prior to publication, Vincent Cunliffe for sharing <italic>p-mylpfa</italic>:GCaMP3 plasmid, Sara Whiteman, Arthur Beyder, and Constanza Alcaino (Enteric Neuroscience Program, Mayo Clinic) for allowing us to use their Ca<sup>2+</sup> imaging setup and to Krista Habing and David Linden (Enteric Neuroscience Program, Mayo Clinic) for technical help with Ca<sup>2+</sup> imaging analysis. Additional thanks to the Mayo Clinic Media Services for providing the image in <xref ref-type="fig" rid="fig5">Figure 5A</xref>. Appreciation is also extended to the Mayo Clinic Zebrafish Facility staff for their excellent support.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Resources, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con3"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con4"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con5"><p>Resources, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Investigation, Writing - original draft</p></fn><fn fn-type="con" id="con7"><p>Resources, Investigation, Methodology, Writing - original draft</p></fn><fn fn-type="con" id="con8"><p>Data curation, Investigation, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con10"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con11"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con12"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con13"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con14"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con15"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con16"><p>Resources, Investigation</p></fn><fn fn-type="con" id="con17"><p>Investigation, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con18"><p>Investigation, Writing - original draft</p></fn><fn fn-type="con" id="con19"><p>Investigation</p></fn><fn fn-type="con" id="con20"><p>Data curation, Supervision, Writing - review and editing</p></fn><fn fn-type="con" id="con21"><p>Supervision, Funding acquisition, Investigation</p></fn><fn fn-type="con" id="con22"><p>Resources</p></fn><fn fn-type="con" id="con23"><p>Supervision, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con24"><p>Supervision, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con25"><p>Resources, Supervision, Funding acquisition, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con26"><p>Resources, Supervision, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con27"><p>Resources, Supervision, Funding acquisition, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con28"><p>Resources, Supervision, Funding acquisition, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con29"><p>Data curation, Supervision, Funding acquisition, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con30"><p>Conceptualization, Resources, Data curation, Supervision, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con31"><p>Conceptualization, Resources, Data curation, Supervision, Funding acquisition, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All zebrafish were maintained according to the guidelines and the standard procedures approved by the Mayo Clinic Institutional Animal Care and Use Committee (Mayo IACUC). The Mayo IACUC approved all protocols involving live vertebrate animals (A23107, A21710 and A34513).</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Genes disrupted in GBT-confirmed lines.</title><p>Table lists the tagged genes (or unannotated coding sequence) of GBT-confirmed lines, genomic location and orientation of integrated loci, novel expression at 2 and 4 dpf, their human orthologs, and disease associations of their human orthologs. Blue text: published GBT-confirmed line, Red text: Integration locus in unannotated coding sequence, *: RNA sequencing reads mapping on the unannotated loci in at least one public dataset, †; zebrafish paralogs of GBT-tagged genes with one human ortholog, ‡: sequence of single 5’ or 3’ RACE product matched to two separate transcripts, *: integration locus mapped to GRCz11, <sup>γ</sup>: line previously published as GBT0136, <sup>d</sup>: denotes replicate genes with distinct integration events.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54572-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Homozygous phenotypes in GBT-confirmed lines.</title><p>List of GBT-confirmed line number, tagged gene, a summary of their established phenotype, and references where more detailed characterization of each line can be found.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54572-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Publicly available human disease models.</title><p>Established models of 32 human genetic disorders associated with 24 human orthologs of the GBT-tagged genes are generated by alternative genetic approaches in zebrafish and mice. This table listed the GBT ID of the tagged genes, both zebrafish tagged genes and their human orthologs, disease association of the human orthologs, disease ontology ID, number of models in zebrafish and mice listed in ZFIN (<ext-link ext-link-type="uri" xlink:href="http://zfin.org/">http://zfin.org/</ext-link>)(<xref ref-type="bibr" rid="bib50">Ruzicka et al., 2019</xref>) and MGI (<ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org">http://www.informatics.jax.org</ext-link>)(<xref ref-type="bibr" rid="bib9">Bult et al., 2019</xref>) databases and references.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54572-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Subcellular localization of human orthologs tagged in GBT-confirmed lines.</title><p>Subcellular localizations of 177 human orthologs tagged in GBT-confirmed lines were listed using experimental data from Human Protein Atlas (<ext-link ext-link-type="uri" xlink:href="http://www.proteinatlas.org">www.proteinatlas.org</ext-link>) (<xref ref-type="bibr" rid="bib58">Uhlén et al., 2015</xref>) and knowledge base data from the UniProt knowledge base (UniProtKB, <ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/">https://www.uniprot.org/</ext-link>, <xref ref-type="bibr" rid="bib59">UniProt Consortium, 2018</xref>). *: UniProt annotation data, †: GO – Cellular Component, ‡: sequence of single 5’ or 3’ RACE product matched to two separate transcripts.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54572-supp4-v2.xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Oligo names and sequences.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-54572-supp5-v2.xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>The R code and output for sample size estimation and statistical analysis.</title><p>Individual worksheets in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref> represent the individual ‘.csv’ files read into R to perform these analyses and are named accordingly.</p></caption><media mime-subtype="pdf" mimetype="application" xlink:href="elife-54572-supp6-v2.pdf"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-54572-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figure 3, Figure 4, Figure 4-Figure Supplement 1, Figure 5 and Figure 6.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afgan</surname> <given-names>E</given-names></name><name><surname>Baker</surname> <given-names>D</given-names></name><name><surname>Batut</surname> <given-names>B</given-names></name><name><surname>van den Beek</surname> <given-names>M</given-names></name><name><surname>Bouvier</surname> <given-names>D</given-names></name><name><surname>Cech</surname> <given-names>M</given-names></name><name><surname>Chilton</surname> <given-names>J</given-names></name><name><surname>Clements</surname> <given-names>D</given-names></name><name><surname>Coraor</surname> <given-names>N</given-names></name><name><surname>Grüning</surname> <given-names>BA</given-names></name><name><surname>Guerler</surname> <given-names>A</given-names></name><name><surname>Hillman-Jackson</surname> <given-names>J</given-names></name><name><surname>Hiltemann</surname> <given-names>S</given-names></name><name><surname>Jalili</surname> <given-names>V</given-names></name><name><surname>Rasche</surname> <given-names>H</given-names></name><name><surname>Soranzo</surname> <given-names>N</given-names></name><name><surname>Goecks</surname> <given-names>J</given-names></name><name><surname>Taylor</surname> <given-names>J</given-names></name><name><surname>Nekrutenko</surname> <given-names>A</given-names></name><name><surname>Blankenberg</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>W537</fpage><lpage>W544</lpage><pub-id pub-id-type="doi">10.1093/nar/gky379</pub-id><pub-id pub-id-type="pmid">29790989</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amberger</surname> <given-names>JS</given-names></name><name><surname>Bocchini</surname> <given-names>CA</given-names></name><name><surname>Scott</surname> <given-names>AF</given-names></name><name><surname>Hamosh</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Omim.org: leveraging knowledge across phenotype-gene relationships</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D1038</fpage><lpage>D1043</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1151</pub-id><pub-id pub-id-type="pmid">30445645</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amsterdam</surname> <given-names>A</given-names></name><name><surname>Hopkins</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Retroviral-mediated insertional mutagenesis in zebrafish</article-title><source>Methods in Cell Biology</source><volume>77</volume><fpage>3</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/s0091-679x(04)77001-6</pub-id><pub-id pub-id-type="pmid">15602903</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname> <given-names>JL</given-names></name><name><surname>Mulligan</surname> <given-names>TS</given-names></name><name><surname>Shen</surname> <given-names>MC</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Scahill</surname> <given-names>CM</given-names></name><name><surname>Tan</surname> <given-names>FJ</given-names></name><name><surname>Du</surname> <given-names>SJ</given-names></name><name><surname>Busch-Nentwich</surname> <given-names>EM</given-names></name><name><surname>Farber</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>mRNA processing in mutant zebrafish lines generated by chemical and CRISPR-mediated mutagenesis produces unexpected transcripts that escape nonsense-mediated decay</article-title><source>PLOS Genetics</source><volume>13</volume><elocation-id>e1007105</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007105</pub-id><pub-id pub-id-type="pmid">29161261</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balciunas</surname> <given-names>D</given-names></name><name><surname>Wangensteen</surname> <given-names>KJ</given-names></name><name><surname>Wilber</surname> <given-names>A</given-names></name><name><surname>Bell</surname> <given-names>J</given-names></name><name><surname>Geurts</surname> <given-names>A</given-names></name><name><surname>Sivasubbu</surname> <given-names>S</given-names></name><name><surname>Wang</surname> <given-names>X</given-names></name><name><surname>Hackett</surname> <given-names>PB</given-names></name><name><surname>Largaespada</surname> <given-names>DA</given-names></name><name><surname>McIvor</surname> <given-names>RS</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Harnessing a high cargo-capacity transposon for genetic applications in vertebrates</article-title><source>PLOS Genetics</source><volume>2</volume><elocation-id>e169</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.0020169</pub-id><pub-id pub-id-type="pmid">17096595</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balciunas</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fish mutant<italic>, where is thy phenotype?</italic></article-title><source>PLOS Genetics</source><volume>14</volume><elocation-id>e1007197</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1007197</pub-id><pub-id pub-id-type="pmid">29470494</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnett</surname> <given-names>DW</given-names></name><name><surname>Garrison</surname> <given-names>EK</given-names></name><name><surname>Quinlan</surname> <given-names>AR</given-names></name><name><surname>Strömberg</surname> <given-names>MP</given-names></name><name><surname>Marth</surname> <given-names>GT</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>BamTools: a C++ API and toolkit for analyzing and managing BAM files</article-title><source>Bioinformatics</source><volume>27</volume><fpage>1691</fpage><lpage>1692</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr174</pub-id><pub-id pub-id-type="pmid">21493652</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baxendale</surname> <given-names>S</given-names></name><name><surname>Holdsworth</surname> <given-names>CJ</given-names></name><name><surname>Meza Santoscoy</surname> <given-names>PL</given-names></name><name><surname>Harrison</surname> <given-names>MR</given-names></name><name><surname>Fox</surname> <given-names>J</given-names></name><name><surname>Parkin</surname> <given-names>CA</given-names></name><name><surname>Ingham</surname> <given-names>PW</given-names></name><name><surname>Cunliffe</surname> <given-names>VT</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures</article-title><source>Disease Models &amp; Mechanisms</source><volume>5</volume><fpage>773</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1242/dmm.010090</pub-id><pub-id pub-id-type="pmid">22730455</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bult</surname> <given-names>CJ</given-names></name><name><surname>Blake</surname> <given-names>JA</given-names></name><name><surname>Smith</surname> <given-names>CL</given-names></name><name><surname>Kadin</surname> <given-names>JA</given-names></name><name><surname>Richardson</surname> <given-names>JE</given-names></name><collab>Mouse Genome Database Group</collab></person-group><year iso-8601-date="2019">2019</year><article-title>Mouse genome database (MGD) 2019</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D801</fpage><lpage>D806</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1056</pub-id><pub-id pub-id-type="pmid">30407599</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Balciunas</surname> <given-names>D</given-names></name><name><surname>Pogoda</surname> <given-names>HM</given-names></name><name><surname>Ding</surname> <given-names>Y</given-names></name><name><surname>Westcot</surname> <given-names>SE</given-names></name><name><surname>Bedell</surname> <given-names>VM</given-names></name><name><surname>Greenwood</surname> <given-names>TM</given-names></name><name><surname>Urban</surname> <given-names>MD</given-names></name><name><surname>Skuster</surname> <given-names>KJ</given-names></name><name><surname>Petzold</surname> <given-names>AM</given-names></name><name><surname>Ni</surname> <given-names>J</given-names></name><name><surname>Nielsen</surname> <given-names>AL</given-names></name><name><surname>Patowary</surname> <given-names>A</given-names></name><name><surname>Scaria</surname> <given-names>V</given-names></name><name><surname>Sivasubbu</surname> <given-names>S</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name><name><surname>Hammerschmidt</surname> <given-names>M</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2011">2011a</year><article-title>In vivo protein trapping produces a functional expression codex of the vertebrate proteome</article-title><source>Nature Methods</source><volume>8</volume><fpage>506</fpage><lpage>512</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1606</pub-id><pub-id pub-id-type="pmid">21552255</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Urban</surname> <given-names>MD</given-names></name><name><surname>Skuster</surname> <given-names>KJ</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2011">2011b</year><article-title>Transgenic zebrafish using transposable elements</article-title><source>Methods in Cell Biology</source><volume>104</volume><fpage>137</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-374814-0.00008-2</pub-id><pub-id pub-id-type="pmid">21924161</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Argue</surname> <given-names>DP</given-names></name><name><surname>Petzold</surname> <given-names>AM</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Zfishbook: connecting you to a world of zebrafish revertible mutants</article-title><source>Nucleic Acids Research</source><volume>40</volume><fpage>D907</fpage><lpage>D911</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr957</pub-id><pub-id pub-id-type="pmid">22067444</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname> <given-names>AE</given-names></name><name><surname>Balciunas</surname> <given-names>D</given-names></name><name><surname>Mohn</surname> <given-names>D</given-names></name><name><surname>Shaffer</surname> <given-names>J</given-names></name><name><surname>Hermanson</surname> <given-names>S</given-names></name><name><surname>Sivasubbu</surname> <given-names>S</given-names></name><name><surname>Cliff</surname> <given-names>MP</given-names></name><name><surname>Hackett</surname> <given-names>PB</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Efficient gene delivery and gene expression in zebrafish using the sleeping beauty transposon</article-title><source>Developmental Biology</source><volume>263</volume><fpage>191</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1016/j.ydbio.2003.07.013</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>Deng</surname> <given-names>Y</given-names></name><name><surname>Jomok</surname> <given-names>B</given-names></name><name><surname>Yang</surname> <given-names>J</given-names></name><name><surname>Huang</surname> <given-names>W</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Zhong</surname> <given-names>TP</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Trapping cardiac recessive mutants via expression-based insertional mutagenesis screening</article-title><source>Circulation Research</source><volume>112</volume><fpage>606</fpage><lpage>617</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.300603</pub-id><pub-id pub-id-type="pmid">23283723</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname> <given-names>Y</given-names></name><name><surname>Long</surname> <given-names>PA</given-names></name><name><surname>Bos</surname> <given-names>JM</given-names></name><name><surname>Shih</surname> <given-names>Y-H</given-names></name><name><surname>Ma</surname> <given-names>X</given-names></name><name><surname>Sundsbak</surname> <given-names>RS</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Jiang</surname> <given-names>Y</given-names></name><name><surname>Zhao</surname> <given-names>L</given-names></name><name><surname>Hu</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Ackerman</surname> <given-names>MJ</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name><name><surname>Redfield</surname> <given-names>MM</given-names></name><name><surname>Olson</surname> <given-names>TM</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene</article-title><source>JCI Insight</source><volume>2</volume><elocation-id>e94086</elocation-id><pub-id pub-id-type="doi">10.1172/jci.insight.94086</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draper</surname> <given-names>BW</given-names></name><name><surname>Moens</surname> <given-names>CB</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>A High-Throughput method for zebrafish sperm cryopreservation and &lt;em&gt;in vitro&lt;/em&gt; fertilization</article-title><source>Journal of Visualized Experiments</source><volume>29</volume><elocation-id>1395</elocation-id><pub-id pub-id-type="doi">10.3791/1395</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Khoury</surname> <given-names>LY</given-names></name><name><surname>Campbell</surname> <given-names>JM</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The transition of zebrafish functional genetics from random mutagenesis to targeted integration</article-title><source>Molecular-Genetic and Statistical Techniques for Behavioral and Neural Research</source><volume>2018</volume><fpage>401</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-804078-2.00017-9</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Brolosy</surname> <given-names>MA</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Genetic compensation: a phenomenon in search of mechanisms</article-title><source>PLOS Genetics</source><volume>13</volume><elocation-id>e1006780</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006780</pub-id><pub-id pub-id-type="pmid">28704371</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Rass</surname> <given-names>S</given-names></name><name><surname>Eisa-Beygi</surname> <given-names>S</given-names></name><name><surname>Khong</surname> <given-names>E</given-names></name><name><surname>Brand-Arzamendi</surname> <given-names>K</given-names></name><name><surname>Mauro</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name><name><surname>Wen</surname> <given-names>XY</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Disruption of <italic>pdgfra</italic> alters endocardial and myocardial fusion during zebrafish cardiac assembly</article-title><source>Biology Open</source><volume>6</volume><fpage>348</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1242/bio.021212</pub-id><pub-id pub-id-type="pmid">28167492</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haffter</surname> <given-names>P</given-names></name><name><surname>Granato</surname> <given-names>M</given-names></name><name><surname>Brand</surname> <given-names>M</given-names></name><name><surname>Mullins</surname> <given-names>MC</given-names></name><name><surname>Hammerschmidt</surname> <given-names>M</given-names></name><name><surname>Kane</surname> <given-names>DA</given-names></name><name><surname>Odenthal</surname> <given-names>J</given-names></name><name><surname>van Eeden</surname> <given-names>FJ</given-names></name><name><surname>Jiang</surname> <given-names>YJ</given-names></name><name><surname>Heisenberg</surname> <given-names>CP</given-names></name><name><surname>Kelsh</surname> <given-names>RN</given-names></name><name><surname>Furutani-Seiki</surname> <given-names>M</given-names></name><name><surname>Vogelsang</surname> <given-names>E</given-names></name><name><surname>Beuchle</surname> <given-names>D</given-names></name><name><surname>Schach</surname> <given-names>U</given-names></name><name><surname>Fabian</surname> <given-names>C</given-names></name><name><surname>Nüsslein-Volhard</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>The identification of genes with unique and essential functions in the development of the zebrafish, <italic>Danio rerio</italic></article-title><source>Development</source><volume>123</volume><fpage>1</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">9007226</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernández-Ochoa</surname> <given-names>EO</given-names></name><name><surname>Pratt</surname> <given-names>SJP</given-names></name><name><surname>Lovering</surname> <given-names>RM</given-names></name><name><surname>Schneider</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Critical role of intracellular RyR1 calcium release channels in skeletal muscle function and disease</article-title><source>Frontiers in Physiology</source><volume>6</volume><elocation-id>420</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2015.00420</pub-id><pub-id pub-id-type="pmid">26793121</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirata</surname> <given-names>H</given-names></name><name><surname>Watanabe</surname> <given-names>T</given-names></name><name><surname>Hatakeyama</surname> <given-names>J</given-names></name><name><surname>Sprague</surname> <given-names>SM</given-names></name><name><surname>Saint-Amant</surname> <given-names>L</given-names></name><name><surname>Nagashima</surname> <given-names>A</given-names></name><name><surname>Cui</surname> <given-names>WW</given-names></name><name><surname>Zhou</surname> <given-names>W</given-names></name><name><surname>Kuwada</surname> <given-names>JY</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Zebrafish relatively relaxed mutants have a ryanodine receptor defect, show slow swimming and provide a model of multi-minicore disease</article-title><source>Development</source><volume>134</volume><fpage>2771</fpage><lpage>2781</lpage><pub-id pub-id-type="doi">10.1242/dev.004531</pub-id><pub-id pub-id-type="pmid">17596281</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hothorn</surname> <given-names>T</given-names></name><name><surname>Hornik</surname> <given-names>K</given-names></name><name><surname>van de Wiel</surname> <given-names>MA</given-names></name><name><surname>Zeileis</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A lego system for conditional inference</article-title><source>The American Statistician</source><volume>60</volume><fpage>257</fpage><lpage>263</lpage><pub-id pub-id-type="doi">10.1198/000313006X118430</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hothorn</surname> <given-names>T</given-names></name><name><surname>Hornik</surname> <given-names>K</given-names></name><name><surname>van de Wiel</surname> <given-names>MA</given-names></name><name><surname>Zeileis</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Implementing a class of permutation tests: the coin package</article-title><source>Journal of Statistical Software </source><volume>28</volume><elocation-id>23</elocation-id><pub-id pub-id-type="doi">10.18637/jss.v028.i08</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howe</surname> <given-names>K</given-names></name><name><surname>Clark</surname> <given-names>MD</given-names></name><name><surname>Torroja</surname> <given-names>CF</given-names></name><name><surname>Torrance</surname> <given-names>J</given-names></name><name><surname>Berthelot</surname> <given-names>C</given-names></name><name><surname>Muffato</surname> <given-names>M</given-names></name><name><surname>Collins</surname> <given-names>JE</given-names></name><name><surname>Humphray</surname> <given-names>S</given-names></name><name><surname>McLaren</surname> <given-names>K</given-names></name><name><surname>Matthews</surname> <given-names>L</given-names></name><name><surname>McLaren</surname> <given-names>S</given-names></name><name><surname>Sealy</surname> <given-names>I</given-names></name><name><surname>Caccamo</surname> <given-names>M</given-names></name><name><surname>Churcher</surname> <given-names>C</given-names></name><name><surname>Scott</surname> <given-names>C</given-names></name><name><surname>Barrett</surname> <given-names>JC</given-names></name><name><surname>Koch</surname> <given-names>R</given-names></name><name><surname>Rauch</surname> <given-names>GJ</given-names></name><name><surname>White</surname> <given-names>S</given-names></name><name><surname>Chow</surname> <given-names>W</given-names></name><name><surname>Kilian</surname> <given-names>B</given-names></name><name><surname>Quintais</surname> <given-names>LT</given-names></name><name><surname>Guerra-Assunção</surname> <given-names>JA</given-names></name><name><surname>Zhou</surname> <given-names>Y</given-names></name><name><surname>Gu</surname> <given-names>Y</given-names></name><name><surname>Yen</surname> <given-names>J</given-names></name><name><surname>Vogel</surname> <given-names>JH</given-names></name><name><surname>Eyre</surname> <given-names>T</given-names></name><name><surname>Redmond</surname> <given-names>S</given-names></name><name><surname>Banerjee</surname> <given-names>R</given-names></name><name><surname>Chi</surname> <given-names>J</given-names></name><name><surname>Fu</surname> <given-names>B</given-names></name><name><surname>Langley</surname> <given-names>E</given-names></name><name><surname>Maguire</surname> <given-names>SF</given-names></name><name><surname>Laird</surname> <given-names>GK</given-names></name><name><surname>Lloyd</surname> <given-names>D</given-names></name><name><surname>Kenyon</surname> <given-names>E</given-names></name><name><surname>Donaldson</surname> <given-names>S</given-names></name><name><surname>Sehra</surname> <given-names>H</given-names></name><name><surname>Almeida-King</surname> <given-names>J</given-names></name><name><surname>Loveland</surname> <given-names>J</given-names></name><name><surname>Trevanion</surname> <given-names>S</given-names></name><name><surname>Jones</surname> <given-names>M</given-names></name><name><surname>Quail</surname> <given-names>M</given-names></name><name><surname>Willey</surname> <given-names>D</given-names></name><name><surname>Hunt</surname> <given-names>A</given-names></name><name><surname>Burton</surname> <given-names>J</given-names></name><name><surname>Sims</surname> <given-names>S</given-names></name><name><surname>McLay</surname> <given-names>K</given-names></name><name><surname>Plumb</surname> <given-names>B</given-names></name><name><surname>Davis</surname> <given-names>J</given-names></name><name><surname>Clee</surname> <given-names>C</given-names></name><name><surname>Oliver</surname> <given-names>K</given-names></name><name><surname>Clark</surname> <given-names>R</given-names></name><name><surname>Riddle</surname> <given-names>C</given-names></name><name><surname>Elliot</surname> <given-names>D</given-names></name><name><surname>Eliott</surname> <given-names>D</given-names></name><name><surname>Threadgold</surname> <given-names>G</given-names></name><name><surname>Harden</surname> <given-names>G</given-names></name><name><surname>Ware</surname> <given-names>D</given-names></name><name><surname>Begum</surname> <given-names>S</given-names></name><name><surname>Mortimore</surname> <given-names>B</given-names></name><name><surname>Mortimer</surname> <given-names>B</given-names></name><name><surname>Kerry</surname> <given-names>G</given-names></name><name><surname>Heath</surname> <given-names>P</given-names></name><name><surname>Phillimore</surname> <given-names>B</given-names></name><name><surname>Tracey</surname> <given-names>A</given-names></name><name><surname>Corby</surname> <given-names>N</given-names></name><name><surname>Dunn</surname> <given-names>M</given-names></name><name><surname>Johnson</surname> <given-names>C</given-names></name><name><surname>Wood</surname> <given-names>J</given-names></name><name><surname>Clark</surname> <given-names>S</given-names></name><name><surname>Pelan</surname> <given-names>S</given-names></name><name><surname>Griffiths</surname> <given-names>G</given-names></name><name><surname>Smith</surname> <given-names>M</given-names></name><name><surname>Glithero</surname> <given-names>R</given-names></name><name><surname>Howden</surname> <given-names>P</given-names></name><name><surname>Barker</surname> <given-names>N</given-names></name><name><surname>Lloyd</surname> <given-names>C</given-names></name><name><surname>Stevens</surname> <given-names>C</given-names></name><name><surname>Harley</surname> <given-names>J</given-names></name><name><surname>Holt</surname> <given-names>K</given-names></name><name><surname>Panagiotidis</surname> <given-names>G</given-names></name><name><surname>Lovell</surname> <given-names>J</given-names></name><name><surname>Beasley</surname> <given-names>H</given-names></name><name><surname>Henderson</surname> <given-names>C</given-names></name><name><surname>Gordon</surname> <given-names>D</given-names></name><name><surname>Auger</surname> <given-names>K</given-names></name><name><surname>Wright</surname> <given-names>D</given-names></name><name><surname>Collins</surname> <given-names>J</given-names></name><name><surname>Raisen</surname> <given-names>C</given-names></name><name><surname>Dyer</surname> <given-names>L</given-names></name><name><surname>Leung</surname> <given-names>K</given-names></name><name><surname>Robertson</surname> <given-names>L</given-names></name><name><surname>Ambridge</surname> <given-names>K</given-names></name><name><surname>Leongamornlert</surname> <given-names>D</given-names></name><name><surname>McGuire</surname> <given-names>S</given-names></name><name><surname>Gilderthorp</surname> <given-names>R</given-names></name><name><surname>Griffiths</surname> <given-names>C</given-names></name><name><surname>Manthravadi</surname> <given-names>D</given-names></name><name><surname>Nichol</surname> <given-names>S</given-names></name><name><surname>Barker</surname> <given-names>G</given-names></name><name><surname>Whitehead</surname> <given-names>S</given-names></name><name><surname>Kay</surname> <given-names>M</given-names></name><name><surname>Brown</surname> <given-names>J</given-names></name><name><surname>Murnane</surname> <given-names>C</given-names></name><name><surname>Gray</surname> <given-names>E</given-names></name><name><surname>Humphries</surname> <given-names>M</given-names></name><name><surname>Sycamore</surname> <given-names>N</given-names></name><name><surname>Barker</surname> <given-names>D</given-names></name><name><surname>Saunders</surname> <given-names>D</given-names></name><name><surname>Wallis</surname> <given-names>J</given-names></name><name><surname>Babbage</surname> <given-names>A</given-names></name><name><surname>Hammond</surname> <given-names>S</given-names></name><name><surname>Mashreghi-Mohammadi</surname> <given-names>M</given-names></name><name><surname>Barr</surname> <given-names>L</given-names></name><name><surname>Martin</surname> <given-names>S</given-names></name><name><surname>Wray</surname> <given-names>P</given-names></name><name><surname>Ellington</surname> <given-names>A</given-names></name><name><surname>Matthews</surname> <given-names>N</given-names></name><name><surname>Ellwood</surname> <given-names>M</given-names></name><name><surname>Woodmansey</surname> <given-names>R</given-names></name><name><surname>Clark</surname> <given-names>G</given-names></name><name><surname>Cooper</surname> <given-names>J</given-names></name><name><surname>Cooper</surname> <given-names>J</given-names></name><name><surname>Tromans</surname> <given-names>A</given-names></name><name><surname>Grafham</surname> <given-names>D</given-names></name><name><surname>Skuce</surname> <given-names>C</given-names></name><name><surname>Pandian</surname> <given-names>R</given-names></name><name><surname>Andrews</surname> <given-names>R</given-names></name><name><surname>Harrison</surname> <given-names>E</given-names></name><name><surname>Kimberley</surname> <given-names>A</given-names></name><name><surname>Garnett</surname> <given-names>J</given-names></name><name><surname>Fosker</surname> <given-names>N</given-names></name><name><surname>Hall</surname> <given-names>R</given-names></name><name><surname>Garner</surname> <given-names>P</given-names></name><name><surname>Kelly</surname> <given-names>D</given-names></name><name><surname>Bird</surname> <given-names>C</given-names></name><name><surname>Palmer</surname> <given-names>S</given-names></name><name><surname>Gehring</surname> <given-names>I</given-names></name><name><surname>Berger</surname> <given-names>A</given-names></name><name><surname>Dooley</surname> <given-names>CM</given-names></name><name><surname>Ersan-Ürün</surname> <given-names>Z</given-names></name><name><surname>Eser</surname> <given-names>C</given-names></name><name><surname>Geiger</surname> <given-names>H</given-names></name><name><surname>Geisler</surname> <given-names>M</given-names></name><name><surname>Karotki</surname> <given-names>L</given-names></name><name><surname>Kirn</surname> <given-names>A</given-names></name><name><surname>Konantz</surname> <given-names>J</given-names></name><name><surname>Konantz</surname> <given-names>M</given-names></name><name><surname>Oberländer</surname> <given-names>M</given-names></name><name><surname>Rudolph-Geiger</surname> <given-names>S</given-names></name><name><surname>Teucke</surname> <given-names>M</given-names></name><name><surname>Lanz</surname> <given-names>C</given-names></name><name><surname>Raddatz</surname> <given-names>G</given-names></name><name><surname>Osoegawa</surname> <given-names>K</given-names></name><name><surname>Zhu</surname> <given-names>B</given-names></name><name><surname>Rapp</surname> <given-names>A</given-names></name><name><surname>Widaa</surname> <given-names>S</given-names></name><name><surname>Langford</surname> <given-names>C</given-names></name><name><surname>Yang</surname> <given-names>F</given-names></name><name><surname>Schuster</surname> <given-names>SC</given-names></name><name><surname>Carter</surname> <given-names>NP</given-names></name><name><surname>Harrow</surname> <given-names>J</given-names></name><name><surname>Ning</surname> <given-names>Z</given-names></name><name><surname>Herrero</surname> <given-names>J</given-names></name><name><surname>Searle</surname> <given-names>SM</given-names></name><name><surname>Enright</surname> <given-names>A</given-names></name><name><surname>Geisler</surname> <given-names>R</given-names></name><name><surname>Plasterk</surname> <given-names>RH</given-names></name><name><surname>Lee</surname> <given-names>C</given-names></name><name><surname>Westerfield</surname> <given-names>M</given-names></name><name><surname>de Jong</surname> <given-names>PJ</given-names></name><name><surname>Zon</surname> <given-names>LI</given-names></name><name><surname>Postlethwait</surname> <given-names>JH</given-names></name><name><surname>Nüsslein-Volhard</surname> <given-names>C</given-names></name><name><surname>Hubbard</surname> <given-names>TJ</given-names></name><name><surname>Roest Crollius</surname> <given-names>H</given-names></name><name><surname>Rogers</surname> <given-names>J</given-names></name><name><surname>Stemple</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The zebrafish reference genome sequence and its relationship to the human genome</article-title><source>Nature</source><volume>496</volume><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1038/nature12111</pub-id><pub-id pub-id-type="pmid">23594743</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hulsen</surname> <given-names>T</given-names></name><name><surname>de Vlieg</surname> <given-names>J</given-names></name><name><surname>Alkema</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>BioVenn - a web application for the comparison and visualization of biological lists using area-proportional venn diagrams</article-title><source>BMC Genomics</source><volume>9</volume><elocation-id>488</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2164-9-488</pub-id><pub-id pub-id-type="pmid">18925949</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagannathan</surname> <given-names>S</given-names></name><name><surname>Bradley</surname> <given-names>RK</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Translational plasticity facilitates the accumulation of nonsense genetic variants in the human population</article-title><source>Genome Research</source><volume>26</volume><fpage>1639</fpage><lpage>1650</lpage><pub-id pub-id-type="doi">10.1101/gr.205070.116</pub-id><pub-id pub-id-type="pmid">27646533</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jungbluth</surname> <given-names>H</given-names></name><name><surname>Treves</surname> <given-names>S</given-names></name><name><surname>Zorzato</surname> <given-names>F</given-names></name><name><surname>Sarkozy</surname> <given-names>A</given-names></name><name><surname>Ochala</surname> <given-names>J</given-names></name><name><surname>Sewry</surname> <given-names>C</given-names></name><name><surname>Phadke</surname> <given-names>R</given-names></name><name><surname>Gautel</surname> <given-names>M</given-names></name><name><surname>Muntoni</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Congenital myopathies: disorders of excitation-contraction coupling and muscle contraction</article-title><source>Nature Reviews Neurology</source><volume>14</volume><fpage>151</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1038/nrneurol.2017.191</pub-id><pub-id pub-id-type="pmid">29391587</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname> <given-names>K</given-names></name><name><surname>Takeda</surname> <given-names>H</given-names></name><name><surname>Kawakami</surname> <given-names>N</given-names></name><name><surname>Kobayashi</surname> <given-names>M</given-names></name><name><surname>Matsuda</surname> <given-names>N</given-names></name><name><surname>Mishina</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>A transposon-mediated gene trap approach identifies developmentally regulated genes in zebrafish</article-title><source>Developmental Cell</source><volume>7</volume><fpage>133</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2004.06.005</pub-id><pub-id pub-id-type="pmid">15239961</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kettleborough</surname> <given-names>RN</given-names></name><name><surname>Busch-Nentwich</surname> <given-names>EM</given-names></name><name><surname>Harvey</surname> <given-names>SA</given-names></name><name><surname>Dooley</surname> <given-names>CM</given-names></name><name><surname>de Bruijn</surname> <given-names>E</given-names></name><name><surname>van Eeden</surname> <given-names>F</given-names></name><name><surname>Sealy</surname> <given-names>I</given-names></name><name><surname>White</surname> <given-names>RJ</given-names></name><name><surname>Herd</surname> <given-names>C</given-names></name><name><surname>Nijman</surname> <given-names>IJ</given-names></name><name><surname>Fényes</surname> <given-names>F</given-names></name><name><surname>Mehroke</surname> <given-names>S</given-names></name><name><surname>Scahill</surname> <given-names>C</given-names></name><name><surname>Gibbons</surname> <given-names>R</given-names></name><name><surname>Wali</surname> <given-names>N</given-names></name><name><surname>Carruthers</surname> <given-names>S</given-names></name><name><surname>Hall</surname> <given-names>A</given-names></name><name><surname>Yen</surname> <given-names>J</given-names></name><name><surname>Cuppen</surname> <given-names>E</given-names></name><name><surname>Stemple</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A systematic genome-wide analysis of zebrafish protein-coding gene function</article-title><source>Nature</source><volume>496</volume><fpage>494</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1038/nature11992</pub-id><pub-id pub-id-type="pmid">23594742</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Pertea</surname> <given-names>G</given-names></name><name><surname>Trapnell</surname> <given-names>C</given-names></name><name><surname>Pimentel</surname> <given-names>H</given-names></name><name><surname>Kelley</surname> <given-names>R</given-names></name><name><surname>Salzberg</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions</article-title><source>Genome Biology</source><volume>14</volume><elocation-id>R36</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2013-14-4-r36</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kinsella</surname> <given-names>RJ</given-names></name><name><surname>Kähäri</surname> <given-names>A</given-names></name><name><surname>Haider</surname> <given-names>S</given-names></name><name><surname>Zamora</surname> <given-names>J</given-names></name><name><surname>Proctor</surname> <given-names>G</given-names></name><name><surname>Spudich</surname> <given-names>G</given-names></name><name><surname>Almeida-King</surname> <given-names>J</given-names></name><name><surname>Staines</surname> <given-names>D</given-names></name><name><surname>Derwent</surname> <given-names>P</given-names></name><name><surname>Kerhornou</surname> <given-names>A</given-names></name><name><surname>Kersey</surname> <given-names>P</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Ensembl BioMarts: a hub for data retrieval across taxonomic space</article-title><source>Database</source><volume>2011</volume><elocation-id>bar030</elocation-id><pub-id pub-id-type="doi">10.1093/database/bar030</pub-id><pub-id pub-id-type="pmid">21785142</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lalonde</surname> <given-names>S</given-names></name><name><surname>Stone</surname> <given-names>OA</given-names></name><name><surname>Lessard</surname> <given-names>S</given-names></name><name><surname>Lavertu</surname> <given-names>A</given-names></name><name><surname>Desjardins</surname> <given-names>J</given-names></name><name><surname>Beaudoin</surname> <given-names>M</given-names></name><name><surname>Rivas</surname> <given-names>M</given-names></name><name><surname>Stainier</surname> <given-names>DYR</given-names></name><name><surname>Lettre</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Frameshift indels introduced by genome editing can lead to in-frame exon skipping</article-title><source>PLOS ONE</source><volume>12</volume><elocation-id>e0178700</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0178700</pub-id><pub-id pub-id-type="pmid">28570605</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leveque</surname> <given-names>RE</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mayo clinic zebrafish facility overview</article-title><source>Zebrafish</source><volume>13</volume><fpage>S44</fpage><lpage>S46</lpage><pub-id pub-id-type="doi">10.1089/zeb.2015.1227</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>HK</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Noack Watt</surname> <given-names>KE</given-names></name><name><surname>Wen</surname> <given-names>Q</given-names></name><name><surname>Breitbach</surname> <given-names>J</given-names></name><name><surname>Kemmet</surname> <given-names>CK</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name><name><surname>Essner</surname> <given-names>JJ</given-names></name><name><surname>McGrail</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Tol2 gene trap integrations in the zebrafish amyloid precursor protein genes appa and aplp2 reveal accumulation of secreted APP at the embryonic veins</article-title><source>Developmental Dynamics</source><volume>241</volume><fpage>415</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1002/dvdy.23725</pub-id><pub-id pub-id-type="pmid">22275008</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>TL</given-names></name><name><surname>Upadhyayula</surname> <given-names>S</given-names></name><name><surname>Milkie</surname> <given-names>DE</given-names></name><name><surname>Singh</surname> <given-names>V</given-names></name><name><surname>Wang</surname> <given-names>K</given-names></name><name><surname>Swinburne</surname> <given-names>IA</given-names></name><name><surname>Mosaliganti</surname> <given-names>KR</given-names></name><name><surname>Collins</surname> <given-names>ZM</given-names></name><name><surname>Hiscock</surname> <given-names>TW</given-names></name><name><surname>Shea</surname> <given-names>J</given-names></name><name><surname>Kohrman</surname> <given-names>AQ</given-names></name><name><surname>Medwig</surname> <given-names>TN</given-names></name><name><surname>Dambournet</surname> <given-names>D</given-names></name><name><surname>Forster</surname> <given-names>R</given-names></name><name><surname>Cunniff</surname> <given-names>B</given-names></name><name><surname>Ruan</surname> <given-names>Y</given-names></name><name><surname>Yashiro</surname> <given-names>H</given-names></name><name><surname>Scholpp</surname> <given-names>S</given-names></name><name><surname>Meyerowitz</surname> <given-names>EM</given-names></name><name><surname>Hockemeyer</surname> <given-names>D</given-names></name><name><surname>Drubin</surname> <given-names>DG</given-names></name><name><surname>Martin</surname> <given-names>BL</given-names></name><name><surname>Matus</surname> <given-names>DQ</given-names></name><name><surname>Koyama</surname> <given-names>M</given-names></name><name><surname>Megason</surname> <given-names>SG</given-names></name><name><surname>Kirchhausen</surname> <given-names>T</given-names></name><name><surname>Betzig</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Observing the cell in its native state: imaging subcellular dynamics in multicellular organisms</article-title><source>Science</source><volume>360</volume><elocation-id>eaaq1392</elocation-id><pub-id pub-id-type="doi">10.1126/science.aaq1392</pub-id><pub-id pub-id-type="pmid">29674564</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname> <given-names>E</given-names></name><name><surname>Freeling</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>How to usefully compare homologous plant genes and chromosomes as DNA sequences</article-title><source>The Plant Journal</source><volume>53</volume><fpage>661</fpage><lpage>673</lpage><pub-id pub-id-type="doi">10.1111/j.1365-313X.2007.03326.x</pub-id><pub-id pub-id-type="pmid">18269575</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname> <given-names>X</given-names></name><name><surname>Zhu</surname> <given-names>P</given-names></name><name><surname>Ding</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Qiu</surname> <given-names>Q</given-names></name><name><surname>Dvornikov</surname> <given-names>AV</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Kim</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Lowerison</surname> <given-names>M</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>Norton</surname> <given-names>N</given-names></name><name><surname>Herrmann</surname> <given-names>J</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name><name><surname>Hsiai</surname> <given-names>TK</given-names></name><name><surname>Lin</surname> <given-names>X</given-names></name><name><surname>Xu</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Retinoid X receptor alpha is a spatiotemporally predominant therapeutic target for anthracycline-induced cardiotoxicity</article-title><source>Science Advances</source><volume>6</volume><elocation-id>eaay2939</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aay2939</pub-id><pub-id pub-id-type="pmid">32064346</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matthews</surname> <given-names>JL</given-names></name><name><surname>Murphy</surname> <given-names>JM</given-names></name><name><surname>Carmichael</surname> <given-names>C</given-names></name><name><surname>Yang</surname> <given-names>H</given-names></name><name><surname>Tiersch</surname> <given-names>T</given-names></name><name><surname>Westerfield</surname> <given-names>M</given-names></name><name><surname>Varga</surname> <given-names>ZM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Changes to extender, cryoprotective medium, and in vitro fertilization improve zebrafish sperm cryopreservation</article-title><source>Zebrafish</source><volume>15</volume><fpage>279</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1089/zeb.2017.1521</pub-id><pub-id pub-id-type="pmid">29369744</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meadows</surname> <given-names>JRS</given-names></name><name><surname>Lindblad-Toh</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Dissecting evolution and disease using comparative vertebrate genomics</article-title><source>Nature Reviews Genetics</source><volume>18</volume><fpage>624</fpage><lpage>636</lpage><pub-id pub-id-type="doi">10.1038/nrg.2017.51</pub-id><pub-id pub-id-type="pmid">28736437</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mi</surname> <given-names>H</given-names></name><name><surname>Muruganujan</surname> <given-names>A</given-names></name><name><surname>Ebert</surname> <given-names>D</given-names></name><name><surname>Huang</surname> <given-names>X</given-names></name><name><surname>Thomas</surname> <given-names>PD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D419</fpage><lpage>D426</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1038</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname> <given-names>TT</given-names></name><name><surname>Lu</surname> <given-names>J</given-names></name><name><surname>Zhu</surname> <given-names>M</given-names></name><name><surname>Maddison</surname> <given-names>LA</given-names></name><name><surname>Boyd</surname> <given-names>KL</given-names></name><name><surname>Huskey</surname> <given-names>L</given-names></name><name><surname>Ju</surname> <given-names>B</given-names></name><name><surname>Hesselson</surname> <given-names>D</given-names></name><name><surname>Zhong</surname> <given-names>TP</given-names></name><name><surname>Page-McCaw</surname> <given-names>PS</given-names></name><name><surname>Stainier</surname> <given-names>DY</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Conditional control of gene function by an invertible gene trap in zebrafish</article-title><source>PNAS</source><volume>109</volume><fpage>15389</fpage><lpage>15394</lpage><pub-id pub-id-type="doi">10.1073/pnas.1206131109</pub-id><pub-id pub-id-type="pmid">22908272</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname> <given-names>J</given-names></name><name><surname>Wangensteen</surname> <given-names>KJ</given-names></name><name><surname>Nelsen</surname> <given-names>D</given-names></name><name><surname>Balciunas</surname> <given-names>D</given-names></name><name><surname>Skuster</surname> <given-names>KJ</given-names></name><name><surname>Urban</surname> <given-names>MD</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Active recombinant Tol2 transposase for gene transfer and gene discovery applications</article-title><source>Mobile DNA</source><volume>7</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.1186/s13100-016-0062-z</pub-id><pub-id pub-id-type="pmid">27042235</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parinov</surname> <given-names>S</given-names></name><name><surname>Kondrichin</surname> <given-names>I</given-names></name><name><surname>Korzh</surname> <given-names>V</given-names></name><name><surname>Emelyanov</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Tol2 transposon-mediated enhancer trap to identify developmentally regulated zebrafish genes in vivo</article-title><source>Developmental Dynamics</source><volume>231</volume><fpage>449</fpage><lpage>459</lpage><pub-id pub-id-type="doi">10.1002/dvdy.20157</pub-id><pub-id pub-id-type="pmid">15366023</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petzold</surname> <given-names>AM</given-names></name><name><surname>Balciunas</surname> <given-names>D</given-names></name><name><surname>Sivasubbu</surname> <given-names>S</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Bedell</surname> <given-names>VM</given-names></name><name><surname>Westcot</surname> <given-names>SE</given-names></name><name><surname>Myers</surname> <given-names>SR</given-names></name><name><surname>Moulder</surname> <given-names>GL</given-names></name><name><surname>Thomas</surname> <given-names>MJ</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Nicotine response genetics in the zebrafish</article-title><source>PNAS</source><volume>106</volume><fpage>18662</fpage><lpage>18667</lpage><pub-id pub-id-type="doi">10.1073/pnas.0908247106</pub-id><pub-id pub-id-type="pmid">19858493</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petzold</surname> <given-names>AM</given-names></name><name><surname>Bedell</surname> <given-names>VM</given-names></name><name><surname>Boczek</surname> <given-names>NJ</given-names></name><name><surname>Essner</surname> <given-names>JJ</given-names></name><name><surname>Balciunas</surname> <given-names>D</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>SCORE imaging: specimen in a corrected optical rotational enclosure</article-title><source>Zebrafish</source><volume>7</volume><fpage>149</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1089/zeb.2010.0660</pub-id><pub-id pub-id-type="pmid">20528262</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prykhozhij</surname> <given-names>SV</given-names></name><name><surname>Steele</surname> <given-names>SL</given-names></name><name><surname>Razaghi</surname> <given-names>B</given-names></name><name><surname>Berman</surname> <given-names>JN</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A rapid and effective method for screening, sequencing and reporter verification of engineered frameshift mutations in zebrafish</article-title><source>Disease Models &amp; Mechanisms</source><volume>10</volume><fpage>811</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1242/dmm.026765</pub-id><pub-id pub-id-type="pmid">28280001</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="report"><person-group person-group-type="author"><name><surname>Robe</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2005">2005</year><source>Rare Diseases: Understanding This Public Health Priority</source><publisher-name>EURORDIS</publisher-name></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ronzitti</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Transcriptional adaptation: another reason why your disease model fails you</article-title><source>Science Translational Medicine</source><volume>11</volume><elocation-id>eaax1731</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aax1731</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruzicka</surname> <given-names>L</given-names></name><name><surname>Howe</surname> <given-names>DG</given-names></name><name><surname>Ramachandran</surname> <given-names>S</given-names></name><name><surname>Toro</surname> <given-names>S</given-names></name><name><surname>Van Slyke</surname> <given-names>CE</given-names></name><name><surname>Bradford</surname> <given-names>YM</given-names></name><name><surname>Eagle</surname> <given-names>A</given-names></name><name><surname>Fashena</surname> <given-names>D</given-names></name><name><surname>Frazer</surname> <given-names>K</given-names></name><name><surname>Kalita</surname> <given-names>P</given-names></name><name><surname>Mani</surname> <given-names>P</given-names></name><name><surname>Martin</surname> <given-names>R</given-names></name><name><surname>Moxon</surname> <given-names>ST</given-names></name><name><surname>Paddock</surname> <given-names>H</given-names></name><name><surname>Pich</surname> <given-names>C</given-names></name><name><surname>Schaper</surname> <given-names>K</given-names></name><name><surname>Shao</surname> <given-names>X</given-names></name><name><surname>Singer</surname> <given-names>A</given-names></name><name><surname>Westerfield</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The zebrafish information network: new support for non-coding genes, richer gene ontology annotations and the alliance of genome resources</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D867</fpage><lpage>D873</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1090</pub-id><pub-id pub-id-type="pmid">30407545</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivasubbu</surname> <given-names>S</given-names></name><name><surname>Balciunas</surname> <given-names>D</given-names></name><name><surname>Davidson</surname> <given-names>AE</given-names></name><name><surname>Pickart</surname> <given-names>MA</given-names></name><name><surname>Hermanson</surname> <given-names>SB</given-names></name><name><surname>Wangensteen</surname> <given-names>KJ</given-names></name><name><surname>Wolbrink</surname> <given-names>DC</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Gene-breaking transposon mutagenesis reveals an essential role for histone H2afza in zebrafish larval development</article-title><source>Mechanisms of Development</source><volume>123</volume><fpage>513</fpage><lpage>529</lpage><pub-id pub-id-type="doi">10.1016/j.mod.2006.06.002</pub-id><pub-id pub-id-type="pmid">16859902</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smedley</surname> <given-names>D</given-names></name><name><surname>Haider</surname> <given-names>S</given-names></name><name><surname>Durinck</surname> <given-names>S</given-names></name><name><surname>Pandini</surname> <given-names>L</given-names></name><name><surname>Provero</surname> <given-names>P</given-names></name><name><surname>Allen</surname> <given-names>J</given-names></name><name><surname>Arnaiz</surname> <given-names>O</given-names></name><name><surname>Awedh</surname> <given-names>MH</given-names></name><name><surname>Baldock</surname> <given-names>R</given-names></name><name><surname>Barbiera</surname> <given-names>G</given-names></name><name><surname>Bardou</surname> <given-names>P</given-names></name><name><surname>Beck</surname> <given-names>T</given-names></name><name><surname>Blake</surname> <given-names>A</given-names></name><name><surname>Bonierbale</surname> <given-names>M</given-names></name><name><surname>Brookes</surname> <given-names>AJ</given-names></name><name><surname>Bucci</surname> <given-names>G</given-names></name><name><surname>Buetti</surname> <given-names>I</given-names></name><name><surname>Burge</surname> <given-names>S</given-names></name><name><surname>Cabau</surname> <given-names>C</given-names></name><name><surname>Carlson</surname> <given-names>JW</given-names></name><name><surname>Chelala</surname> <given-names>C</given-names></name><name><surname>Chrysostomou</surname> <given-names>C</given-names></name><name><surname>Cittaro</surname> <given-names>D</given-names></name><name><surname>Collin</surname> <given-names>O</given-names></name><name><surname>Cordova</surname> <given-names>R</given-names></name><name><surname>Cutts</surname> <given-names>RJ</given-names></name><name><surname>Dassi</surname> <given-names>E</given-names></name><name><surname>Di Genova</surname> <given-names>A</given-names></name><name><surname>Djari</surname> <given-names>A</given-names></name><name><surname>Esposito</surname> <given-names>A</given-names></name><name><surname>Estrella</surname> <given-names>H</given-names></name><name><surname>Eyras</surname> <given-names>E</given-names></name><name><surname>Fernandez-Banet</surname> <given-names>J</given-names></name><name><surname>Forbes</surname> <given-names>S</given-names></name><name><surname>Free</surname> <given-names>RC</given-names></name><name><surname>Fujisawa</surname> <given-names>T</given-names></name><name><surname>Gadaleta</surname> <given-names>E</given-names></name><name><surname>Garcia-Manteiga</surname> <given-names>JM</given-names></name><name><surname>Goodstein</surname> <given-names>D</given-names></name><name><surname>Gray</surname> <given-names>K</given-names></name><name><surname>Guerra-Assunção</surname> <given-names>JA</given-names></name><name><surname>Haggarty</surname> <given-names>B</given-names></name><name><surname>Han</surname> <given-names>DJ</given-names></name><name><surname>Han</surname> <given-names>BW</given-names></name><name><surname>Harris</surname> <given-names>T</given-names></name><name><surname>Harshbarger</surname> <given-names>J</given-names></name><name><surname>Hastings</surname> <given-names>RK</given-names></name><name><surname>Hayes</surname> <given-names>RD</given-names></name><name><surname>Hoede</surname> <given-names>C</given-names></name><name><surname>Hu</surname> <given-names>S</given-names></name><name><surname>Hu</surname> <given-names>ZL</given-names></name><name><surname>Hutchins</surname> <given-names>L</given-names></name><name><surname>Kan</surname> <given-names>Z</given-names></name><name><surname>Kawaji</surname> <given-names>H</given-names></name><name><surname>Keliet</surname> <given-names>A</given-names></name><name><surname>Kerhornou</surname> <given-names>A</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Kinsella</surname> <given-names>R</given-names></name><name><surname>Klopp</surname> <given-names>C</given-names></name><name><surname>Kong</surname> <given-names>L</given-names></name><name><surname>Lawson</surname> <given-names>D</given-names></name><name><surname>Lazarevic</surname> <given-names>D</given-names></name><name><surname>Lee</surname> <given-names>JH</given-names></name><name><surname>Letellier</surname> <given-names>T</given-names></name><name><surname>Li</surname> <given-names>CY</given-names></name><name><surname>Lio</surname> <given-names>P</given-names></name><name><surname>Liu</surname> <given-names>CJ</given-names></name><name><surname>Luo</surname> <given-names>J</given-names></name><name><surname>Maass</surname> <given-names>A</given-names></name><name><surname>Mariette</surname> <given-names>J</given-names></name><name><surname>Maurel</surname> <given-names>T</given-names></name><name><surname>Merella</surname> <given-names>S</given-names></name><name><surname>Mohamed</surname> <given-names>AM</given-names></name><name><surname>Moreews</surname> <given-names>F</given-names></name><name><surname>Nabihoudine</surname> <given-names>I</given-names></name><name><surname>Ndegwa</surname> <given-names>N</given-names></name><name><surname>Noirot</surname> <given-names>C</given-names></name><name><surname>Perez-Llamas</surname> <given-names>C</given-names></name><name><surname>Primig</surname> <given-names>M</given-names></name><name><surname>Quattrone</surname> <given-names>A</given-names></name><name><surname>Quesneville</surname> <given-names>H</given-names></name><name><surname>Rambaldi</surname> <given-names>D</given-names></name><name><surname>Reecy</surname> <given-names>J</given-names></name><name><surname>Riba</surname> <given-names>M</given-names></name><name><surname>Rosanoff</surname> <given-names>S</given-names></name><name><surname>Saddiq</surname> <given-names>AA</given-names></name><name><surname>Salas</surname> <given-names>E</given-names></name><name><surname>Sallou</surname> <given-names>O</given-names></name><name><surname>Shepherd</surname> <given-names>R</given-names></name><name><surname>Simon</surname> <given-names>R</given-names></name><name><surname>Sperling</surname> <given-names>L</given-names></name><name><surname>Spooner</surname> <given-names>W</given-names></name><name><surname>Staines</surname> <given-names>DM</given-names></name><name><surname>Steinbach</surname> <given-names>D</given-names></name><name><surname>Stone</surname> <given-names>K</given-names></name><name><surname>Stupka</surname> <given-names>E</given-names></name><name><surname>Teague</surname> <given-names>JW</given-names></name><name><surname>Dayem Ullah</surname> <given-names>AZ</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Ware</surname> <given-names>D</given-names></name><name><surname>Wong-Erasmus</surname> <given-names>M</given-names></name><name><surname>Youens-Clark</surname> <given-names>K</given-names></name><name><surname>Zadissa</surname> <given-names>A</given-names></name><name><surname>Zhang</surname> <given-names>SJ</given-names></name><name><surname>Kasprzyk</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The BioMart community portal: an innovative alternative to large, centralized data repositories</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>W589</fpage><lpage>W598</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv350</pub-id><pub-id pub-id-type="pmid">25897122</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnhammer</surname> <given-names>EL</given-names></name><name><surname>Östlund</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>InParanoid 8: orthology analysis between 273 proteomes, mostly eukaryotic</article-title><source>Nucleic Acids Research</source><volume>43</volume><fpage>D234</fpage><lpage>D239</lpage><pub-id pub-id-type="doi">10.1093/nar/gku1203</pub-id><pub-id pub-id-type="pmid">25429972</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoeger</surname> <given-names>T</given-names></name><name><surname>Gerlach</surname> <given-names>M</given-names></name><name><surname>Morimoto</surname> <given-names>RI</given-names></name><name><surname>Nunes Amaral</surname> <given-names>LA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Large-scale investigation of the reasons why potentially important genes are ignored</article-title><source>PLOS Biology</source><volume>16</volume><elocation-id>e2006643</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.2006643</pub-id><pub-id pub-id-type="pmid">30226837</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thorvaldsdóttir</surname> <given-names>H</given-names></name><name><surname>Robinson</surname> <given-names>JT</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration</article-title><source>Briefings in Bioinformatics</source><volume>14</volume><fpage>178</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1093/bib/bbs017</pub-id><pub-id pub-id-type="pmid">22517427</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinh</surname> <given-names>leA</given-names></name><name><surname>Hochgreb</surname> <given-names>T</given-names></name><name><surname>Graham</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Ruf-Zamojski</surname> <given-names>F</given-names></name><name><surname>Jayasena</surname> <given-names>CS</given-names></name><name><surname>Saxena</surname> <given-names>A</given-names></name><name><surname>Hawk</surname> <given-names>R</given-names></name><name><surname>Gonzalez-Serricchio</surname> <given-names>A</given-names></name><name><surname>Dixson</surname> <given-names>A</given-names></name><name><surname>Chow</surname> <given-names>E</given-names></name><name><surname>Gonzales</surname> <given-names>C</given-names></name><name><surname>Leung</surname> <given-names>HY</given-names></name><name><surname>Solomon</surname> <given-names>I</given-names></name><name><surname>Bronner-Fraser</surname> <given-names>M</given-names></name><name><surname>Megason</surname> <given-names>SG</given-names></name><name><surname>Fraser</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A versatile gene trap to visualize and interrogate the function of the vertebrate proteome</article-title><source>Genes &amp; Development</source><volume>25</volume><fpage>2306</fpage><lpage>2320</lpage><pub-id pub-id-type="doi">10.1101/gad.174037.111</pub-id><pub-id pub-id-type="pmid">22056673</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trinh</surname> <given-names>leA</given-names></name><name><surname>Fraser</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Enhancer and gene traps for molecular imaging and genetic analysis in zebrafish</article-title><source>Development, Growth &amp; Differentiation</source><volume>55</volume><fpage>434</fpage><lpage>445</lpage><pub-id pub-id-type="doi">10.1111/dgd.12055</pub-id><pub-id pub-id-type="pmid">23565993</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uhlén</surname> <given-names>M</given-names></name><name><surname>Fagerberg</surname> <given-names>L</given-names></name><name><surname>Hallström</surname> <given-names>BM</given-names></name><name><surname>Lindskog</surname> <given-names>C</given-names></name><name><surname>Oksvold</surname> <given-names>P</given-names></name><name><surname>Mardinoglu</surname> <given-names>A</given-names></name><name><surname>Sivertsson</surname> <given-names>Å</given-names></name><name><surname>Kampf</surname> <given-names>C</given-names></name><name><surname>Sjöstedt</surname> <given-names>E</given-names></name><name><surname>Asplund</surname> <given-names>A</given-names></name><name><surname>Olsson</surname> <given-names>I</given-names></name><name><surname>Edlund</surname> <given-names>K</given-names></name><name><surname>Lundberg</surname> <given-names>E</given-names></name><name><surname>Navani</surname> <given-names>S</given-names></name><name><surname>Szigyarto</surname> <given-names>CA</given-names></name><name><surname>Odeberg</surname> <given-names>J</given-names></name><name><surname>Djureinovic</surname> <given-names>D</given-names></name><name><surname>Takanen</surname> <given-names>JO</given-names></name><name><surname>Hober</surname> <given-names>S</given-names></name><name><surname>Alm</surname> <given-names>T</given-names></name><name><surname>Edqvist</surname> <given-names>PH</given-names></name><name><surname>Berling</surname> <given-names>H</given-names></name><name><surname>Tegel</surname> <given-names>H</given-names></name><name><surname>Mulder</surname> <given-names>J</given-names></name><name><surname>Rockberg</surname> <given-names>J</given-names></name><name><surname>Nilsson</surname> <given-names>P</given-names></name><name><surname>Schwenk</surname> <given-names>JM</given-names></name><name><surname>Hamsten</surname> <given-names>M</given-names></name><name><surname>von Feilitzen</surname> <given-names>K</given-names></name><name><surname>Forsberg</surname> <given-names>M</given-names></name><name><surname>Persson</surname> <given-names>L</given-names></name><name><surname>Johansson</surname> <given-names>F</given-names></name><name><surname>Zwahlen</surname> <given-names>M</given-names></name><name><surname>von Heijne</surname> <given-names>G</given-names></name><name><surname>Nielsen</surname> <given-names>J</given-names></name><name><surname>Pontén</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Proteomics Tissue-based map of the human proteome</article-title><source>Science</source><volume>347</volume><elocation-id>1260419</elocation-id><pub-id pub-id-type="doi">10.1126/science.1260419</pub-id><pub-id pub-id-type="pmid">25613900</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>UniProt Consortium</collab></person-group><year iso-8601-date="2018">2018</year><article-title>UniProt: a worldwide hub of protein knowledge</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D506</fpage><lpage>D515</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1049</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urasaki</surname> <given-names>A</given-names></name><name><surname>Morvan</surname> <given-names>G</given-names></name><name><surname>Kawakami</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Functional dissection of the Tol2 transposable element identified the minimal cis-sequence and a highly repetitive sequence in the subterminal region essential for transposition</article-title><source>Genetics</source><volume>174</volume><fpage>639</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1534/genetics.106.060244</pub-id><pub-id pub-id-type="pmid">16959904</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varga</surname> <given-names>M</given-names></name><name><surname>Ralbovszki</surname> <given-names>D</given-names></name><name><surname>Balogh</surname> <given-names>E</given-names></name><name><surname>Hamar</surname> <given-names>R</given-names></name><name><surname>Keszthelyi</surname> <given-names>M</given-names></name><name><surname>Tory</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Zebrafish models of rare hereditary pediatric diseases</article-title><source>Diseases</source><volume>6</volume><elocation-id>43</elocation-id><pub-id pub-id-type="doi">10.3390/diseases6020043</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname> <given-names>GK</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Lu</surname> <given-names>J</given-names></name><name><surname>Gildea</surname> <given-names>DE</given-names></name><name><surname>Yang</surname> <given-names>Z</given-names></name><name><surname>Wolfsberg</surname> <given-names>TG</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name><name><surname>Burgess</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>The zebrafish insertion collection (ZInC): a web based, searchable collection of zebrafish mutations generated by DNA insertion</article-title><source>Nucleic Acids Research</source><volume>41</volume><fpage>D861</fpage><lpage>D864</lpage><pub-id pub-id-type="doi">10.1093/nar/gks946</pub-id><pub-id pub-id-type="pmid">23180778</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varshney</surname> <given-names>GK</given-names></name><name><surname>Lu</surname> <given-names>J</given-names></name><name><surname>Gildea</surname> <given-names>DE</given-names></name><name><surname>Huang</surname> <given-names>H</given-names></name><name><surname>Pei</surname> <given-names>W</given-names></name><name><surname>Yang</surname> <given-names>Z</given-names></name><name><surname>Huang</surname> <given-names>SC</given-names></name><name><surname>Schoenfeld</surname> <given-names>D</given-names></name><name><surname>Pho</surname> <given-names>NH</given-names></name><name><surname>Casero</surname> <given-names>D</given-names></name><name><surname>Hirase</surname> <given-names>T</given-names></name><name><surname>Mosbrook-Davis</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>S</given-names></name><name><surname>Jao</surname> <given-names>LE</given-names></name><name><surname>Zhang</surname> <given-names>B</given-names></name><name><surname>Woods</surname> <given-names>IG</given-names></name><name><surname>Zimmerman</surname> <given-names>S</given-names></name><name><surname>Schier</surname> <given-names>AF</given-names></name><name><surname>Wolfsberg</surname> <given-names>TG</given-names></name><name><surname>Pellegrini</surname> <given-names>M</given-names></name><name><surname>Burgess</surname> <given-names>SM</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>A large-scale zebrafish gene knockout resource for the genome-wide study of gene function</article-title><source>Genome Research</source><volume>23</volume><fpage>727</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1101/gr.151464.112</pub-id><pub-id pub-id-type="pmid">23382537</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wangler</surname> <given-names>MF</given-names></name><name><surname>Yamamoto</surname> <given-names>S</given-names></name><name><surname>Chao</surname> <given-names>HT</given-names></name><name><surname>Posey</surname> <given-names>JE</given-names></name><name><surname>Westerfield</surname> <given-names>M</given-names></name><name><surname>Postlethwait</surname> <given-names>J</given-names></name><name><surname>Hieter</surname> <given-names>P</given-names></name><name><surname>Boycott</surname> <given-names>KM</given-names></name><name><surname>Campeau</surname> <given-names>PM</given-names></name><name><surname>Bellen</surname> <given-names>HJ</given-names></name><collab>Members of the Undiagnosed Diseases Network (UDN)</collab></person-group><year iso-8601-date="2017">2017</year><article-title>Model organisms facilitate rare disease diagnosis and therapeutic research</article-title><source>Genetics</source><volume>207</volume><fpage>9</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1534/genetics.117.203067</pub-id><pub-id pub-id-type="pmid">28874452</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westcot</surname> <given-names>SE</given-names></name><name><surname>Hatzold</surname> <given-names>J</given-names></name><name><surname>Urban</surname> <given-names>MD</given-names></name><name><surname>Richetti</surname> <given-names>SK</given-names></name><name><surname>Skuster</surname> <given-names>KJ</given-names></name><name><surname>Harm</surname> <given-names>RM</given-names></name><name><surname>Lopez Cervera</surname> <given-names>R</given-names></name><name><surname>Umemoto</surname> <given-names>N</given-names></name><name><surname>McNulty</surname> <given-names>MS</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Hammerschmidt</surname> <given-names>M</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Protein-Trap insertional mutagenesis uncovers new genes involved in zebrafish skin development, including a neuregulin 2a-Based ErbB signaling pathway required during median fin fold morphogenesis</article-title><source>PLOS ONE</source><volume>10</volume><elocation-id>e0130688</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0130688</pub-id><pub-id pub-id-type="pmid">26110643</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>RJ</given-names></name><name><surname>Collins</surname> <given-names>JE</given-names></name><name><surname>Sealy</surname> <given-names>IM</given-names></name><name><surname>Wali</surname> <given-names>N</given-names></name><name><surname>Dooley</surname> <given-names>CM</given-names></name><name><surname>Digby</surname> <given-names>Z</given-names></name><name><surname>Stemple</surname> <given-names>DL</given-names></name><name><surname>Murphy</surname> <given-names>DN</given-names></name><name><surname>Billis</surname> <given-names>K</given-names></name><name><surname>Hourlier</surname> <given-names>T</given-names></name><name><surname>Füllgrabe</surname> <given-names>A</given-names></name><name><surname>Davis</surname> <given-names>MP</given-names></name><name><surname>Enright</surname> <given-names>AJ</given-names></name><name><surname>Busch-Nentwich</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A high-resolution mRNA expression time course of embryonic development in zebrafish</article-title><source>eLife</source><volume>6</volume><elocation-id>e30860</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.30860</pub-id><pub-id pub-id-type="pmid">29144233</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wierson</surname> <given-names>WA</given-names></name><name><surname>Welker</surname> <given-names>JM</given-names></name><name><surname>Almeida</surname> <given-names>MP</given-names></name><name><surname>Mann</surname> <given-names>CM</given-names></name><name><surname>Webster</surname> <given-names>DA</given-names></name><name><surname>Torrie</surname> <given-names>ME</given-names></name><name><surname>Weiss</surname> <given-names>TJ</given-names></name><name><surname>Kambakam</surname> <given-names>S</given-names></name><name><surname>Vollbrecht</surname> <given-names>MK</given-names></name><name><surname>Lan</surname> <given-names>M</given-names></name><name><surname>McKeighan</surname> <given-names>KC</given-names></name><name><surname>Levey</surname> <given-names>J</given-names></name><name><surname>Ming</surname> <given-names>Z</given-names></name><name><surname>Wehmeier</surname> <given-names>A</given-names></name><name><surname>Mikelson</surname> <given-names>CS</given-names></name><name><surname>Haltom</surname> <given-names>JA</given-names></name><name><surname>Kwan</surname> <given-names>KM</given-names></name><name><surname>Chien</surname> <given-names>CB</given-names></name><name><surname>Balciunas</surname> <given-names>D</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Webber</surname> <given-names>BR</given-names></name><name><surname>Moriarity</surname> <given-names>BS</given-names></name><name><surname>Solin</surname> <given-names>SL</given-names></name><name><surname>Carlson</surname> <given-names>DF</given-names></name><name><surname>Dobbs</surname> <given-names>DL</given-names></name><name><surname>McGrail</surname> <given-names>M</given-names></name><name><surname>Essner</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Efficient targeted integration directed by short homology in zebrafish and mammalian cells</article-title><source>eLife</source><volume>9</volume><elocation-id>e53968</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.53968</pub-id><pub-id pub-id-type="pmid">32412410</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname> <given-names>J</given-names></name><name><surname>Luu</surname> <given-names>A</given-names></name><name><surname>Gapinske</surname> <given-names>M</given-names></name><name><surname>Manandhar</surname> <given-names>S</given-names></name><name><surname>Shirguppe</surname> <given-names>S</given-names></name><name><surname>Woods</surname> <given-names>WS</given-names></name><name><surname>Song</surname> <given-names>JS</given-names></name><name><surname>Perez-Pinera</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Targeted exon skipping with AAV-mediated split Adenine base editors</article-title><source>Cell Discovery</source><volume>5</volume><elocation-id>41</elocation-id><pub-id pub-id-type="doi">10.1038/s41421-019-0109-7</pub-id><pub-id pub-id-type="pmid">31636954</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Gao</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Xue</surname> <given-names>L</given-names></name><name><surname>Clark</surname> <given-names>KJ</given-names></name><name><surname>Ekker</surname> <given-names>SC</given-names></name><name><surname>Du</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Functional analysis of slow myosin heavy chain 1 and myomesin-3 in sarcomere organization in zebrafish embryonic slow muscles</article-title><source>Journal of Genetics and Genomics</source><volume>39</volume><fpage>69</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/j.jgg.2012.01.005</pub-id><pub-id pub-id-type="pmid">22361506</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zerbino</surname> <given-names>DR</given-names></name><name><surname>Achuthan</surname> <given-names>P</given-names></name><name><surname>Akanni</surname> <given-names>W</given-names></name><name><surname>Amode</surname> <given-names>MR</given-names></name><name><surname>Barrell</surname> <given-names>D</given-names></name><name><surname>Bhai</surname> <given-names>J</given-names></name><name><surname>Billis</surname> <given-names>K</given-names></name><name><surname>Cummins</surname> <given-names>C</given-names></name><name><surname>Gall</surname> <given-names>A</given-names></name><name><surname>Girón</surname> <given-names>CG</given-names></name><name><surname>Gil</surname> <given-names>L</given-names></name><name><surname>Gordon</surname> <given-names>L</given-names></name><name><surname>Haggerty</surname> <given-names>L</given-names></name><name><surname>Haskell</surname> <given-names>E</given-names></name><name><surname>Hourlier</surname> <given-names>T</given-names></name><name><surname>Izuogu</surname> <given-names>OG</given-names></name><name><surname>Janacek</surname> <given-names>SH</given-names></name><name><surname>Juettemann</surname> <given-names>T</given-names></name><name><surname>To</surname> <given-names>JK</given-names></name><name><surname>Laird</surname> <given-names>MR</given-names></name><name><surname>Lavidas</surname> <given-names>I</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Loveland</surname> <given-names>JE</given-names></name><name><surname>Maurel</surname> <given-names>T</given-names></name><name><surname>McLaren</surname> <given-names>W</given-names></name><name><surname>Moore</surname> <given-names>B</given-names></name><name><surname>Mudge</surname> <given-names>J</given-names></name><name><surname>Murphy</surname> <given-names>DN</given-names></name><name><surname>Newman</surname> <given-names>V</given-names></name><name><surname>Nuhn</surname> <given-names>M</given-names></name><name><surname>Ogeh</surname> <given-names>D</given-names></name><name><surname>Ong</surname> <given-names>CK</given-names></name><name><surname>Parker</surname> <given-names>A</given-names></name><name><surname>Patricio</surname> <given-names>M</given-names></name><name><surname>Riat</surname> <given-names>HS</given-names></name><name><surname>Schuilenburg</surname> <given-names>H</given-names></name><name><surname>Sheppard</surname> <given-names>D</given-names></name><name><surname>Sparrow</surname> <given-names>H</given-names></name><name><surname>Taylor</surname> <given-names>K</given-names></name><name><surname>Thormann</surname> <given-names>A</given-names></name><name><surname>Vullo</surname> <given-names>A</given-names></name><name><surname>Walts</surname> <given-names>B</given-names></name><name><surname>Zadissa</surname> <given-names>A</given-names></name><name><surname>Frankish</surname> <given-names>A</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Kostadima</surname> <given-names>M</given-names></name><name><surname>Langridge</surname> <given-names>N</given-names></name><name><surname>Martin</surname> <given-names>FJ</given-names></name><name><surname>Muffato</surname> <given-names>M</given-names></name><name><surname>Perry</surname> <given-names>E</given-names></name><name><surname>Ruffier</surname> <given-names>M</given-names></name><name><surname>Staines</surname> <given-names>DM</given-names></name><name><surname>Trevanion</surname> <given-names>SJ</given-names></name><name><surname>Aken</surname> <given-names>BL</given-names></name><name><surname>Cunningham</surname> <given-names>F</given-names></name><name><surname>Yates</surname> <given-names>A</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ensembl 2018</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>D754</fpage><lpage>D761</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1098</pub-id><pub-id pub-id-type="pmid">29155950</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.54572.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Chen</surname><given-names>Wenbiao</given-names></name><role>Reviewing Editor</role><aff><institution>Vanderbilt University</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Chen</surname><given-names>Wenbiao</given-names> </name><role>Reviewer</role><aff><institution>Vanderbilt University</institution><country>United States</country></aff></contrib><contrib contrib-type="reviewer"><name><surname>Cheng</surname><given-names>Keith</given-names> </name><role>Reviewer</role><aff><institution>Penn State College of Medicine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for sending your article entitled &quot;Building the vertebrate codex using the gene breaking protein trap library&quot; for peer review at <italic>eLife</italic> and very sorry for the delay in getting back to you. Your article is being evaluated by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation is being overseen by a Reviewing Editor and Didier Stainier as the Senior Editor.</p><p>Given the list of essential revisions, including new experiments, the editors and reviewers invite you to respond with an action plan and timetable for the completion of the additional work. We plan to share your responses with the reviewers and then advise further with a formal decision. We fully understand that due to the current situation, it is difficult to predict how long the revisions will actually take, but we would still like to get an estimate of how much time you would need if the circumstances were normal.</p><p>Essential revisions:</p><p>1) No direct evidence for protein trapping is provided. The authors provided analysis of the subcellular localization of the protein product of GBT affected genes based on the PANTHER classification system. One of the promised powers of the GBT is the ability to show the subcellular localization of at least some of the affected proteins. Representative images of subcellular localization of mRFP that matches that of the endogenous proteins or PANTHER annotation will further demonstrate the utility of the resources.</p><p>2) The mutagenicity data are based on RP2 work that was published several years ago. The authors emphasize the development of RP8 in the manuscript, yet there are no data supporting that RP8 is as mutagenic as RP2. Although it is likely that they have similar mutagenicity, it is possible that the additional DNA may alter the mutagenicity.</p><p>3) The authors identified a GBT allele in each of 12 previously unannotated protein coding genes. While novel, the authors did not provide support for these claims with evidence such as expression in WT, expression patterns, gene structure, and integration sites. Only referencing the online materials is insufficient.</p><p>4) The manuscript reports 12 embryonic lethal mutations, yet only mentioned the gene name of 6 published mutants. Phenotypic description of the 6 other embryonic lethal mutations will make them a better resource for the community.</p><p>5) The manuscript reports 1200 GBT lines, but only 213 of them have insertion site mapped. Since unmapped lines are less interesting, the authors need to propose a way forward. Are the unmapped lines unmappable, or is there a way forward? If there is a way forward, why was this not already done?</p><p>6) In the Results section, it is difficult for the readers to distinguish published results from unpublished results. The authors need to make them clear.</p><p><italic>Reviewer #1:</italic></p><p>The manuscript reports a resource of more than 1,200 zebrafish mutant lines generated by a gene-trap approach. Some of the collection was generated by improved gene breaking transposons (GBT) that differ from previous published GBT from the group in two ways: 3 vectors that covers all 3 reading frames by the 5' trap and a lens-specific promoter-driven BFP for the 3' trap. One feature of these mutant lines is that each allele carries a mRFP tag allowing live imaging of the expression pattern of the affected gene. The authors have acquired dorsal, ventral, and sagittal images of mRFP signal at 2 and 4 dpf for each allele and uncovered many previous undescribed expression patterns. The images can be accessed on a previously described website. The authors have also cryopreserved each line and deposited one copy of the library at the Zebrafish International Resource Center for distribution. Another feature of these alleles is that they are potentially revertible by Cre. Despite the ease of generating mutations in zebrafish nowadays, these features may still make the collection a useful resource for zebrafish investigators. In addition, these alleles cause &gt;97% reduction of the mRNA and recapitulate published phenotypes in mutant generated using other approaches. Many of the alleles affect genes whose human orthologs have been implicated in diseases. The mutant collection therefore may be a useful resource for human disease modeling and mechanism studies. As an example, the authors characterized muscle Ca<sup>2+</sup> transients in the ryr1b homozygous mutant and demonstrated substantial decrease of the amplitude and increase of rising time of spike, consistent with its known function in regulating sarcoplasmic reticulum Ca<sup>2+</sup> release. In addition, the authors identified a number of novel expressed loci. Overall, the manuscript describes an unique resource important for the zebrafish field and have the potential to accelerate discovery and disease modeling. However, there are still a number of issues that needs to be addressed for making the resources more attractive to other investigators.</p><p>Essential revisions:</p><p>1) One of the claimed advantages of insertional mutagenesis approach is the ease of identification of the affected loci. Knowing the affected gene in a line will tremendously increase its usage. Of the 1200 lines, however, only 213 have the integration site and affected gene determined. These include previously published 40 lines. Yet the authors touted the advantage of their NGS-based cloning pipeline. The reason for the gap is not clearly stated, although the authors mentioned poor genome annotation.</p><p>2) In the Results section, the distinction between published results and new results is not clearly. For example, it seems that the mutagenic efficiency of GBT section is almost entirely based on published data except for irpprc and eef1al1. The same seems to be true for the phenotype appearance rate. The authors should make state clearly what results are new in the manuscript.</p><p>3) The authors claim that mRFP expression enabled them to identify new expression patterns of the trapped gene. At least for expression at 2 dpf, it is not clear if the new expression patterns are due to ectopic expression of mRFP, or incomplete annotation of previous results. They author should provide additional supporting evidence, such as in situ hybridization results, to validate that mRFP recapitulates endogenous mRNA expression patterns.</p><p>4) The authors claimed that they identified 13 novel genes but did not provide additional supporting evidence other than the detection of fusion transcripts. More information, such as additional expression evidence of these genes and the existence of their orthologs in human or other species would provide more confidence.</p><p><italic>Reviewer #2:</italic></p><p>Nine out of every 10 human genes has yet to be functionally characterized. To address this issue, Ichino et al. designed and tested several generations of gene trap constructs for probing expression pattern and gene function in the powerful vertebrate model system, the zebrafish. The work presented explains the design of an extremely clever three reading frame, fluorescently tagged and experimentally revertible splice acceptor-based gene trap vector, which they call the gene-break transposon protein trap (&quot;GBT system&quot;). The injection of vector and transposase into zebrafish eggs yielded some 1200 insertion lines in a powerful model system, the zebrafish. Heterozygous insertions yield normal expression pattern through larval development (and potentially beyond); homozygosing these mutagenizing insertions yields mutant fish whose phenotypes yield functional insights. This work lays a powerful foundation for potentially studying the expression patterns and functions of every gene in the vertebrate genome. The results include the discovery of previously unknown expression patterns for 91% of their trapped genes, based on imaging at 4 days post-fertilization. Mutant lines were shown to phenocopy existing mutants, and include models of human genetic disease. Overall, they authors present a compelling basis for consideration of the &quot;vertebrate codex&quot; – a term I find compelling.</p><p>Introduction: The Abstract was well-written, but the last sentence of the Introduction is overstated. Since phenotyping is dependent upon assays that may or may not have been used, it would seem more accurate to say something like, &quot;…this GBT system lays a foundation for functional annotation of the vertebrate genome…&quot; It would also add clarity to community thinking to explicitly note that mutant phenotyping is a key to functional annotation of genes.</p><p>Subsection “GBT protein trapping generates a variety of potential models of human disease”: The consideration of RYR1 in discussion would better be placed in one, not two, sections. The degree of repetition should be reduced.</p><p>Subsection “Gene-break transposon system as a next generation mutagenesis system”: The limitations of the old gene trap lines were already explained in the Results section. Emphasis in the Discussion section should focus on benefits of the new system.</p><p>Subsection “Gene-break transposon system as a next generation mutagenesis system”: The second paragraph seems to repeat what is in the Results section.</p><p>Figure 4: There is a striking degree of overlap in the beeswarm plots. It would be helpful to make the utility of these results more clear or to perhaps detail only the key aspects of the model, enough to be convincing of the focus of the paper – the novelty and utility of the gene-break transposon approach.</p><p><italic>Reviewer #3:</italic></p><p>The authors published a paper describing a protein trap screen in 2011 in which they collected 350 patterns and characterized 40 lines extensively (Table 1 in the 2011 paper). The current manuscript is the expansion of the previous work. In this manuscript, (1) they constructed new protein trap vectors, (2) they collected 1200 lines (patterns) and performed molecular characterization of 213 lines (GBT-confirmed lines), (3) based on the trapped gene information, they grouped the trap lines from views of human diseases, ontology, and subcellular localization, (4) calcium imaging using the ryr1b mutant. This should have been a lot of work and the resources will be useful to the community. However, the advances made since work published in 2011 are unclear.</p><p>1) They constructed RP2 series vectors that contained RFP gene in three frames. Also, the RP8 series vectors have RFP in three frames and the crystalline promoter. I admit this is an interesting idea. However when one of them was used for injection, introns which cannot be targeted by the other vectors may be targeted, but at the same time it cannot target introns which can be targeted by the other vectors. Thus, a set of new vectors may increase coverage of the genome, but I do not think the modifications affect effectiveness of the mutagenesis screen. Also, the number of insertions created by using each vector is too small to evaluate the vectors and their idea. They need to mention such limitations.</p><p>2) In Supplementary file 1, most (nearly all) of the lines were created by using RP2.1. Since the authors reported the other new vectors, they need to evaluate those vectors with actual data (trapping events and efficiencies, etc). They need to show the power of these vectors.</p><p>3) Their indication of &quot;97% knockdown efficiency&quot; was already described in the 2011 paper. In this manuscript, since they constructed new RP8 series, they should measure the efficiencies of these vectors and discuss in comparison with the RP2 series.</p><p>4) In this manuscript, they described the nature of the traps mainly by based on the gene information (in relation to human disease genes, gene ontology (PANTHER), and subcellular localization). The power of this system is visualization of subcellular localization of the trapped protein. The expression patterns can be visualized without the protein trap mechanism. They need to show the data for subcellular localization of a certain number of the trapped proteins (at least more than 10?). They should show co-localization of the fusion protein and endogenous protein if the antibody is available.</p><p>5) ryr1b gene and mutants had been extensively reported by Hirata et al., (2007) and by themselves (Clark et al., 2011). What is new here is calcium imaging of muscle activities in the ryr1b mutant. However, the same result was obtained and described in Hirata et al., (2007) by electrophysiology. Thus, the novelty is poor. They should describe analysis of another gene which was not described previously.</p><p>6) They identified 12 homozygous lethal mutants, but I do not see any data for this. The authors should show the data. 5 mutants they mentioned in the text were already described in the previous manuscript.</p><p>7) In Table 3, they say they identified 12 new previously-unannotated genes. What are those genes? and how they were trapped by the vector? More data should be shown.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.54572.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) No direct evidence for protein trapping is provided. The authors provided analysis of the subcellular localization of the protein product of GBT affected genes based on the PANTHER classification system. One of the promised powers of the GBT is the ability to show the subcellular localization of at least some of the affected proteins. Representative images of subcellular localization of mRFP that matches that of the endogenous proteins or PANTHER annotation will further demonstrate the utility of the resources.</p></disp-quote><p>We certainly appreciate the concern about subcellular localization data gained through GBT protein trapping. In our previous work, the subcellular localizations have, in most cases, been consistent with what is expected. These observations lead us to perform the new analyses based upon PANTHER and Human Protein Atlas instead using a high resolution imaging approach. We realize that we did not explicitly state this or cite these previous publications in this section. In the revision, we have added citations to our previous work and our rational for these analyses.</p><p>Similarly, we agree that showing some new protein trapping expression data, especially some that we can relate to our PANTHER and/or Human Protein Atlas analyses, is useful for readers. We have therefore included confocal images of the GBT-confirmed lines GBT0235 (<italic>lrpprc</italic>) and GBT0348 (<italic>ryr1b</italic>) to highlight distinctive subcellular localization patterns at the top of the revised Figure 6. The human ortholog of <italic>lrpprc</italic> maps to mitochondria in Human Protein Atlas, but fails to map to a PANTHER class. The human ortholog of <italic>ryr1b</italic> maps to the cytosol, Golgi, and vesicles in Human Protein Atlas and is classified as a transporter in PANTHER analysis. We have also added additional confocal images that show distinct subcellular localizations in GBT-candidate lines and GBT lines to further demonstrate protein trapping in these lines in Figure 6—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>2) The mutagenicity data are based on RP2 work that was published several years ago. The authors emphasize the development of RP8 in the manuscript, yet there are no data supporting that RP8 is as mutagenic as RP2. Although it is likely that they have similar mutagenicity, it is possible that the additional DNA may alter the mutagenicity.</p></disp-quote><p>We acknowledge that the RP2 mutagenicity data is an aggregate of prior work plus GBT0235 (<italic>lrpprc</italic>). However, given the regular questions we have received on this innovative mutagen, we took the opportunity to conduct and present this novel analysis compiling our mutagenicity data and the comparison to other protein trapping methods. We also describe here the first description of the two additional RP2-based vectors with only a single nucleotide difference from RP2.1 to enable the capture in any protein reading frame.</p><p>The RP8 variants were built for two reasons – to avoid the use of GFP as a reporter and to be a modular molecular cassette for others to use (i.e. with non-transposon genetic engineering methods such as GeneWeld targeted integration, (Wierson et al., 2018)). We report that the protein trap component is functioning as expected (and 18 of the GBT-confirmed lines we present contain RP8 integrations). We also included the same 1.6kb poly(A)/presumptive scaffold attachment transcriptional termination cassette we showed to be effective mutagens with the PX and RP2 vectors. Given that the major functional change to RP8 lies in its 3’ exon trap, we expect its mutagenicity to be similar to RP2, but we don’t have the data to confirm that it is the same at this time. We therefore have explicitly acknowledged in the revisions (subsection “Gene-break transposon system as a next generation mutagenesis system”) that we have not performed the analyses of RP8 mutagenicity and kept the RP8 vector description with this caveat.</p><disp-quote content-type="editor-comment"><p>3) The authors identified a GBT allele in each of 12 previously unannotated protein coding genes. While novel, the authors did not provide support for these claims with evidence such as expression in WT, expression patterns, gene structure, and integration sites. Only referencing the online materials is insufficient.</p></disp-quote><p>We appreciate the interest in the previously unannotated transcripts. We have spent additional time analyzing these loci using additional publicly available resources, our own in-house RNA-Seq datasets and GRCz10. We focused on WT embryos at 4 different developmental stages, 36 hpf, 48 hpf, and 4 dpf (Data source: ftp://ftp.ensembl.org/pub/data_files/danio_rerio/ across). The detail of this analysis is described in the revised method section. At the end of this additional work, we were able to resolved 7 lines (GBT0148, GBT0264, GBT0724, GBT1024, GBT1100 and GBT1168) into new cloned loci with likely transcripts (in the revised Supplementary file 1). In total, we resolved 7 out of these 10 unannotated GBT lines (in the revision) and moved this into our main catalog. Since we have informed genomic location of all 204 integration loci in the revised Supplementary file 1, we removed the previous Table 3 with the redundancy. We have also removed the individual section discussing Table 3. Instead, we have added the following text:</p><p>In subsection “Molecular cloning of a subset of GBT lines highlights the genetic diversity of this protein trap collection”, “A small subset of these GBT-confirmed lines mapped to areas in the genome without annotated transcripts. Publicly available RNA-sequencing data revealed reads flanking a majority of these mapped integrations. Some of these reads contained evidence of splicing in the sense orientation of the mRFP reporter (Supplementary file 1)”.</p><p>In subsection “GBT protein trapping provides the basis for annotation of functionally diverse proteins and novel transcripts mapped on poorly assembled genomic regions” it now reads, “We indeed found that 10 population of GBT integrations in the confirmed lines (with mRFP expression) failed to map to any predicted gene. However, RNA sequencing reads in public datasets identified potential unannotated coding sequences aligned with these GBT integration loci (Supplementary file 1). While 5' and 3' RACE are necessary to confirm the mRNA fusion products, these unannotated coding sequences represent the possibility to annotate novel, protein-coding transcripts in these GBT lines. Therefore, GBT protein trapping can find, illuminate expression, and elucidate in vivo functions of novel genes and/or gene variants in poorly annotated regions of reference genomes”.</p><disp-quote content-type="editor-comment"><p>4) The manuscript reports 12 embryonic lethal mutations, yet only mentioned the gene name of 6 published mutants. Phenotypic description of the 6 other embryonic lethal mutations will make them a better resource for the community.</p></disp-quote><p>Phenotypic descriptions definitely make a line particularly valuable for the community. A number of these lines with embryonic phenotypes have been cloned and published following this initial forward genetic screening assessment. Further, additional non-embryonic phenotypes have been discovered in some GBT-confirmed lines. Overall, 17 of our GBT-confirmed lines have been published or characterized to have a phenotype, ranging from embryonic lethal to reduced adult viability to differences in drug susceptibility. We have therefore created a new table (Supplementary file 2 in the revision) that contains the GBT-confirmed line number, zebrafish gene symbol, a description of the phenotype observed, and a reference to the publication where that has been described to make this information readily available to the readers. We added the following text in the Phenotype appearance in GBT lines is comparable to other mutagenic technologies for forward genetic screening section of the results: “To date, 17 of our GBT-confirmed lines have been published with homozygous phenotypes ranging from embryonic lethal, to reduced adult viability, to differences in pharmacological susceptibility (Supplementary file 2). Additional GBT-confirmed lines with homozygous phenotypes will continue to be identified and characterized”.</p><disp-quote content-type="editor-comment"><p>5) The manuscript reports 1200 GBT lines, but only 213 of them have insertion site mapped.</p></disp-quote><p>Mapping confirmation is a technical throughput bottleneck in our work due to its multi-step and the artisanal nature of this process: (1) Initial isolation of a candidate genomic sequence (this was conducted in a parallel molecular screening process). (2) Manual design of primers to this genomic sequence and linkage confirmation to mRFP against cDNA generated from mRFP-positive embryos/larvae.</p><p>We understand that ~200 out of 1200 lines may have been portrayed as a small contribution, but every single of the 147 new lines reported here were all manually confirmed using this time-intensive process. We take this comment as an opportunity to elaborate on the number of new GBT-confirmed lines that this manuscript offers the community. We thus added text to emphasize the following points. (1) Before this manuscript, we and our collaborators had published 57 total GBT-confirmed lines across five studies. (2) The present study alone provides an additional 147 unique GBT-confirmed lines, including 15 GBT lines that had been used in previous studies without their trapped genes being mapped. Many of these new GBT-confirmed lines stemmed from successful confirmation of GBT-candidate lines mapped with our next-generation sequencing pipeline.</p><disp-quote content-type="editor-comment"><p>Since unmapped lines are less interesting, the authors need to propose a way forward. Are the unmapped lines unmappable, or is there a way forward? If there is a way forward, why was this not already done?</p></disp-quote><p>The next-generation sequencing pipeline revealed candidate genes for an additional 144 GBT lines in the revision. These lines have simply not undergone the comprehensive manual confirmation/cloning process but have a full way forward to molecular isolation (as do all of the other hundreds of lines with only a described expression pattern). Indeed, between methods like inverse/splinkerette PCR and 5’ and 3’ RACE, we are confident nearly all protein trap lines can be readily mapped and confirmed. We have added an explicit section with the following description, “Gene-break protein trap library is a rich resource for the community” in the discussion on the road forward for (1) 144 candidate lines and (2) over 800 GBT lines with a novel expression pattern for any member of the zebrafish community. “Taken together, GBT-based mRFP-reporters demonstrate how much we still have left to understand about the expression patterns of the overall proteome and, ultimately, the complex codex that is our genome. Even at the relatively well-studied 2-dpf stage, nearly 40% of GBT-confirmed lines elucidated novel gene expression data (Figure 7). Cataloging these expression patterns enables investigators to make collections of lines with expression in their cell/tissue of interest and/or a phenotype. The remaining 144 GBT-candidate lines and over 800 GBT lines represent a rich resource for genomic discoveries. For any GBT-candidate or GBT lines of interest, a similar cloning pipeline (Figure 2) can be employed to identify the GBT integration locus. In addition, the refinement of the zebrafish genome will enhance our ability to complete the annotation from GBT-line to GBT-confirmed line for any given line with a desired expression profile and/or phenotype. Together, this 1,200+ GBT-line collection is a new contribution for using zebrafish to annotate the vertebrate genome.”</p><disp-quote content-type="editor-comment"><p>6) In the Results section, it is difficult for the readers to distinguish published results from unpublished results. The authors need to make them clear.</p></disp-quote><p>We thank the editor/reviewers for this comment! We realize in our compendium mindset and the nature of how we wrote this paper as an overview that we made it very difficult to distinguish published data from novel results. We appreciate the opportunity to focus on highlighting the new data that we present. We have therefore prioritized clear separation of published and unpublished results. We have taken the following actions in a revised manuscript to better assist readers in finding new data in this manuscript:</p><p>1) At the beginning of the third paragraph of the Introduction, we changed the wording from “with a single GBT protein trap construct” to “In the original GBT protein trap construct” to signal to previous work that we have published. We also denoted RP2.1 as the “original” GBT protein trap construct in the remainder of the paper.</p><p>2) In the middle of the third paragraph of the Introduction, we modified the sentence to include the word “new” when referring to the constructs generated in this paper. In the same sentence, we changed from stating “over 1200” to “over 800 additional” to acknowledge the cumulative nature of the project while highlighting the new numbers in this paper as follows: “Alongside the original, we employed these new vectors in zebrafish to generate and catalog over 800 additional GBT protein trap lines with visible mRFP expression at 2 dpf (end of embryogenesis) or 4 dpf (larval stage)”. We also employ “over 800 additional” instead of “over 1200” when first describing the creation of the collection of the GBT lines in this manuscript.</p><p>3) In the last half of the third paragraph of the Introduction, we only highlight new analyses and data presented in this manuscript and remove any reference to data that has been previously published to give readers and overview to focus on the novel work in this paper.</p><p>4) We added a key citation to (Clark et al., 2011) in the middle of the second paragraph of subsection “GBT vector series RP2 and RP8 illuminate all three vertebrate proteomic reading frames” that provides the motivation to develop GBT constructs that trap expression in all three reading frames and to develop RP8 with a new 3’ exon trap.</p><p>5) We revised the end of the second paragraph of subsection “GBT vector series RP2 and RP8 to illuminate all three vertebrate proteomic reading frames” to be consistent with Figure 1—figure supplement 1 and only demonstrate the new expression off of RP2.2, RP2.3 and the RP8 series as follows: “Using all five of these new GBT constructs in zebrafish, we conducted an initial screen for expression of protein trap mRFP and observed that all RP2 and RP8 series constructs readily produced mRFP fusion proteins expressed from their endogenous promoters (Figure 1—figure supplement 1)”.</p><p>6) We specified how many of the GBT-confirmed lines in the 200+ collection are newly published as confirmed lines in this manuscript at the beginning of the subsection “Molecular cloning of a subset of GBT lines highlights the genetic diversity of this protein trap collection” as follows: “147 of these GBT-confirmed lines are newly characterized in this manuscript and were selected for confirmation based upon their expression pattern and/or homozygous phenotype (Supplementary file 1)”.</p><p>7) Under subsection “RP2.1 induces high knockdown efficiency of endogenous transcripts in GBT-confirmed lines” , we clarified that this section is the result of data compilation from previous publications with one additional dataset in the RP2.1 group as follows: “We wanted to know the knockdown efficacy of the GBT system as a quantitative assessment of mutagenicity. We therefore compiled qRT-PCR data to compare wild-type and truncated, mRFP-fused transcript levels for all 26 RP2.1-derived GBT-confirmed lines that we and others have tested (Clark et al., 2011; Ding et al., 2013; Ding et al., 2016), GBT0235 (RP2.1)—this manuscript). This compilation determined at minimum 97% knockdown in animals homozygous for the RP2.1 alleles”.</p><p>8) We now point out data that has been published before that is being reported in the Results section using words such as “published”, “compiled”, “initial”, “original”, “previously”, “reported”, and “previous study”.</p><p>9) Where unpublished data is juxtaposed with published data, we explicitly point out the unpublished data using words such as “new”, “additional”, “novel”, “in this study”, and “novel approach”.</p><p>10) While Figure 5 and Figure 6 do include some previously published GBT-confirmed lines, the analysis of human disease-associated genes, PANTHER classification, and subcellular localization via Human Protein Atlas are all new for this manuscript.</p><p>11) Figure 7 also represents a compilation of the entire GBT-confirmed line collection. However, all images in this figure are newly described and the comparison between zfishbook and ZFIN is entirely novel.</p><disp-quote content-type="editor-comment"><p>Reviewer #1:</p><p>The manuscript reports a resource of more than 1,200 zebrafish mutant lines generated by a gene-trap approach. Some of the collection was generated by improved gene breaking transposons (GBT) that differ from previous published GBT from the group in two ways: 3 vectors that covers all 3 reading frames by the 5' trap and a lens-specific promoter-driven BFP for the 3' trap. One feature of these mutant lines is that each allele carries a mRFP tag allowing live imaging of the expression pattern of the affected gene. The authors have acquired dorsal, ventral, and sagittal images of mRFP signal at 2 and 4 dpf for each allele and uncovered many previous undescribed expression patterns. The images can be accessed on a previously described website. The authors have also cryopreserved each line and deposited one copy of the library at the Zebrafish International Resource Center for distribution. Another feature of these alleles is that they are potentially revertible by Cre. Despite the ease of generating mutations in zebrafish nowadays, these features may still make the collection a useful resource for zebrafish investigators. In addition, these alleles cause &gt;97% reduction of the mRNA and recapitulate published phenotypes in mutant generated using other approaches. Many of the alleles affect genes whose human orthologs have been implicated in diseases. The mutant collection therefore may be a useful resource for human disease modeling and mechanism studies. As an example, the authors characterized muscle Ca<sup>2+</sup> transients in the ryr1b homozygous mutant and demonstrated substantial decrease of the amplitude and increase of rising time of spike, consistent with its known function in regulating sarcoplasmic reticulum Ca<sup>2+</sup> release. In addition, the authors identified a number of novel expressed loci. Overall, the manuscript describes an unique resource important for the zebrafish field and have the potential to accelerate discovery and disease modeling. However, there are still a number of issues that needs to be addressed for making the resources more attractive to other investigators.</p><p>Essential revisions:</p><p>1) One of the claimed advantages of insertional mutagenesis approach is the ease of identification of the affected loci. Knowing the affected gene in a line will tremendously increase its usage. Of the 1200 lines, however, only 213 have the integration site and affected gene determined. These include previously published 40 lines. Yet the authors touted the advantage of their NGS-based cloning pipeline. The reason for the gap is not clearly stated, although the authors mentioned poor genome annotation.</p></disp-quote><p>We have added context for these 200plus lines and a discussion on the way forward for the unmapped lines.</p><p>Mapping confirmation is a technical throughput bottleneck in our work due to its multi-step and the artisanal nature of this process: (1) Initial isolation of a candidate genomic sequence (this was conducted in a parallel molecular screening process). (2) Manual design of primers to this genomic sequence and linkage confirmation to mRFP against cDNA generated from mRFP-positive embryos/larvae.</p><p>We understand that ~200 out of 1200 lines may have been portrayed as a small contribution, but every single of the 147 new lines reported here were all manually confirmed using this time-intensive process. We take this comment as an opportunity to elaborate on the number of new GBT-confirmed lines that this manuscript offers the community. We thus added text to emphasize the following points. (1) Before this manuscript, we and our collaborators had published 57 total GBT-confirmed lines across five studies. (2) The present study alone provides an additional 147 unique GBT-confirmed lines, including 15 GBT lines that had been used in previous studies without their trapped genes being mapped. Many of these new GBT-confirmed lines stemmed from successful confirmation of GBT-candidate lines mapped with our next-generation sequencing pipeline.</p><disp-quote content-type="editor-comment"><p>2) In the Results section, the distinction between published results and new results is not clearly. For example, it seems that the mutagenic efficiency of GBT section is almost entirely based on published data except for irpprc and eef1al1. The same seems to be true for the phenotype appearance rate. The authors should make state clearly what results are new in the manuscript.</p></disp-quote><p>We acknowledge that the mutagenicity data, with the exception of <italic>lrpprc</italic>, was compiled from previous publications. We have added signal words to state which results represent new data and which rely on previously published information. Please see “Essential revision 2 and Essential revision 6”. In addition, we quantified the expression levels of <italic>eef1al1</italic> as a reference gene to normalize the expression level of <italic>lrpprc</italic> in both WT and <italic>lrpprc</italic> mutant animals. (Please see the Materials and methods section.)</p><disp-quote content-type="editor-comment"><p>3) The authors claim that mRFP expression enabled them to identify new expression patterns of the trapped gene. At least for expression at 2 dpf, it is not clear if the new expression patterns are due to ectopic expression of mRFP, or incomplete annotation of previous results. They author should provide additional supporting evidence, such as in situ hybridization results, to validate that mRFP recapitulates endogenous mRNA expression patterns.</p></disp-quote><p>We acknowledge that this point is ambiguous due to the nature of the word “description” in this section of the results that could mean additional (possibly ectopic) expression, incomplete annotation of previous images, or novel expression for genes without any known expression patterns. This analysis was performed to highlight genes that our GBT-confirmed lines provided the first publicly available expression patterns. We have therefore modified wording to explicitly say, “Our GBT-confirmed lines revealed expression patterns (available on www.zfishbook.org) for 67 genes at 2 dpf and 173 genes at 4 dpf without publicly available expression data in ZFIN”.</p><disp-quote content-type="editor-comment"><p>4) The authors claimed that they identified 13 novel genes but did not provide additional supporting evidence other than the detection of fusion transcripts. More information, such as additional expression evidence of these genes and the existence of their orthologs in human or other species would provide more confidence.</p></disp-quote><p>We appreciate the interest in the previously unannotated transcripts. We have spent additional time analyzing these loci using additional publicly available resources, our own in-house RNA-Seq datasets and GRCz10. We focused on WT embryos at 4 different developmental stages, 36 hpf, 48 hpf and 4 dpf (Data source: ftp://ftp.ensembl.org/pub/data_files/danio_rerio/ across). The detail of this analysis is described in the revised method section. At the end of this additional work, we were able to resolved 7 lines (GBT0148, GBT0264, GBT0724, GBT1024, GBT1100 and GBT1168) into new cloned loci with likely transcripts (in the revised Supplementary file 1). In total, we resolved 7 out of these 10 unannotated GBT lines (in the revision) and moved this into our main catalog. Since we have informed genomic location of all 204 integration loci in the revised Supplementary file 1, we removed the previous Table 3 with the redundancy. We have also removed the individual section discussing Table 3. Instead, we have added the following text:</p><p>In subsection “Molecular cloning of a subset of GBT lines highlights the genetic diversity of this protein trap collection”, “A small subset of these GBT-confirmed lines mapped to areas in the genome without annotated transcripts. Publicly available RNA-sequencing data revealed reads flanking a majority of these mapped integrations. Some of these reads contained evidence of splicing in the sense orientation of the mRFP reporter (Supplementary file 1)”.</p><p>In subsection “GBT protein trapping provides the basis for annotation of functionally diverse proteins and novel transcripts mapped on poorly assembled genomic regions” it now reads, “We indeed found that 10 population of GBT integrations in the confirmed lines (with mRFP expression) failed to map to any predicted gene. However, RNA sequencing reads in public datasets identified potential unannotated coding sequences aligned with these GBT integration loci (Supplementary file 1). While 5' and 3' RACE are necessary to confirm the mRNA fusion products, these unannotated coding sequences represent the possibility to annotate novel, protein-coding transcripts in these GBT lines. Therefore, GBT protein trapping can find, illuminate expression, and elucidate in vivo functions of novel genes and/or gene variants in poorly annotated regions of reference genomes”.</p><disp-quote content-type="editor-comment"><p>Reviewer #2:</p><p>Nine out of every 10 human genes has yet to be functionally characterized. To address this issue, Ichino et al. designed and tested several generations of gene trap constructs for probing expression pattern and gene function in the powerful vertebrate model system, the zebrafish. The work presented explains the design of an extremely clever three reading frame, fluorescently tagged and experimentally revertible splice acceptor-based gene trap vector, which they call the gene-break transposon protein trap (&quot;GBT system&quot;). The injection of vector and transposase into zebrafish eggs yielded some 1200 insertion lines in a powerful model system, the zebrafish. Heterozygous insertions yield normal expression pattern through larval development (and potentially beyond); homozygosing these mutagenizing insertions yields mutant fish whose phenotypes yield functional insights. This work lays a powerful foundation for potentially studying the expression patterns and functions of every gene in the vertebrate genome. The results include the discovery of previously unknown expression patterns for 91% of their trapped genes, based on imaging at 4 days post-fertilization. Mutant lines were shown to phenocopy existing mutants, and include models of human genetic disease. Overall, they authors present a compelling basis for consideration of the &quot;vertebrate codex&quot; – a term I find compelling.</p><p>Introduction: The Abstract was well-written, but the last sentence of the Introduction is overstated. Since phenotyping is dependent upon assays that may or may not have been used, it would seem more accurate to say something like, &quot;…this GBT system lays a foundation for functional annotation of the vertebrate genome…&quot; It would also add clarity to community thinking to explicitly note that mutant phenotyping is a key to functional annotation of genes.</p></disp-quote><p>We have modified the last sentence of the Introduction to state, “Since detailed investigations of mutant phenotypes are vital to functional annotation of the vertebrate genome, the mutagenic reporters in our GBT system provide the basis for this functional annotation to better understand normal biology and human disease”.</p><disp-quote content-type="editor-comment"><p>Subsection “GBT protein trapping generates a variety of potential models of human disease”: The consideration of RYR1 in the Discussion section would better be placed in one, not two, sections. The degree of repetition should be reduced.</p></disp-quote><p>We have condensed these two sections into one to link the consideration of our <italic>ryr1b</italic> results with <italic>RYR1</italic> mutations in humans and the implications this has for future disease modeling with GBT-confirmed lines.</p><disp-quote content-type="editor-comment"><p>Subsection “Gene-break transposon system as a next generation mutagenesis system”: The limitations of the old gene trap lines were already explained in the Results section. Emphasis in the Discussion section should focus on benefits of the new system.</p></disp-quote><p>We have modified subsection “Gene-break transposon system as a next generation mutagenesis system” to highlight the benefits of the new system and its applications toward future genome engineering approaches using the RP8 series.</p><disp-quote content-type="editor-comment"><p>Subsection “Gene-break transposon system as a next generation mutagenesis system”: The second paragraph seems to repeat what is in the Results section.</p></disp-quote><p>We have modified subsection “Gene-break transposon system as a next generation mutagenesis system” to be less repetitive with what is in the Results section.</p><disp-quote content-type="editor-comment"><p>Figure 4: There is a striking degree of overlap in the beeswarm plots. It would be helpful to make the utility of these results more clear or to perhaps detail only the key aspects of the model, enough to be convincing of the focus of the paper – the novelty and utility of the gene-break transposon approach.</p></disp-quote><p>We have further explained our basis for including the violin plots of both amplitude, peak-width at half-max, rise time, and decay time. We have also modified this section to focus on validating the GBT system as a way to functionally annotate the genome with a comparison of our GBT <italic>ryr1b</italic> allele to the previously published <italic>relatively relaxed</italic> allele.</p><disp-quote content-type="editor-comment"><p>Reviewer #3:</p><p>The authors published a paper describing a protein trap screen in 2011 in which they collected 350 patterns and characterized 40 lines extensively (Table 1 in the 2011 paper). The current manuscript is the expansion of the previous work. In this manuscript, (1) they constructed new protein trap vectors, (2) they collected 1200 lines (patterns) and performed molecular characterization of 213 lines (GBT-confirmed lines), (3) based on the trapped gene information, they grouped the trap lines from views of human diseases, ontology, and subcellular localization, (4) calcium imaging using the ryr1b mutant. This should have been a lot of work and the resources will be useful to the community. However, the advances made since work published in 2011 are unclear.</p><p>1) They constructed RP2 series vectors that contained RFP gene in three frames. Also, the RP8 series vectors have RFP in three frames and the crystalline promoter. I admit this is an interesting idea. However when one of them was used for injection, introns which cannot be targeted by the other vectors may be targeted, but at the same time it cannot target introns which can be targeted by the other vectors. Thus, a set of new vectors may increase coverage of the genome, but I do not think the modifications affect effectiveness of the mutagenesis screen. Also, the number of insertions created by using each vector is too small to evaluate the vectors and their idea. They need to mention such limitations.</p></disp-quote><p>We acknowledge that a single vector cannot be a one size fits all solution for all introns. We have added a sentence in the Discussion section to explicitly point out that each vector can only target a subset of introns as follows, “While each individual construct still only integrates in-frame in a subset of introns, the RP2 series potentiates in-frame mRFP for any intron with Tol2-mediated integration”. We also explicitly highlight that having all three reading frames available offers the highest utility for future targeted integration approaches using RP8 as follows, “The three reading frames and modularity of the RP8 series are especially well suited to targeted integration approaches”.</p><disp-quote content-type="editor-comment"><p>2) In Supplementary file 1, most (nearly all) of the lines were created by using RP2.1. Since the authors reported the other new vectors, they need to evaluate those vectors with actual data (trapping events and efficiencies, etc). They need to show the power of these vectors.</p></disp-quote><p>We acknowledge that nearly all lines were made using RP2.1 and all of the mutagenicity data conducted using RP2.1. We also describe here the first description of the two additional RP2-based vectors with only a single nucleotide difference from RP2.1 to enable the capture in any protein reading frame. We show effective protein trapping with all RP2 series and RP8 series vectors.</p><disp-quote content-type="editor-comment"><p>3) Their indication of &quot;97% knockdown efficiency&quot; was already described in the 2011 paper. In this manuscript, since they constructed new RP8 series, they should measure the efficiencies of these vectors and discuss in comparison with the RP2 series.</p></disp-quote><p>The RP8 variants were built for two reasons – to avoid the use of GFP as a reporter and to be a modular molecular cassette for others to use (i.e. with non-transposon genetic engineering methods such as GeneWeld targeted integration, (Wierson et al., 2018)). We report that the protein trap component is functioning as expected (and 18 of the GBT-confirmed lines we present contain RP8 integrations). We also included the same 1.6kb poly(A)/presumptive scaffold attachment transcriptional termination cassette we showed to be effective mutagens with the PX and RP2 vectors. Given that the major functional change to RP8 lies in its 3’ exon trap, we expect its mutagenicity to be similar to RP2, but we don’t have the data to confirm that it is the same at this time. We therefore have explicitly acknowledged in subsection “Gene-break transposon system as a next generation mutagenesis system” that we have not performed the analyses of RP8 mutagenicity and kept the RP8 vector description with this caveat.</p><disp-quote content-type="editor-comment"><p>4) In this manuscript, they described the nature of the traps mainly by based on the gene information (in relation to human disease genes, gene ontology (PANTHER), and subcellular localization). The power of this system is visualization of subcellular localization of the trapped protein. The expression patterns can be visualized without the protein trap mechanism. They need to show the data for subcellular localization of a certain number of the trapped proteins (at least more than 10?). They should show co-localization of the fusion protein and endogenous protein if the antibody is available.</p></disp-quote><p>We certainly appreciate the concern about subcellular localization data gained through GBT protein trapping. In our previous work, the subcellular localizations have, in most cases, been consistent with what is expected. These observations lead us to perform the new analyses based upon PANTHER and Human Protein Atlas instead using a high resolution imaging approach. We realize that we did not explicitly state this or cite these previous publications in this section. In the revision, we have added citations to our previous work and our rational for these analyses.</p><p>Similarly, we agree that showing some new protein trapping expression data, especially some that we can relate to our PANTHER and/or Human Protein Atlas analyses, is useful for readers. We have therefore included confocal images of the GBT-confirmed lines GBT0235 (<italic>lrpprc</italic>) and GBT0348 (<italic>ryr1b</italic>) to highlight distinctive subcellular localization patterns at the top of the revised Figure 6. The human ortholog of <italic>lrpprc</italic> maps to mitochondria in Human Protein Atlas, but fails to map to a PANTHER class. The human ortholog of <italic>ryr1b</italic> maps to the cytosol, Golgi, and vesicles in Human Protein Atlas and is classified as a transporter in PANTHER analysis. We have also added additional confocal images that show distinct subcellular localizations in GBT-candidate lines and GBT lines to further demonstrate protein trapping in these lines in Figure 6—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>5) ryr1b gene and mutants had been extensively reported by Hirata et al., (2007) and by themselves (Clark et al., 2011). What is new here is calcium imaging of muscle activities in the ryr1b mutant. However, the same result was obtained and described in Hirata et al., (2007) by electrophysiology. Thus, the novelty is poor. They should describe analysis of another gene which was not described previously.</p></disp-quote><p>The inadvertent omission to the prior and excellent Hirata paper has been corrected. Hirata et al., 2007 did a calcium imaging approach to assess the muscle specific phenotype but only quantified peak amplitude.(Hirata et al., 2007) We additionally quantified kinetic parameters in our calcium imaging data. Further, we have re-emphasized these experiments primarily serving as validation study rather than bringing substantial novel data to the table.</p><disp-quote content-type="editor-comment"><p>6) They identified 12 homozygous lethal mutants, but I do not see any data for this. The authors should show the data. 5 mutants they mentioned in the text were already described in the previous manuscript.</p></disp-quote><p>We have developed a table (Supplementary file 2 in the revision) characterizing all published mutants generated with the GBT system to date.</p><disp-quote content-type="editor-comment"><p>7) In Table 3, they say they identified 12 new previously-unannotated genes. What are those genes? and how they were trapped by the vector? More data should be shown.</p></disp-quote><p>We appreciate the interest in the previously unannotated transcripts. We have spent additional time analyzing these loci using additional publicly available resources, our own in-house RNA-Seq datasets and GRCz10. We focused on WT embryos at 4 different developmental stages, 36 hpf, 48 hpf and 4 dpf (Data source: ftp://ftp.ensembl.org/pub/data_files/danio_rerio/ across). The detail of this analysis is described in the revised method section. At the end of this additional work, we were able to resolved 7 lines (GBT0148, GBT0264, GBT0724, GBT1024, GBT1100 and GBT1168) into new cloned loci with likely transcripts (in the revised Supplementary file 1). In total, we resolved 7 out of these 10 unannotated GBT lines (in the revision) and moved this into our main catalog. Since we have informed genomic location of all 204 integration loci in the revised Supplementary file 1, we removed the previous Table 3 with the redundancy. We have also removed the individual section discussing the previous Table 3. Instead, we have added the following text:</p><p>Subsection “Molecular cloning of a subset of GBT lines highlights the genetic diversity of this protein trap collection”, “A small subset of these GBT-confirmed lines mapped to areas in the genome without annotated transcripts. Publicly available RNA-sequencing data revealed reads flanking a majority of these mapped integrations. Some of these reads contained evidence of splicing in the sense orientation of the mRFP reporter (Supplementary file 1)”.</p><p>Subsection “GBT protein trapping provides the basis for annotation of functionally diverse proteins and novel transcripts mapped on poorly assembled genomic regions” now reads, “We indeed found that 10 population of GBT integrations in the confirmed lines (with mRFP expression) failed to map to any predicted gene. However, RNA sequencing reads in public datasets identified potential unannotated coding sequences aligned with these GBT integration loci (Supplementary file 1). While 5' and 3' RACE are necessary to confirm the mRNA fusion products, these unannotated coding sequences represent the possibility to annotate novel, protein-coding transcripts in these GBT lines. Therefore, GBT protein trapping can find, illuminate expression, and elucidate in vivo functions of novel genes and/or gene variants in poorly annotated regions of reference genomes”.</p></body></sub-article></article>